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 High rates of comorbidity have been reported between PTSD and musculoskeletal 
pain (e.g., Asmundson & Hadjistavropolous, 2006; Asmundson et al., 1998).  Comorbid 
PTSD and chronic pain have been associated with elevated levels of affective distress, 
greater perceptions of pain, interference in daily activities, and high rates of disability 
(Otis et al., 2003; Sherman et al., 2000).  Overall, comorbid conditions of PTSD and 
chronic pain are associated with large personal costs for the individual and economic 
costs for society. 
 The triple vulnerability model was originally proposed to account for anxiety 
symptoms in general, and it was later applied to the specific development of PTSD 
(Barlow, 2000; Barlow, 2002; Keane & Barlow, 2002).  Otis and colleagues (2003) 
further proposed that the triple vulnerability model may account for the relationship 
between PTSD and chronic pain.  According to the triple vulnerability model, individuals 
must present with a generalized biological, generalized psychological, and a specific 
psychological vulnerability for either of these conditions to develop (Keane & Barlow, 
2002; Otis et al., 2003). 

  
 In the current study, aspects of the triple vulnerability model were examined 
within the following groups of women: women who have PTSD without chronic pain (n 
= 11), women who have musculoskeletal pain without PTSD (n = 10), women with both 
PTSD and musculoskeletal pain (n = 10), and women without PTSD and chronic pain (n 
= 15).  Cortisol reactivity and anxious mood were assessed before and after the Trier 
Social Stress Task (TSST).  Participants also completed questionnaires to assess for other 
potential indicators of the triple vulnerability model.  
 Results indicate that: 1) the roles of generalized biological, generalized 
psychological, and specific psychological vulnerabilities toward developing PTSD were 
supported; 2) limited findings supported the potential role of these vulnerabilities toward 
developing chronic pain; however, results of these measures were not similar to that of 
PTSD (e.g., family history of chronic pain); 3) it is not thought that PTSD and chronic 
pain are associated with the same vulnerabilities; 4) having a diagnosis of PTSD and 
chronic pain was associated with an increase in symptoms across many measures utilized 
in the current study.   
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Chapter 1 
INTRODUCTION 
 Recently, there has been widespread interest among professionals in the 
behavioral medicine and medical communities regarding the relationship of chronic pain 
and anxiety.  In particular, high comorbidity rates have been observed among individuals 
with chronic pain and posttraumatic stress disorder (PTSD).  Among individuals who are 
seeking treatment for chronic pain, approximately 20% to 34% of these individuals are 
also thought to report high levels of PTSD symptomatology or have an actual PTSD 
diagnosis (Asmundson, Norton, Allerdings, Norton, & Larsen, 1998; Geisser, Roth, 
Bachman, & Eckert, 1996).  Within the fibromyalgia population in particular, 
approximately 56% of individuals tend to report symptoms associated with PTSD, and 
approximately 21% report actual comorbid diagnoses of fibromyalgia and PTSD (Amir et 
al., 1997; Cohen et al., 2002; Sherman, Turk, & Okifuji, 2000).  Thus, high levels of 
PTSD symptomatology are reported within the chronic pain population. 
In studies that assess for the frequency of pain symptomatology within PTSD 
populations, even higher comorbidity rates have been found (Otis, Pincus, & Keane, 
2006).  Furthermore, physical symptoms of pain are thought to be the most commonly 
reported symptoms within the PTSD population, even when different types of traumatic 
events are taken into account (e.g., military combat, motor vehicle accident, or sexual 
assault; Asmundson, Coons, Taylor, & Katz, 2002).  Among community samples, 
approximately 20% to 30% of individuals with PTSD are thought to develop different 
forms of chronic musculoskeletal pain (i.e., general pain conditions that influence 
muscles, ligaments, tendons, and bones), and such estimates are dramatically increased 
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within military populations (Asmundson, & Hadjistavropolous, 2006).  For example, 
multiple regression analyses were used to assess for the effects of exposure to war-zone 
environments on PTSD and health within 109 female Vietnam veterans (Wolfe, Schnurr, 
Brown, and Furey, 1994).  Results indicated that PTSD was the strongest predictor of 
poor health outcomes (Wolfe et al., 1994).  In addition, both PTSD and fibromyalgia 
have been found to occur more frequently in female populations (Otis, Keane, & Kerns, 
2003).   
 Comorbid conditions of PTSD and chronic pain are also associated with other 
difficulties (e.g., perceived levels of pain, affective distress, interference in daily 
activities, higher rates of disability; Otis et al., 2003).  Within a sample of fibromyalgia 
patients who were seeking treatment, those who also reported PTSD symptomatology 
tended to report more significant amounts of pain, interference in their life, emotional 
distress, and inactivity.  In addition, more than 85% of this subsample with both 
fibromyalgia and PTSD reported high levels of disability, as opposed to 50% of the 
subsample that did not report PTSD symptomatology (Sherman et al., 2000).  In a female 
chronic pain population, comorbid reports of childhood sexual abuse were correlated with 
increased chances of receiving a surgical procedure (Finestone et al., 2000).  Overall, 
comorbid conditions of PTSD and chronic pain are associated with higher pain intensity, 
psychological distress, disability, and medical utilization.   
 With such high rates of comorbidity, and subsequent costs to the individual and 
society, it is imperative to assess for potential mechanisms that account for such 
relationships.  Although several models have been proposed to account for the 
relationship between chronic pain and PTSD, limited empirical research has been 
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conducted to provide support for these models.  Even though the theoretical 
underpinnings for these models were based on empirical research to varying degrees, 
many of the models were originally proposed to account for another population and then 
later adapted to account for the relationship of PTSD and chronic pain (e.g., triple 
vulnerability model).  Thus, no studies to date have tested these theoretical models in 
their entirety (Otis et al., 2003).  Prior to discussing specific theories that account for the 
high comorbidity rates between PTSD and chronic pain, the conceptual basis for 
understanding both PTSD and chronic pain individually is presented.   
Posttraumatic Stress Disorder: General Characteristics 
Diagnostic Criteria 
 PTSD was first introduced as a formal psychiatric diagnosis in the third version of 
the Diagnostic and Statistical Manual in 1980 (DSM-III; American Psychiatric 
Association [APA], 1980).  Since this time, the amount of literature that addresses 
various aspects of PTSD has increased significantly (Khouzam, Ghafoori, & Hierholzer, 
2005).  Currently, PTSD is characterized by the experience of a traumatic event, and 
associated feelings of intense helplessness and fear during the time of the event (DSM-
IV-TR; APA, 2000).  Traumatic events are characterized by the direct and personal 
exposure to an extremely distressing event, with subsequent responses involving personal 
perceptions of extreme fear, helplessness, or horror.  In addition, PTSD is characterized 
by re-experiencing aspects of the traumatic event (e.g., flashbacks, nightmares regarding 
the traumatic event), avoidance of stimuli that serve as reminders of the traumatic event 
(e.g., people, places), arousal symptomatology (e.g., hypervigilance), and clinically 
significant levels of distress and interference.  In terms of duration, symptoms must 
  4   
persist for at least one month (APA, 2000).  For many individuals, symptoms associated 
with PTSD tend to diminish within three months of experiencing the traumatic event; 
however, individuals who experience symptomatology for longer than three months tend 
to report fairly stable and chronic symptoms in the absence of any intervention (Resick & 
Calhoun, 2001). 
Prevalence and Demographics 
 Rates of traumatic events are extremely high in the United States.  Within the 
general population, approximately 90% of individuals will experience a traumatic event 
(e.g., car accidents, interpersonal violence, natural disaster, or a combat related event) 
during their lifetime (Breslau et al., 1998). Furthermore, data from the National 
Comorbidity Study (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995) revealed that 
approximately 20.4% of females and 8.1% of males go on to develop PTSD following the 
experience of a traumatic event.  These researchers also found that approximately 7.8% 
of the general population will develop PTSD within their lifetime (Kessler et al., 1995).  
Within the Primary Care Anxiety Project (Bruce et al., 2001; Weisberg et al., 2002), a 
multi-site longitudinal study looking at anxiety disorders, approximately 12% of 1500 
primary care patients met criteria for PTSD.  It is clear that many individuals who 
experience a traumatic event will not go on to develop PTSD.  Thus, the sole experience 
of a traumatic event is not necessarily adequate to account for the development of PTSD 
symptomatology.  Other vulnerability factors must be present for the disorder to develop 
(Brewin, Andrews, & Valentine, 2000). 
 Although prevalence rates of PTSD may vary slightly across different 
populations, women have consistently been found to be twice as likely to develop PTSD 
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than men (e.g., Kessler et al., 1995; Khouzam et al, 2005).  Many hypotheses have been 
proposed to account for these differential rates of PTSD.  One hypothesis is that women 
may be more likely to develop PTSD as a result of the nature of their traumatic event 
(Schnurr, Friedman, & Bernardy, 2002).  According to research on this topic, women 
report experiencing greater frequencies of being raped, sexual molestation, and childhood 
abuse (Schnurr et al., 2002).  Within the National Comorbidity Study, men were more 
likely to report witnessing someone being badly injured or killed, being involved in a fire, 
flood, or natural disaster, being physically attacked, combat related experiences, or being 
threatened with a weapon, held captive, or kidnapped.  Conversely, women were more 
likely to report being raped, sexually molested, neglected by their parents during 
childhood, and being physically abused during childhood (Kessler et al., 1995).  Such 
qualitative differences in reports of traumatic events by men and women may influence 
prevalence rates of PTSD. 
 Although most PTSD research focuses on younger individuals, rates of 
interpersonal traumatic events are also reported within older populations of women.  In a 
study that surveyed 842 women who were 60 years of age or older, rates of abuse were 
still highly prevalent (Fisher & Regan, 2006).  In this sample, 47% of the women 
reported experiencing one or more types of abuse since they were 55 years of age.  In 
particular, 45% of the women reported experiencing psychological/emotional abuse, 12% 
were threatened by somebody, 4% were physically abused and 3% were sexually abused 
(Fisher & Regan, 2006).  These results lend support to the hypothesis that women may be 
more likely to develop PTSD due to the interpersonal nature of many traumatic events 
that they experience compared to men. 
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 Conversely, other researchers argue that women still experience higher rates of 
PTSD after the type of trauma is taken into account (Wong & Yehuda, 2002).  In 
addition, the researchers reported that the higher rates of PTSD in women cannot be 
accounted for by mere exposure to a traumatic event as men are just as likely to 
experience a traumatic event as women.  Gender differences in PTSD development were 
found to be significantly greater if an individual’s trauma occurred before they were 15 
years old (Wong & Yehuda, 2002).  Consequently, the age at which an individual 
experiences a traumatic event may play a large role in PTSD development. 
Many other risk factors for PTSD have also been proposed and debated by 
various researchers (e.g., Khouzam et. al, 2005; Resick & Calhoun, 2001; Tanriverdi, 
Karaca, Unluhizarci, & Kelestimur, 2007; Wong & Yehuda, 2002).  Resick and Calhoun 
(2001) proposed that women may be at a greater risk in the development of PTSD 
because of a biological predisposition in addition to the types of traumas that they 
experience.  In particular, the hypothalamic-pituitary-adrenal axis (HPA axis) has gained 
increasing attention in accounting for PTSD symptomatology.  In general, human 
responses to stress can be largely accounted for by HPA axis functioning (Tanriverdi et 
al., 2007).  Other risk factors may include: lower educational attainment, pre-existing 
psychopathology, early conduct problems, family history of psychopathology, severity of 
initial reaction to the trauma, peritraumatic dissociation, poor social support, history of 
stress or abuse, and early separation from parents (Khouzam et. al, 2005; Wong & 
Yehuda, 2002).  Overall, it is clear that biological, psychological, and social factors may 
all play a role in PTSD development.  
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 As might be expected, PTSD is associated with a very high cost to society.  Not 
only are individuals with PTSD frequently seen within mental health care settings 
(Khouzam et al., 2005), they are even more likely to seek medical care (Gillock, Zayfert, 
Hegel, & Ferguson, 2005).  According to a study by Gillock and colleagues (2005), 
individuals with a diagnosis of PTSD, and those with subsyndromal PTSD symptoms, 
tend to visit their primary care office more frequently over a 3-month period than 
individuals without PTSD.  In addition, PTSD is associated with more severe physical 
symptoms and worse physical functioning with regards to bodily pain, role limitations, 
and general health perceptions (Gillock et al., 2005; Zayfert, Dums, Ferguson, & Hegel, 
2002).  An increase in medical utilization and health related problems is thought to 
partially result from biological changes and physical symptoms that develop out of 
perpetual nervous system activation following the experience of a traumatic event 
(Butterfield & Becker, 2002; Gillock et al., 2005; McFarlane, 2000; Yehuda, 2002).  
Furthermore, prolonged stress and nervous system activation have been shown to reduce 
immune system functioning in both humans and animals (Chiarmonte, 1997; Khouzam et 
al., 2005).  It is clear that the effects of PTSD are costly with regard to physical effects on 
the body and health care utilization.  
Chronic Pain: General Characteristics 
Diagnostic Criteria 
 Pain is defined as the experience of unpleasant sensory and emotional symptoms 
(Merskey, & Bogduk, 1994; Staud, 2004).  Pain is typically conceptualized as being 
either acute or chronic in nature.  When pain is defined as acute, it is generally caused by 
tissue damage (e.g., wound, broken limb) from an injury (Taylor, 2006).  Given that the 
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experience of pain can help alert the body to tissue damage; it is thought to play an 
adaptive role in day to day functioning.  Furthermore, the experience of pain helps to 
motivate an individual to react in a way that may decrease the risk of potential damage 
and to also recover from its effects (Wall, 1978).  Subsequently, pain from this type of 
tissue damage tends to abate as the body repairs the damage.  However, pain that begins 
as an acute episode does not always lessen with treatment and time (Taylor, 2006).  
When pain persists for three or more months and becomes a chronic condition 
(International Association for the Study of Pain, 1986), it is thought to lose its adaptive 
functioning, and can create a significant amount of distress and impairment (APA, 2000).  
Consequently, the experience of pain is often associated with interference, feelings of 
little control over pain symptoms, depression, and anxiety (Lautenbacher, Spernal, 
Schreiber, & Krieg, 1999; Maxwell, Gatchel, & Mayer, 1998; Plehn, Peterson, & 
Williams, 1998).  Pain behaviors may also be rewarded when individuals receive special 
attention from their family or friends (Osterhaus, Lang, Linssen, & Passchier, 1997).  It is 
not surprising that pain is viewed as a very complex experience, with physiological, 
psychological, social, and behavioral influences (Taylor, 2006). 
 Musculoskeletal pain entails widespread pain involving the muscles and skeleton.  
According to the American College of Rheumatology (1990), widespread pain is defined 
as pain that is experienced above and below the waist, on the right and left sides of the 
body, or axial skeletal pain.  Fibromyalgia, in particular, is characterized as the 
experience of widespread pain with tenderness in 11 or more of the 18 specified tender 
points (see Figure 1.1 for a diagram of tender point locations).  Tender points are defined 
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as the experience of severe tenderness upon palpation (American College of 
Rheumatology, 1990).   
Figure 1.1 Fibromyalgia tender point locations (Slavkin, 1997). 
 
 
Although there are numerous forms of musculoskeletal pain, research has 
demonstrated that similar mechanisms (to different magnitudes) play a role in both 
fibromyalgia and other forms of chronic musculoskeletal pain (Bennett, 1998; Carli, 
Suman, Biasi, Marcolongo, 2002; Granges & Littlejohn, 1993).  It has been difficult to 
detect laboratory or radiographic abnormalities that may be used in the assessment of 
musculoskeletal pain.  Overall, little is known about the etiology of musculoskeletal pain 
conditions.   
Researchers have hypothesized that the HPA axis may play a role in the 
development of musculoskeletal pain conditions (e.g., fibromyalgia; Crofford et al., 
2004).  High concentrations of Substance-P, a neurotransmitter associated with pain 
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levels, have also been found to be associated with fibromyalgia diagnoses (Clauw & 
Crofford, 2003; Russell et al., 1994).  With respect to psychological factors, it has 
frequently been reported that symptoms of musculoskeletal pain begin or worsen during 
times of physical or emotional stress (Crofford et al., 2004).  In addition, fibromyalgia is 
frequently associated with childhood and lifetime experiences of physical, sexual, and 
verbal abuse (e.g., Finestone et al., 2000; Goldberg & Goldstein, 2000).  The lengthy and 
stressful process that individuals may go through to be diagnosed with fibromyalgia often 
leaves women feeling as though they are being judged as imagining their symptoms 
(Asbring & Narvanen, 2002; Zavestoski et al., 2004).  Thus, there may be a relationship 
between stress, HPA activity, and symptoms of musculoskeletal pain. 
Prevalence and Demographics 
 Pain is a leading cause of health care utilization in the United States that accounts 
for more than 70 million (80%) visits to physicians every year (Koch, 1986).  According 
to The National Institute of Health, more than 50 million Americans experience various 
forms of pain, leading to more than 100 billion dollars in health care costs (as cited in 
Litcher-Kelly, Martino, Broderick, & Stone, 2007).  Of these individuals who experience 
pain, approximately 17% are experiencing chronic pain (Gureje, 1998).  According to 
epidemiological research, 4.9 million individuals are seeking treatment for their chronic 
pain condition (Marketdata Enterprises, 1999).  Furthermore, approximately 7% of the 
general population report having experienced chronic pain within the last 12 months 
(McWilliams, Cox, & Enns, 2003). 
 Musculoskeletal pain is one of the most frequent forms of chronic pain, and is 
also one of the primary causes of disability in the United States (Davis, Zautra, & Reich, 
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2001).  Fibromyalgia, one of the common types of musculoskeletal pain, is estimated to 
occur in approximately 2% of the population, and is about nine times more likely to 
develop within the female population.  Prevalence rates of fibromyalgia have also been 
found to increase as individuals get older, with approximately 7% of women who are 
between 60 and 79 years of age reporting symptoms of fibromyalgia (Wolfe, Ross, 
Anderson, Russell, & Hebert, 1995).  On average, individuals with fibromyalgia receive 
services from an outpatient physician approximately 10 times per year, costing 
approximately $2,200 for these visits (Wolfe et al., 1997).  Furthermore, up to 25% of 
individuals with fibromyalgia report being on disability (Wolfe, 1996), and symptoms 
tend to persist with little change over long periods of time (Forseth, Forre, & Gran, 1999; 
Norregaard, Bulow, Prescott, Jacobsen, & Danneskiold-Samsoe, 1993; Wigers, 1996).  
Musculoskeletal pain and fibromyalgia, in particular, represent very frequent and 
debilitating chronic pain conditions within the female population.   
Pain Sensitivity  
 Pain sensitivity is often operationalized as tenderness to pain (e.g., Montoya, 
Pauli, Batra, Wiedemann, 2005; Petzke Clauw, Ambrose, Khine, & Gracely).  A 
diagnosis of fibromyalgia is based upon the existence of tender points and their 
sensitivity to touch (American College of Rheumatology, 1990); however, this sensitivity 
to touch is not necessarily limited to these specific tender points, and pain sensitivity is 
frequently reported throughout the whole body (Petzke et al., 2003; Scudds, Rollman, 
Harth, & McCain, 1987; Wolfe et al., 1995).   
 Many factors have been proposed to alter levels of pain sensitivity within 
fibromyalgia populations.  Stress, in particular, has frequently been shown to perpetuate 
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levels of pain within individuals with fibromyalgia (Van Houdenhove & Egle, 2004), and 
people that have a diagnosis of chronic pain tend to report higher levels of environmental 
stressors, general stress, and psychological distress than individuals without chronic pain 
(Naidoo & Pillay, 1994).  Furthermore, factors associated with stress (i.e., anxiety, 
depression, irritability) may perpetuate pain related symptoms of fibromyalgia and 
subsequent levels of disability (Winfield, 1999).  Pain sensitivity may also be enhanced 
as a result of hypervigilance to bodily sensations (Lorenz, Grasedyck, & Bromm, 1996; 
McDermid, Rollman, & McCain, 1996; Chang, Mayer, Johnson, FitzGerald, & Naliboff, 
2000); however, some researchers still argue that no differences in body vigilance reports 
are demonstrated between individuals with fibromyalgia and individuals without the 
diagnosis (e.g., Peters, Vlaeyen, & van Drunen, 2000).  Higher levels of pain 
catastrophizing have been found to be associated with lower pain thresholds and 
tolerance for pain within fibromyalgia populations (Geisser, Casey, Brucksch, Ribbins, 
Appleton, & Crofford, 2003).  Similarly, hypervigilance to pain has been positively 
correlated with pain intensity, negative affectivity, and catastrophizing about pain 
conditions (Crombez, Eccleston, Van den Broeck, Goubert, & Van Houdenhove, 2004).  
Overall, many psychological factors have been found to worsen pain sensitivity within 
fibromyalgia populations.   
Theoretical Models of Comorbid PTSD and Chronic Pain 
 Although there are high comorbidity rates between PTSD and chronic pain, few 
factors have been identified to account for these high prevalence rates.  To date, three 
models have been proposed to account for the comorbidity of PTSD and chronic pain: the 
mutual maintenance model (Sharp & Harvey, 2001), the shared vulnerability model 
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(Asmundson et al., 2002), and the triple vulnerability model (Otis et al., 2006).  Although 
some aspects of these models have been supported in research, no studies have tested the 
complete models (Otis et al., 2006).  Given that the triple vulnerability model accounts 
for biological, psychological, and social aspects of PTSD and chronic pain development, 
the current study will test aspects of this model.  
Mutual Maintenance Model  
 According to the mutual maintenance model (Sharp & Harvey, 2001), there are 
seven components of both PTSD and chronic pain that may work together to mutually 
maintain or worsen the symptoms of one another.  Furthermore, these components 
interact to further worsen an individual’s distress and disability from each condition.  
First, attentional biases resulting from a PTSD diagnosis are thought to cue individuals in 
to potentially threatening or painful stimuli.  In both conditions, individuals may have an 
unrealistically high expectation of confronting or experiencing threatening stimuli (Sharp 
& Harvey, 2001).  Conflicting research has been demonstrated regarding the role of 
attentional biases in PTSD.  When compared to individuals that did not develop PTSD 
following a traumatic event, Vietnam veterans with PTSD did not take longer to process 
threat related words (McNally, Amir, & Lipke, 1996).  However, many other researchers 
have demonstrated that individuals with PTSD do demonstrate attentional biases for 
threat related words (e.g., Bryant & Harvey, 1997; Buckley, Blanchard, & Neill, 2000; 
Foa, Feske, Murdock, Kozak, & McCarthy, 1991; Harvey, Bryant, & Rapee, 1996).  
Research has also found that participants with PTSD tend to overestimate the probability 
of re-experiencing a traumatic event (Warda & Bryant, 1998).  Similarly, participants 
with a chronic pain condition tend to overestimate the likelihood of pain symptomatology 
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and re-injury (McCracken, Gross, Sorg, & Edmunds, 1993).  Consequently, attentional 
biases towards painful stimuli may serve to amplify pain symptomatology.  Research 
assessing response latencies among individuals with chronic pain have tended to be 
slightly more conflicting with regard to the existence of attentional biases (Beck, 
Freeman, Shipherd, Hamblen, & Lackner, 2001).  Only one study (Beck et al., 2001) 
assessed and provided support for the role of attentional biases within a population of 
individuals with comorbid chronic pain and PTSD.  However, the sample was limited to 
individuals who had developed chronic pain following a motor vehicle accident.  Overall, 
preliminary research tends to support the role of attentional biases in PTSD, although 
more conflicting results have been demonstrated in the chronic pain population. 
  Second, anxiety sensitivity is hypothesized to serve as a vulnerability factor for 
both PTSD and chronic pain conditions (Sharp & Harvey, 2001).  Anxiety sensitivity 
refers to the fear of symptoms of arousal that may develop from misattributions regarding 
the potential harmfulness of various sensations (Reiss & McNally, 1985).  In particular, 
individuals may be fearful of public displays of anxiety, cognitive dyscontrol, or bodily 
sensations (Taylor, 2004). High levels of anxiety sensitivity may lead individuals to 
misinterpret and catastrophize physiological symptoms that are associated with both 
chronic pain and PTSD (Sharp & Harvey, 2001).  
 According to a previous hypothesis (Taylor, 2004), anxiety sensitivity may 
increase following the experience of a traumatic event, and this increased level of anxiety 
sensitivity may then heighten the experience of PTSD symptoms (Taylor, 2004).  Not 
only has anxiety sensitivity been found to intensify an individual’s emotional response to 
various stimuli, but it has also been found to be associated with PTSD severity (Taylor, 
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2004).  In a study that assessed anxiety sensitivity in children and adolescents (ages 8 to 
15) five years after the experience of an earth quake, anxiety sensitivity levels were found 
to predict PTSD symptomatology (Kilic, Kilic, & Yilmaz, 2008).  Overall, research 
suggests that there may be a relationship between anxiety sensitivity and PTSD 
symptoms. 
 Support for the role of anxiety sensitivity in pain perception has generally come 
from non-clinical undergraduate populations (Stewart & Asmundson, 2006).  In a study 
that assessed for pain experiences within high and low anxiety sensitivity groups, 90 
female undergraduate students were administered a cold pressor task.  Results 
demonstrated that no significant differences were reported between both groups with 
respect to pain threshold, pain recovery, or pain tolerance following a cold pressor task.  
Conversely, the high anxiety sensitivity group reported greater perceptions of pain and 
fear of pain.  Thus, the relationship between anxiety sensitivity and pain intensity is 
thought to be mediated by fear (Uman, Stewart, Watt, & Johnson, 2006).  Although 
elevated anticipatory anxiety may not be specific to pain; individuals with high anxiety 
sensitivity have been found to report greater anticipatory anxiety prior to the experience 
of a painful stimulus (Conrod, 2006).  Finally, a treatment study focusing on high and 
low anxiety sensitivity groups provided evidence for the role of anxiety sensitivity in pain 
related anxiety.  Following a cognitive-behavioral treatment plan for anxiety sensitivity, 
pain-related anxiety was found to lessen (Watt, Stewart, Lefaivre, & Uman, 2006). 
 Research on anxiety sensitivity and attentional biases has indicated that high 
levels of anxiety sensitivity are associated with color naming interference for physical 
threat words (Stewart, Conrod, Gignac, & Pihl, 1998).  Conversely, other researchers 
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have reported that neither high nor low levels of anxiety sensitivity are associated with 
response latencies for physical threat words in the emotional Stroop task.  It has been 
hypothesized that they may have obtained null results because they did not include 
participants that had experienced panic attacks, whereas Stewart and colleagues (1998) 
did include participants who had experienced panic attacks (McNally, Hornig, Hoffman, 
& Han, 1999).  In another study, a physical threat subscore on the anxiety sensitivity 
index was created and was examined for attentional biases within participants with high, 
moderate, and low physical threat anxiety sensitivity.  These researchers also utilized the 
visual dot probe task instead of the modified Stroop task.  Results indicated that high 
levels of physical threat anxiety sensitivity were associated with attentional biases for 
anxiety related words (Hunt, Keogh, & French, 2006).   
Third, physiological symptoms of pain may serve as a reminder of the traumatic 
event.  One study reported that individuals who have experienced a traumatic event tend 
to report experiencing increased symptoms of panic, and subsequently fear these panic 
related symptoms (Falsetti & Resnick, 1997). In particular, they may fear experiencing 
physiological symptoms such as increased heart rate and numbness and tingling 
sensations (Falsetti & Resnick, 1997).  Arousal responses may lead individuals to further 
avoid activities that increase pain levels and that remind an individual of his or her 
trauma (Sharp & Harvey, 2001).  PTSD research has demonstrated that various reminders 
of a traumatic event may initiate further arousal and PTSD symptomatology (Blanchard, 
Kolb, Gerardi, Ryan, & Pallmeyer, 1986).  Furthermore, the experience of a traumatic 
event has been associated with the onset of chronic pain conditions (e.g., Finestone et al., 
2000; Goldberg & Goldstein, 2000).   
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Fourth, such avoidance may initially lower feared symptomatology; however, 
prolonged behavioral and cognitive avoidance may lead to additional physical and 
anxiety symptomatology.  Evidence for this claim has been supported in both the PTSD 
and chronic pain literature (e.g., Harvey & Bryant, 1998; Sharp, 2001).  One study 
assessed for cognitive avoidance (i.e., suppression of trauma related memories) in 
individuals with acute stress disorder (n = 24) and in a control group (n = 24).  Results 
suggested that attempts to suppress trauma-related thoughts in the acute stress disorder 
group were associated with a greater increase in ratings of anxiety and more frequent 
anxious thoughts than the control group (Harvey & Bryant, 1998).  In chronic pain 
populations, behavior avoidance of physical activities has been associated with decreases 
in physical functioning and increased levels of disability (Waddell et al., 1993).  Thus, 
preliminary evidence has supported the role of behavioral and cognitive avoidance in the 
perpetuation of PTSD and chronic pain symptomatology. 
Fifth, individuals with either PTSD or chronic pain frequently experience 
symptoms of depression as well.  Symptoms of depression have been found to be highly 
prevalent in samples that have comorbid conditions of PTSD and chronic pain (Roy-
Byrne, Smith, Goldberg, Afari, & Buchwald, 2004).  It is commonly known that fatigue 
is a diagnostic symptom for major depressive disorder (APA, 2000).  Greater symptoms 
of fatigue have been associated with decreased participation in physical activities within a 
fibromyalgia sample (Rutledge, Jones, & Jones, 2007).  Thus, symptoms of fatigue and 
lethargy from depression may result in decreased participation in various activities, which 
may then help to maintain or worsen PTSD and pain symptomatology.     
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Sixth, perception of pain may increase due to anxiety associated with PTSD, 
further limiting participation in activities (i.e., activities involving physical exercise; 
Sharp & Harvey, 2001).  Although researchers have not assessed for increased pain 
perceptions within PTSD samples, research has indicated that self-perceptions of pain are 
increased by the experience of anxiety (e.g., Difede, Jaffe, Musngi, Perry, & Yurt, 1997).  
Seventh, high levels of cognitive demands associated with both conditions (i.e., 
catastrophic cognitions and recurrent thoughts of trauma) may limit the use of adaptive 
coping strategies (i.e., cognitive restructuring; Sharp & Harvey, 2001).  Further 
information regarding the use of various coping strategies in PTSD and chronic pain 
populations will be provided below. 
Given that many aspects of the mutual maintenance model are indirectly 
supported in the PTSD and chronic pain literature, it may hold some promising results as 
an explanatory model; however, there are some criticisms regarding various aspects of 
the model.  As mentioned earlier, the modified Stroop task has often been used in the 
PTSD and chronic pain literature as a means of measuring attentional bias, although the 
validity of the modified Stroop paradigm has been questioned.  In particular, it is unclear 
if this task is actually measuring attentional bias, or if it is measuring another form of 
information processing (e.g., determining the meaning of words) or motor response (e.g., 
trying to determine an appropriate response).  Although the extant research has generally 
supported the role of the Stroop paradigm in measuring attentional biases, there is still a 
possibility that this research may be eliciting a more generalized information processing 
bias than the intended attentional bias construct (Roelofs, Peters, Zeegers, & Vlaeyen, 
2002).   
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With regard to the role of anxiety sensitivity, research has demonstrated that 
anxiety sensitivity and pain catastrophizing may independently contribute to the 
experience of chronic pain (Drahovzal, Stewart, & Sullivan, 2006).  As such, the role that 
anxiety sensitivity plays in the development of pain perceptions and symptomatology 
may be more complex than originally thought (Stewart & Asmundson, 2006).  Finally, 
the role of biological functioning (e.g., HPA axis) in both the PTSD literature and chronic 
pain literature has been highly supported (e.g., Crofford et al., 1994; Olff et al., 2006; 
Rasmusson & Friedman, 2002; Wingenfeld et al., 2008; Yehuda, 2003); however, this 
model does not take biological or genetic influences (e.g., inherited vulnerabilities) into 
account.  As a result, the mutual maintenance model may not be the best predictor model 
for the relationship between PTSD and chronic pain. 
Shared Vulnerability Model   
 Asmundson and colleagues (2002) derived the shared vulnerability theory from 
the mutual maintenance model.  In particular, the researchers hypothesized that anxiety 
sensitivity acts as a shared vulnerability that leads to the development of both PTSD and 
chronic pain.  In particular, they proposed that individuals who report higher levels of 
anxiety sensitivity may be more likely to develop these conditions given they are 
experiencing heightened fear levels and avoidance.  Furthermore, these individuals with 
high anxiety sensitivity are thought to demonstrate a greater emotional response (i.e., fear 
and anxiety) when encountering a traumatic experience or physical injury (Asmundson et 
al., 2002).  If these individuals are demonstrating a stronger emotional reaction, then they 
may be more likely to develop PTSD (Taylor, 2004).  If individuals with chronic pain 
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subsequently respond to their pain with fear and avoidance, then their symptoms are 
likely to worsen (Asmundson et al., 2002). 
 Although anxiety sensitivity may serve as a promising vulnerability factor for 
PTSD and chronic pain, many criticisms of this model still exist.  As mentioned earlier, 
the role of anxiety sensitivity in PTSD and chronic pain may be mediated by unknown 
cognitive processes that are not accounted for by pain catastrophizing; thus, the influence 
of anxiety sensitivity may be more complex than originally thought (Stewart & 
Asmudson, 2006).  Furthermore, a study comparing undergraduates with high and low 
anxiety sensitivity demonstrated that fear levels in relation to a cold pressor task were 
found to mediate the relationship between anxiety sensitivity and pain instead of the other 
way around (Uman et al., 2006).  Finally, this model is similar to the mutual maintenance 
model in that it does not account for many other factors that may also play an important 
role (e.g., social, biological, coping styles).  Support for the role of these additional 
factors will be provided below.  Consequently, it is thought that the triple vulnerability 
model may better account for biological, psychological, and social variables in the 
development of PTSD and chronic pain. 
Triple Vulnerability Model 
 The triple vulnerability model was originally proposed by Barlow (2000, 2002) to 
account for the development of anxiety disorders in general.  According to the triple 
vulnerability model, three separate vulnerabilities must be present to develop anxiety 
disorders: 1) a generalized biological vulnerability, 2) a generalized psychological 
vulnerability, and 3) a specific psychological vulnerability.  Keane and Barlow (2002) 
further proposed that the triple vulnerability model may apply to PTSD when an 
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individual experiences a traumatic event (i.e., the true alarm), which develops into a 
specific psychological vulnerability (i.e., the learned alarm).  However, PTSD cannot 
develop without an individual having a generalized biological vulnerability (e.g., 
inherited aspects of personality traits that lead individuals to react to environmental 
stressors in a defensive manner) and a generalized psychological vulnerability (e.g., sense 
of uncontrollability and perceived inability to cope) prior to the traumatic experience 
(Keane & Barlow, 2002).  Further information regarding each of these vulnerabilities will 
be provided below.   
 Otis and colleagues (2003) proposed that the triple vulnerability model can 
account for the development of both PTSD and chronic pain.  According to this variation, 
chronic pain may also develop in a similar manner to that of PTSD with respect to the 
three vulnerabilities.  A sense of uncontrollability may be present prior to the 
development of learned alarms associated with both PTSD and chronic pain.  PTSD and 
chronic pain may serve as a reminder of each other, and may act to maintain and worsen 
symptomatology of each condition.  Thus, increased levels of responsivity (i.e., fear and 
avoidance) following these learned alarms may develop.  Feelings of uncontrollability 
may then worsen, and disability may develop (Otis et al., 2003). 
Generalized Biological Vulnerability 
 According to Barlow (2000, 2002), individuals who go on to develop anxiety 
have inherited personality traits that serve as a vulnerability for anxiety disorders.   Such 
traits are thought to consist of being “high-strung,” “nervous,” or “emotional” (Barlow, 
2002).  Other researchers have also hypothesized that personality traits, such as negative 
affectivity and neuroticism, could also be inherited vulnerability factors (Clark, Watson, 
  22   
& Mineka, 1994).  Negative affectivity is conceptualized as a general predisposition 
towards experiencing negative emotions, with subsequent influences on cognitions, self-
concept, and world views (Watson & Clark, 1984).  Similarly, neuroticism was originally 
conceptualized as a personality dimension that develops out of a lowered threshold for 
limbic system activation.  Subsequently, neuroticism was defined as a personality 
tendency to experience “fight or flight emotions” (i.e., fear, anxiety, anger, and distress), 
which leads to a greater experience of negative moods (Eysenck, 1967, 1981).  It is 
estimated that genetic components of neuroticism may account for about 50% of its 
expression in individuals (Barlow, 2002; Eysenck, 1967).  
Gershuny and Sher (1998) conducted a three year longitudinal study of 466 young 
adults to determine the correlates of neuroticism and extraversion (e.g., level of 
sociability; Eaves & Eysenck, 1975) on anxiety and depression scores.  Results indicated 
that low levels of extraversion and high levels of neuroticism predicted higher levels of 
global anxiety in the third year of the study.  Furthermore, their results suggested that 
there may be similar personality variables (i.e., neuroticism and extraversion) that predict 
the development of both anxiety and depression (Gershuny & Sher, 1998).  Other 
research has also supported the hypothesis that anxiety and depressive disorders may 
have a similar genetic vulnerability, with respect to personality, and that environmental 
stressors may account for specific differences in how the disorders are expressed 
(Barlow, 2002). 
 It has been difficult to determine specific genetic contributions for PTSD. For 
example, it is difficult to differentiate between a vulnerability to being exposed to 
traumatic events versus a vulnerability to developing PTSD symptomatology.  In a study 
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with World War II veterans with a diagnosis of PTSD, researchers found that 66% of 
participants had family members with PTSD as well (Davidson, Swartz, Storck, 
Krishnan, & Hammett, 1985).  In another study, individuals who survived the bush fires 
in Australia were surveyed.  Results support the hypothesis that individuals with a family 
history of PTSD were more likely to develop PTSD than to not develop PTSD following 
this traumatic event (McFarlane, 1988).  However, twin studies have provided conflicting 
evidence regarding the genetic contributions for PTSD.  Many of the studies that have 
been reviewed also have some significant methodological flaws, and offer only 
correlational findings instead of demonstrating causation (Keane & Barlow, 2002). 
 Within the chronic pain population, it has also been hypothesized that 
musculoskeletal pain conditions (e.g., fibromyalgia) are associated with increased 
negative affectivity and decreased positive affectivity.  In particular, individuals with 
fibromyalgia were found to report minimal experiences of positive emotions.  This 
finding, however, was not a direct result of decreased social engagements (Zautra et al., 
2005).  Several researchers have hypothesized that various emotions (e.g., negative 
affectivity) may serve as a vulnerability and maintenance factor for fibromyalgia (e.g., 
Davis, Zautra, & Reich, 2001; Geisser et al., 2003; Staud et al., 2003; Zautra et al., 2005).  
After a prolonged difficulty in maintaining emotional homeostasis during periods of high 
stress, individuals with fibromyalgia are thought to perceive future events as stressful.  
This perception of future events as stressful is thought to perpetuate the cycle of poor 
maintenance of emotional homeostasis (Zautra et al., 2005).  Overall, researchers seem to 
agree that aspects of Barlow’s original conception of a generalized biological 
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vulnerability (i.e., negative affectivity) may apply to musculoskeletal pain populations as 
well.   
 Researchers have provided initial support for 10 psychiatric conditions (i.e., 
attention-deficit hyperactivity disorder, bulimia nervosa, dysthymic disorder, generalized 
anxiety disorder, major depressive disorder, obsessive-compulsive disorder, PTSD, panic 
disorder, premenstrual dysphoric disorder, and social phobia) and 4 medical conditions 
(i.e., fibromyalgia, irritable bowel syndrome, migraine, and cataplexy) to be grouped 
together as affective spectrum disorders (ASD; Hudson & Pope, 1989, 1990, 1994; 
Hudson et al., 2004).  In particular, these researchers hypothesized that that the 
psychological disorders and the medical conditions might share a physiological 
irregularity (i.e., difference in physiological functioning) that plays a role in their 
etiology.  Support for this conception comes from similar responsivity among individuals 
with the different diagnoses to antidepressant medications (e.g., tricyclics, monoamine 
oxidase inhibitors, and serotonin reuptake inhibitors).  Furthermore, this unknown 
physiological irregularity is thought to be based in heredity (Hudson & Pope, 1989, 1990, 
1994; Hudson et al., 2004).  In a study that assessed for heritable pathophysiological 
features of fibromyalgia, data were collected from 533 relatives of individuals with 
fibromyalgia and 272 relatives of individuals without fibromyalgia.  Results of this study 
supported the original hypothesis that there are higher familial rates of ASD in relatives 
of individuals with fibromyalgia as compared to relatives of individuals without 
fibromyalgia.  Subsequently, the idea of a similar genetic heritable component among 
several conditions (i.e., fibromyalgia and PTSD) was supported. However, the exact 
nature of this physiological irregularity has not been identified. 
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 With regards to the biological inheritance of personality traits, Barlow (2002) 
proposed these personality traits (i.e., nervous, emotional, neuroticism, negative 
affectivity) may lead individuals who develop anxiety disorders to react differently to 
various changes in their environment.  The genetic contribution is viewed as being non-
specific and it represents a general tendency to be emotionally unstable.  In this sense, an 
individual is genetically predisposed to respond to environmental changes/stressors in a 
defensive way with an alarm reaction.  Since they are perpetually ready for danger, the 
threshold needed to initiate the fight or flight response is thought to be lower.  However, 
this biological tendency is only viewed as being vulnerability for the individual if they 
present with specific psychological variables as well (Barlow, 2002). 
 Similar to research on PTSD, researchers have begun to look at abnormal brain 
processing of pain related information (Gracely, Petzke, Wolf, & Clauw; 2002; Yunus, 
1992).  In particular, it has been hypothesized that musculoskeletal pain conditions (e.g., 
fibromyalgia), may be initiated and maintained by the hyperexcitability of the central 
nervous system (Desmeules et al., 2003).  Subsequently, hyperexcitability of the central 
nervous system, and the negative feedback loop of the HPA axis, have been associated 
with a blunted cortisol reaction following the experience of stressful events (e.g., 
Crofford et al., 1994; Wingenfeld et al., 2008).  Similar to Barlow’s (2000, 2002) 
conception of a generalized biological vulnerability, this HPA responsivity is not thought 
to be specific to just that of chronic pain (Abeles, Pillinger, Solitar, & Abeles, 2007).  
Further information regarding the role of HPA axis activation within PTSD and 
musculoskeletal pain populations will be provided below. 
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 Given that individuals with anxiety disorders and chronic musculoskeletal pain 
conditions are thought to be in a perpetual state of hyperarousal, it is not surprising that 
researchers would anticipate that psychophysiological changes at baseline and in 
response to stressful stimuli within these populations would be different than individuals 
who do not have this predisposition.  Various psychophysiological measures have been 
used in PTSD and chronic pain research to examine arousal: facial electromyography 
(EMG; muscle contractions), heart rate (HR; activity associated with cardiac 
functioning), skin conductance (SC; activity associated with the sweat glands), systolic 
blood pressure (SBP; blood pressure in the circulatory system with contractions of the 
heart), and diastolic blood pressure (DBP; blood pressure in the circulatory system when 
the heart is resting)(e.g., Flor & Turk, 1989; Pole, 2007,). In general, baseline 
assessments using such measures have tended to show inconsistent results with respect to 
various psychophysiological measurements within PTSD samples (Pole, 2007).  
However, inconsistent results may be due to methodological limitations (i.e., differing 
target muscles for various diagnoses, varying length of adaptation phases, lack of rest 
between experimental stimuli, failure to counterbalance stressors, poor sampling rates; 
Flor & Turk, 1989; Pole, 2007).  
 Frontalis (muscle located on the forehead) or corrugator (muscle located at the 
end of the eye brow) EMG responsivity is thought to relate to the display of negative 
emotions, zygomaticus (muscle located along the cheek bone) EMG is thought to reflect 
positive emotions, and orbicularis oculi (muscle located above the eyelid) EMG is 
thought to reflect an individual’s startle reflex (Blumenthal et al., 2005; Lang, Bradley, & 
Cuthbert, 1998).  The sympathetic nervous system (that prepares the body to react to 
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emergencies, heightened emotions, or strenuous activity) is thought to regulate SC, and 
both the sympathetic nervous system and the parasympathetic nervous system (that 
maintains or helps the body return to normal functioning following reactivity of the 
sympathetic nervous system) are thought to play a role in HR functioning.  Thus, 
increases in HR might reflect activation of the sympathetic nervous system, a decrease in 
functioning of the parasympathetic nervous system, or both (Bernston, Cacioppo, & 
Quigley, 1993; Taylor, 2006).  Subsequently, a stronger increase in HR instead of SC 
might reflect a greater role of the parasympathetic nervous system.  Finally, measures of 
SBP and DBP could provide information regarding reactivity during either contraction or 
relaxation of the heart (Pole, 2007). 
 Baseline psychophysiological measurements have been frequently reported within 
the PTSD literature.  In a study of Vietnam veterans, baseline physiological 
measurements were taken while they were sitting in a reclining position.  Results 
demonstrated that there were no significant differences between the PTSD group and the 
control group with respect to heart rate (HR), systolic blood pressure (SBP), and diastolic 
blood pressure (DBP; Orr, Meyerhoff, Edwards, & Pitman, 1998).  In a meta-analysis 
(Prins, Kaloupek, & Keane, 1995), five out of 13 studies focusing on PTSD samples were 
found to demonstrate higher baseline HR values for the PTSD group than for control 
groups.  Only one study was found to demonstrate significant baseline differences in skin 
conductance levels (SC); however, this study actually demonstrated that the PTSD group 
had lower SC levels than the control group.  Statistical analyses comparing these studies 
demonstrated that those with shorter baseline levels (5 minutes) tended to demonstrate 
more variability within and between groups.  It was thought that this increase in 
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autonomic arousal may be more due to the shorter duration of the baseline period than to 
group differences (Prins et al., 1995).  However, it should also be noted that many of 
these studies did not report including an adaptation phase in addition to the baseline 
phase.  Conversely, another meta-analysis (Buckley & Kaloupek, 2001) reported that 
PTSD groups did tend to show higher resting baseline HR and DBP than those without 
PTSD.  It is possible that baseline elevation of HR in PTSD could be mediated by 
decreased parasympathetic activity instead of increased sympathetic activity (Pole, 2007). 
 Within the chronic pain literature, elevated baseline psychophysiological 
measurements have not been demonstrated on a consistent basis in individuals with 
chronic headaches, chronic back pain, and temporomandibular pain disorders (Flor & 
Turk, 1989).  In contrast, other researchers have found elevated levels. For example, one 
study assessed baseline levels of HR and SC in 30 patients with fibromyalgia and 30 
healthy control patients.  Following a 30 minute adaptation phase, baseline 
psychophysiological measures were collected for 4 minutes while participants were asked 
to sit quietly and as still as possible with their eyes open.  Results demonstrated that the 
fibromyalgia group had significantly higher HR at baseline than the healthy controls.  No 
significant differences were demonstrated with respect to SCL at baseline (Thieme et al., 
2006).  Similarly, results from another study indicated significantly higher resting 
baseline levels of HR, SBP, and DBP in a 10 minute resting baseline period in the low 
back pain group compared to individuals in the control group; however, this study did not 
include an adaptation period prior to recording resting baseline measures (Burns, 2006). 
Similar to findings with PTSD samples, baseline elevation of HR in chronic pain could 
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also potentially be mediated by decreased parasympathetic activity instead of increased 
sympathetic activity (Pole, 2007). 
 In summary, a generalized biological vulnerability is thought to be characterized 
by a genetic tendency to be emotionally unstable in response to environmental changes 
and stressors.  This emotional instability may be caused by personality traits (i.e., 
nervousness, emotionality, neuroticism, negative affectivity) that lead individuals to be 
more responsive to environmental stimuli (Barlow, 2002).  Research within the PTSD 
and chronic pain literature has supported the hypothesis that these personality traits are 
associated with aspects of both PTSD (e.g., Davidson et al., 1985; Gershuny and Sher, 
1998) and chronic pain (e.g., Davis et al., 2001; Geisser et al., 2003; Staud et al., 2003; 
Zautra et al., 2005).  Furthermore, baseline levels of physiological hyperarousal and 
physiological reactivity to environmental stressors have been demonstrated within both of 
these populations (e.g. Crofford et al., 1994; Desmeules et al., 2003; Orr et al., 1998; 
Prins et al., 1995; Wingenfeld et al., 2008).  Thus, the current literature supports aspects 
of the generalized vulnerability hypothesis; however, limited research has assessed for 
these factors within a comorbid PTSD and chronic pain population.  
Generalized Psychological Vulnerability   
 A generalized psychological vulnerability refers to a general sense of 
uncontrollability and perceived inability to cope with unpredictable negative life events.  
In particular, individuals may perceive past attempts at coping with various situations as 
signs of failure.  Conversely, individuals without this vulnerability are thought to develop 
an “illusion of control,” and they are more likely to attribute deficiencies to transient 
external causes (Barlow, 2002).  With respect to chronic pain, individuals with chronic 
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pain may first view their pain as being uncontrollable and unpredictable.  When the pain 
condition is viewed as being uncontrollable and unpredictable, decreased feelings of self-
efficacy and increased negative affect may develop (Otis et al., 2003).  According to 
Barlow (2002), the ability to produce anxiety symptomatology specific to an individual’s 
disorder within laboratory settings is essential to measuring this change in coping 
strategies and feelings of uncontrollability.   
 Attributional Style.  Attempts to assess for the role of control in humans were 
initiated by Rotter (1954).  He hypothesized that an individual’s “locus of control” might 
be rated along a continuum with internal causality on one end and external causality on 
the other.  Thus, psychometric measures were developed that assessed for “locus of 
control” and “attributional style” (Barlow, 2002).  Seligman (1975) hypothesized that 
individuals develop a sense of uncontrollability with respect to the environment when 
they experience numerous negative life events.  Consequently, they develop a sense of 
learned helplessness, and stop attempting to cope with environmental stimuli.  
Furthermore, the relationship between negative events that individuals experience and the 
development of learned helplessness is thought to be moderated by an individual’s 
attributional style.  In particular, the experience of negative life events is likely to lead to 
the development of learned helplessness when individuals make internal, global, and 
stable attributions regarding the negative life events that they experience (Abramson, 
Seligman, & Teasdale, 1978).  Helplessness was then thought to play a role in the 
development of anxiety, although hopelessness was thought to play a larger role in the 
development of depression (Abramson, Metalsky, & Alloy, 1989). 
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 Limited research has assessed for the role of learned helplessness in PTSD and 
within the chronic pain literature.  It is thought that similar types of events are 
experienced that lead to the development of both learned helplessness and PTSD, and that 
both conditions may be associated with similar behavioral and physiological symptoms 
(Mineka & Zinbarg, 1996).  Animal research has also suggested that similarities may 
exist (e.g., sense of uncontrollability) in the development and perpetuation of learned 
helplessness and PTSD (Maier, 2001).  With respect to attribution styles within the PTSD 
literature, helpless attributional styles have been associated with reports of abuse during 
childhood and the onset of PTSD in adulthood (e.g., Casella & Motta, 1990; Gibb, 2002).  
Many clinicians who have worked with individuals with PTSD have tended to notice that 
PTSD is associated with personal feelings of helplessness in which individuals reportedly 
feel that resolution of additional stressful events after their trauma is uncontrollable 
(McKeever, McWhirter, & Huff, 2006).  Similarly, regression analyses have 
demonstrated that learned helplessness predicted PTSD symptom severity (McKeever, 
McWhirter, & Huff, 2006).  Only one study was found that assessed for the role of 
attributional style within the chronic pain literature.  This study compared attribution 
styles within a depressed and chronic pain sample, a chronic pain sample that was not 
depressed, and a control group.  No differences were demonstrated between the groups 
with regards to attribution styles (Ingram, Atkinson, Slater, Saccuzzo, & Garfin, 1990).   
 Coping Strategies. Within the PTSD literature, coping strategies have generally 
been categorized as cognitive or behavioral (De Ridder, 1997; Holahan & Moos, 1987).  
Cognitive coping strategies involve altering thoughts regarding an event to decrease 
feelings of distress and to assign meaning to the event.  Examples of cognitive coping 
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strategies include cognitive restructuring, wishful thinking, self-blame, and self-criticism.  
Conversely, behavioral coping strategies involve observable actions that an individual 
engages in to help alleviate distress following a traumatic event (e.g., withdrawing from 
others, seeking social support, and problem-avoidance; Waldrop & Resick, 2004).  
Research has consistently demonstrated that avoidant coping strategies (e.g., diverting 
attention) are associated with PTSD severity following the experience of a traumatic 
event.  In a study that assessed coping strategies in a sample of 74 rape victims and 48 
physical assault victims, an increased tendency to express emotions, use cognitive 
restructuring, and seek social support over a three month period of time was positively 
correlated with diminished PTSD symptomatology.  Conversely, increased levels of 
wishful thinking and social withdrawal were associated with the perpetuation of PTSD 
symptomatology.  Self-criticism was found to be positively associated with PTSD 
symptomatology at both one and three months following a traumatic event.  Thus, some 
coping strategies have been shown to change over time following a traumatic event (e.g., 
cognitive restructuring, seeking social support, social withdrawal), while others may 
remain more stable (e.g., self-criticism; Gutner, Rizvi, Monson, & Resick, 2006).  
 Since the 1990s, a plethora of research has focused on coping styles in the chronic 
pain literature (DeGood & Tait, 2001).  Research has demonstrated that passive coping 
styles are positively correlated with increased severity of pain, disability associated with 
pain conditions, and psychological distress.  Conversely, active coping strategies (i.e., 
seeking social support) have been found to be positively correlated with increased levels 
of positive affect and higher levels of activity (Snow-Turek, Norris, & Tan, 1996; Zautra 
et al., 1995).  Longitudinal research has demonstrated a similar trend within a 
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musculoskeletal pain population (DeGood & Tait, 2001; Potter & Jones, 1992).  Coping 
flexibility refers to the number of coping strategies that an individual utilizes on a regular 
basis to cope with their pain (DeGood & Tait, 2001).  In a chronic pain sample that was 
seeking treatment for their pain; higher levels of coping flexibility were found to predict 
greater self-perception of control regarding the pain condition, and potentially greater use 
of effective coping strategies.  However, coping flexibility did not predict ratings of pain 
severity (Haythornthwaite, Menefee, Heinberg, & Clark, 1998).  Research that has 
focused on diverting attention away from the pain condition has been correlated with 
positive adjustment to pain; however, this relationship has often been found to be 
moderated by additional variables (e.g., pain intensity; Affleck, Urrows, Tennen, & 
Higgins, 1992; DeGood & Tait, 2001).  Conflicting results have been found regarding the 
use of reinterpreting pain, coping self-statements, and ignoring pain (DeGood & Tait, 
2001).  Coping strategies such as praying or hoping have been found to be associated 
with poor adjustment to pain.  Subsequently, it has been hypothesized that this 
relationship may exist since individuals tend to use these strategies when their pain levels 
have worsened already (Boothby et al., 1999).  Finally, research has also reported that 
participants with increased symptoms of pain from fibromyalgia tended to experience 
more difficulty in coping with chronic pain, and that increased levels of illness 
uncertainty was associated with increased difficulty in coping with pain when 
participants pain levels were exacerbated; however, a direct relationship between illness 
uncertainty and coping with chronic pain was not demonstrated (Johnson, Zautra, & 
Davis, 2006).  In general, coping strategies have been found to play an important role in 
the prediction and maintenance of pain. 
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Specific Psychological Vulnerability  
 Specific psychological vulnerabilities refer to factors that lead an individual to 
view a specific object or events as their primary focus of anxiety.  In this sense, 
individuals are learning what it is that might be threatening to them, and they are focusing 
their anxious apprehension on stimuli that they view as being dangerous (Barlow, 2002).  
This perception may occur when a true alarm becomes a learned alarm following the 
experience of a traumatic event.  Symptoms of numbing (i.e., avoidance of feelings) with 
respect to general responsiveness may reflect avoidance of these learned alarms.  Events 
and the way in which an individual tends to respond to these events are viewed as being 
unpredictable, which then may perpetuate the experience of anxious apprehension.  
However, the development of PTSD is thought to be moderated by social support 
networks and the ability to cope (Keane & Barlow, 2002). 
 Initial support for the role of learning mechanisms in the development of PTSD 
began in the 1970s when researchers were treating rape victims and Vietnam veterans 
(Resick & Calhoun, 2001).  Originally, Mowrer’s (1947) two-factor theory was proposed 
to account for the role of classical and operant conditioning in the development of PTSD 
symptomatology following a traumatic event (e.g., Holmes & St. Lawrence, 1983).  
Classical conditioning is thought to account for elevated levels of distress and fear that 
are associated with a traumatic event, and operant conditioning was thought to account 
for PTSD avoidance and long term maintenance of fear.  In particular, traumatic 
memories are thought to serve as the new conditioned stimuli, whereas fear and anxiety 
serve as the conditioned emotional responses.  Such cues are then avoided, which 
provides negative reinforcement with the temporary decrease of fear and anxiety (Keane 
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& Barlow, 2002).  Although this model offers some compelling arguments, it is thought 
that it may not be comprehensive enough to account for all PTSD symptomatology (e.g., 
recurrent memories, high rates of generalization; Foa, Steketee, & Rothbaum, 1989; 
Resick & Calhoun, 2001). 
 Classical and operant conditioning accounts have also been proposed in the 
chronic pain literature.  Researchers have found that fear of pain and re-injury is 
associated with avoidance of activities that may lead to additional pain; however, this 
avoidance is associated with even greater physical deconditioning (i.e., deterioration of 
physical functioning) and maintenance of pain (Asmundson, Norton, & Norton, 1999).  
Given that anticipatory anxiety regarding potentially pain inducing activities may be 
reduced through avoidance, such behaviors are then negatively reinforced via operant 
conditioning with the reduction of anticipatory anxiety (McCracken, Zayfert & Gross, 
1993).  According to the triple vulnerability model, activities and sensations that are 
associated with additional pain may serve as the learned alarms, and individuals may try 
to avoid such activities as a result of their anxious apprehension. 
Summary 
 In summary, research has provided preliminary support for Barlow’s (2002) 
conception of a generalized biological and generalized psychological vulnerability within 
PTSD and chronic pain populations.  These vulnerabilities are thought to be the same for 
both PTSD and chronic pain (Otis et al., 2003). With respect to a generalized biological 
vulnerability, both groups have demonstrated baseline levels of hyperarousal, and blunted 
cortisol responses following experimental stressors (e.g., Crofford et al., 1994; Olff et al., 
2006; Rasmusson & Friedman, 2002; Wingenfeld et al., 2008; Yehuda, 2003).  Although 
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preliminary research supports the role of a negative attributional style as a generalized 
psychological vulnerability for PTSD (e.g., Cassella & Motta, 1990; McKeener et al., 
2006; Mineka & Zinbarg, 1996); limited research has been conducted with either 
condition.  Furthermore, the role of negative coping strategies in the maintenance of both 
conditions individually has been frequently reported (e.g., Gutner et al., 2006; Snow-
Turek et al., 1996; Zautra et al., 1995).  Finally, evidence of learned alarms has been 
reported in a number of PTSD and chronic pain related studies (e.g., Asmundson et al., 
1999; Holmes & St. Lawrence, 1983; McCracken et al., 1993).  However, limited 
research on all aspects of the triple vulnerability model has been conducted on a 
comorbid PTSD and chronic pain population. 
Stress and Cortisol 
Hypothalamic-Pituitary-Adrenal Axis (HPA axis) 
 As mentioned earlier, HPA axis functioning has received increased attention in 
efforts to account for PTSD and chronic pain symptomatology development and 
maintenance.  In particular, human responses to stress can be largely accounted for by the 
HPA axis (Tanriverdi et al., 2007).  Prior to discussing the specific relationship of the 
HPA axis to PTSD and chronic pain, a conceptual basis for how the HPA axis functions 
and why it is activated in response to stress is presented.   
 Hypothalamus and Corticotropin-Releasing Hormone.  At a general level, the 
hypothalamus is part of the diencephalon, which is part of a larger structure of the brain 
known as the forebrain.  The size of the hypothalamus is fairly small compared to other 
areas of the brain, but it contains a significant number of nuclei that play many critical 
roles.  In particular, the hypothalamus has been found to help regulate hunger, thirst, 
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bodily regulation of temperature, behavior associated with reproductive functioning, and 
the pituitary gland (Breedlove, Rosenzweig, & Watson, 2007).  The hypothalamus 
subsequently controls the pituitary gland by producing either releasing hormones that 
activate the anterior pituitary or inhibiting hormones that limit activation of the anterior 
pituitary.  Through its control over the pituitary gland, the hypothalamus subsequently 
functions as a connector between the nervous system and the endocrine system.  The 
main releasing hormone that the hypothalamus secretes in relation to the HPA axis is 
corticotrophin-releasing hormone (CRH).  CRH is a protein hormone that is released by 
the hypothalamus via its neurosecretory cells to subsequently increase the amount of 
cortisol that is secreted (Tortora & Grabowski, 2001). 
 Anterior Pituitary and Adrenocorticotropic Hormone.  The anterior pituitary is 
located in the front lobe within the pituitary gland, and it has been found to create and 
release the majority of the hormones within our bodies (Breedlove et al., 2007).  As 
mentioned earlier, stimulation of the anterior pituitary is caused by releasing hormones 
from the hypothalamus.  The pituitary stalk is made up of many axons and blood vessels 
that allow for the communication of hormones between the hypothalamus and anterior 
pituitary.  The anterior pituitary then secretes adrenocorticotropic hormones (ACTH), a 
tropic hormone that helps to regulate other endocrine glands.  Since ACTH is a protein 
hormone, it tends to respond to stimulation very quickly, and it subsequently initiates 
activation of the adrenal cortex (Breedlove et al., 2007).    
 Adrenal Glands and Glucocorticoids.  Within the adrenal glands, the adrenal 
cortex has been found to control the metabolism of carbohydrates, sodium, and bodily 
reactions to inflammation.  Conversely, the adrenal medulla is thought to regulate 
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emotional arousal.  Upon stimulation of the adrenal cortex, various steroid hormones are 
released that are known as adrenocorticoids.  Of the adrenocorticoids, glucocorticoids 
have been found to directly affect the metabolism of carbohydrates and subsequently 
increase levels of glucose within the body.  Cortisol, in particular, is a glucocorticoid 
hormone that is released in response to stress.   
Since hormonal systems are able to both create and evaluate levels of hormones 
within our bodies, the secretion of these hormones tends to be regulated depending on 
what the body needs.  Therefore, in negative feedback systems, the resulting release of 
hormones returns to suppress the secretion of additional hormones of that type.  Through 
the process of negative feedback in the HPA axis, glucocorticoids return to the 
hypothalamus to inhibit the production of releasing hormones and ACTH (Breedlove et 
al., 2007).  In addition, Dehydroepiandrosterone (DHEA) is also released by the adrenal 
cortex during the experience of stressful situations as a result of changing ACTH levels.  
DHEA helps to return the body’s cortisol levels back to their baseline state. Thus, the 
production of DHEA may help to protect individuals with PTSD from developing even 
more detrimental problems with their health (Charney, 2004). 
 Cortisol.  Cortisol, in particular, is one of the most prevalent glucocorticoids, and 
its production has been found to result in numerous changes within the body.  In general, 
it is known that the negative feedback of cortisol to the hypothalamus subsequently 
inhibits activation of the HPA axis.  Cortisol also activates various energy sources within 
the body to initiate an automatic fight or flight response (Charney, 2004).  This process 
takes place through the breakdown of proteins, conversion of amino acids and lactic acid 
to glucose, and through the breakdown of triglycerides (Tortora & Grabowski, 2001).  
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This activation of energy sources eventually results in fatigue, wear and tear on bodily 
muscles, and steroid diabetes (Breedlove et al., 2007).  Secondly, processes associated 
with inflammation and immune responses are inhibited (Charney, 2004).  Not only does 
cortisol inhibit the production of white blood cells, it also inhibits the repair of potential 
wounds and diseases (Breedlove et al., 2007).  Next, the inhibition of growth and 
reproductive systems in response to cortisol may lead to bone degeneration, inability to 
ovulate, and loss of sexual interest (Breedlove et al., 2007; Charney, 2004).  Increased 
cortisol may also lead to increased arousal, hypervigilance, focused attention, and 
memory formation associated with emotions.  Finally, regulation of the hippocampus, 
amygdala, and prefrontal cortex are also altered (Charney, 2004; Gold, Drevets, & 
Charney, 2002).  Consistently high levels of cortisol may also lead to the development of 
hypertension, osteoporosis, immunosuppression conditions, insulin resistance, 
dyslipidemia (i.e., increased levels of plasma cortisol that can lead to atherosclerosis), 
dyscoagulation (i.e., change in blood clotting), atherosclerosis, and cardiovascular disease 
(Charney, 2004; Karlamangla, Singer, McEwen, Rowe, & Seeman). 
Fight or Flight Response 
 Although the fight or flight response is not directly part of HPA axis activation, it 
is worth mentioning as it is initiated in response to increased cortisol levels within this 
process.  The fight or flight response has been found to be associated with numerous 
additional changes in body functioning including: 1) dilated pupils, 2) increased heart 
rate, heart contractions, and blood pressure, 3) dilated airways, 4) constriction of blood 
vessels that are connected to nonessential organs, 5) greater blood flow to organs 
associated with exercise or fighting against dangerous stimuli, 6) glycogen and glucose 
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are broken down by the liver, and triglycerides are broken down by adipose cells, 7) 
glucose is released by the liver to increase glucose levels in blood vessels, and 8) all other 
processes involved in nonessential tasks are inhibited (e.g., digestive secretions).  Thus, 
an extensive array of bodily changes occurs during the experience of stressful events 
(Tortora & Grabowski, 2001). 
HPA Axis and the Menstrual Cycle 
 With respect to women, conflicting results have been found when assessing for 
cortisol levels across the menstrual cycle.  Some researchers have found that there are no 
differences in cortisol levels across the menstrual cycle, whereas other researchers have 
found higher levels of cortisol during the luteal phase (i.e., the time period just before 
menstruation begins; Kajantie & Phillips, 2006; Rasmusson & Friedman, 2002).  To date, 
no studies have found higher levels of cortisol during the follicular phase of the menstrual 
cycle (i.e., the time period just after menstruation ends).  In addition, higher levels of 
cortisol have been associated with higher levels of estrogen (Lindholm & Schultz-Moller, 
1973).  Therefore, it may be possible that lower levels of cortisol during the follicular 
phase of the menstrual cycle may serve as an additional risk factor for the development of 
PTSD.  Conversely, women who experience a traumatic event during the luteal phase of 
their menstrual cycle may be more likely to develop depressive symptomatology 
(Rasmusson & Friedman, 2002; Yehuda, 2003). 
 Only one study was found that assessed cortisol responsivity to stressful 
laboratory tasks (e.g., the Trier Social Stress Task [TSST]) across phases of the menstrual 
cycle.  In an initial attempt to look at menstrual cycle phase influences, Kirschbaum and 
colleagues (1999) examined cortisol reactivity to the TSST in men and women. Cortisol 
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reactivity was compared in a sample of men (n = 20), women in the follicular phase of 
the menstrual cycle (n = 19), women in the luteal phase of the menstrual cycle (n = 21), 
and women who were taking oral contraceptives (n = 21).  Results indicated that women 
in the follicular phase of the menstrual cycle had similar salivary cortisol level increases 
following the TSST as women taking oral contraceptives.  Conversely, women in the 
luteal phase of their menstrual cycle had similar cortisol levels to men.  Both women in 
the luteal phase of their menstrual cycle and men demonstrated greater cortisol reactivity 
to the TSST than women in the follicular phase of their menstrual cycle and women 
taking oral contraceptives.  No significant salivary cortisol level differences were 
demonstrated at baseline between any of the groups.  Within the group as a whole, 
cortisol levels peaked at 10 minutes following the TSST, and ACTH levels peaked 1 
minute following the TSST (Kirschbaum et al., 1999).  Thus, women in all phases of the 
menstrual cycles may demonstrate similar baseline levels of cortisol; however, their 
cortisol reactivity following the experience of stressful events may vary.  Overall, all 
groups demonstrated significant cortisol responsivity following the TSST; however, 
women in the luteal phase of their menstrual cycle and men demonstrated larger cortisol 
increases than women in their follicular phase and women taking oral contraceptives. 
HPA Axis and Aging 
 Research assessing for aging effects on HPA axis functioning has also resulted in 
conflicting outcomes.  Although researchers in one study found that older participants 
may demonstrate greater cortisol responsivity to stressful situations (Gotthardt et al., 
1995), other researchers have found no differences in older versus younger populations in 
men or women (Kudielka, Schmidt-Reinwald, Hellhammer, & Kirschbaum, 1999, 2000).  
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In an analysis that compiled data from five independent studies to investigate the role of 
age and gender on HPA axis functioning and reactivity following the TSST, all age 
groups (i.e., elderly, adults, young adults, and children) were found to have significant 
and similar cortisol reactivity to the TSST.  Furthermore, post-hoc analyses indicated that 
there were no age effects in cortisol and ACTH reactivity across the different subgroups 
of women.  Only studies that assessed for cortisol responsivity of premenopausal women 
in the luteal phase of their menstrual cycle were included to avoid confounding effects of 
the menstrual cycle.  Postmenopausal women were not included if they were receiving 
hormone replacement therapy.  Conversely, younger men were found to have greater 
ACTH reactivity than older men (Kudielka, Buske-Kirschbaum, Hellhammer, & 
Kirschbaum, 2004).  Overall, age effects in cortisol and ACTH reactivity were not 
demonstrated when women in the luteal phase of their menstrual cycle were compared to 
postmenopausal women. 
HPA Axis and PTSD 
 In general, lower levels of cortisol and increased negative feedback inhibition 
have been associated with hypersensitization of the HPA-axis following the experience of 
stressful events.  Hypersecretion of corticotrophin-releasing factor (CRF) has also been 
reported, as well as a reduction of the corticotrophin response to CRF (Kaufman et al., 
1997; Rasmusson & Friedman, 2002).  One hypothesis is that individuals with PTSD 
have greater numbers of lymphocyte glucocorticoid receptors (which are needed for 
cortisol to create a strong effect), and that they have greater suppression to cortisol 
following secretion of dexamethasone (Rasmusson & Friedman, 2002; Stein, Yehuda, & 
Koverola, 1997; Yehuda et al., 1995).   However, conflicting results have been found 
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regarding the relationship of HPA axis dysregulation and PTSD, and some researchers 
argue that individuals with PTSD do not have lower levels of cortisol (Rasmusson & 
Friedman, 2002).  In a meta-analysis that cumulated the results of 37 studies assessing for 
basal cortisol levels among participants with PTSD, inconsistent results were 
demonstrated with regards to differences in basal cortisol levels between participants 
with PTSD and those in a control group; however, lower levels of basal cortisol tended to 
be demonstrated among participants with PTSD that were female and/or those that had 
experienced physical or sexual abuse,  The inability to consistently obtain low cortisol 
levels in PTSD tends to suggest that other factors may also play a role in the relationship 
of HPA-axis regulation and PTSD (e.g., chronic pain). 
 Similarly, cortisol levels have been known to vary due to many factors which may 
make the assessment of cortisol somewhat complicated.  For example, individuals tend to 
have higher cortisol levels in the morning and late in the evening (Crofford et al., 2004; 
Kudielka et al., 2004).  Levels of cortisol may also vary throughout the menstrual cycle, 
or with daily stressors (Rasmusson & Friedman, 2002; Yehuda, 2003).  In addition, much 
of the research that has assessed the relationship between PTSD and HPA-axis 
functioning has been limited in that researchers have tended to focus primarily on male 
combat veterans (Rasmusson & Friedman, 2002).  In a recent review article (Wong 
&Yehuda, 2002), 20 studies were found that focused on male combat veterans, whereas 
only 7 focused on other populations (4 of which focused on women specifically).  More 
recently, researchers have been starting to focus more on some of these less researched 
populations. 
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 Conflicting results have been found with several studies assessing cortisol levels 
after the experience of a traumatic event.  Several studies have found that low levels of 
cortisol following traumatic events were associated with the development of a PTSD 
diagnosis within one month of the event (Delahanty, Raimonde, & Spoonster, 2000; 
Yehuda, Shalev, & McFarlane, 1998). Types of traumatic events in these studies included 
motor vehicle accidents, natural disasters, and a mining accident.  However, one study 
found that the predictive power of lower cortisol levels immediately following the 
traumatic event was not predictive of a PTSD diagnosis at a one year follow-up 
(Anisman, Griffiths, Matheson, Ravindran, & Merali, 2001).  For individuals who were 
recently raped, low cortisol levels following the most recent event were associated with 
the experience of prior events that were similar in nature (Resnick, Yehuda, Pitman, & 
Foy, 1995).  Research has consistently demonstrated that prior experiences of traumatic 
events are indicative of greater risk for the development of PTSD (e.g., Yehuda, 2003). 
 A recent study examined cortisol levels in individuals varying in traumatic event 
history. In a study looking at PTSD and urinary cortisol levels (Young & Breslau, 2004), 
292 participants were assigned to one of three groups: participants that were exposed to a 
traumatic event, participants with a current diagnosis of PTSD, and a control group.  
Participants completed a 32 hour sleep study, while urinary cortisol samples were taken 
every 8 hours (at 8:00 a.m. and 8 p.m.).  No main effects were found for the type of 
trauma that individuals experienced and their levels of cortisol.  Similarly, no significant 
differences were found between individuals who experienced a traumatic event early in 
their life (prior to the age of 16) versus traumatic events later in life.  No group 
differences were found with respect to urinary cortisol in the PTSD and control groups.  
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However, women with comorbid PTSD and major depressive disorder (MDD) had higher 
levels of urinary cortisol than controls and participants with either diagnosis alone.  This 
trend was not demonstrated in male participants (Young & Breslau, 2004). 
 Another recent study examined cortisol levels and severity of PTSD symptoms.  
Olff and colleagues (2006) assessed cortisol, DHEA and DHEA sulfate (DHEA-S) levels 
and severity of PTSD symptoms.  Given that many studies have found conflicting results 
regarding the effects of a comorbid diagnosis of depression, the researchers investigated 
the potential moderating role of major depressive disorder (MDD).  Participants consisted 
of 39 civilian outpatients with PTSD and 44 healthy controls.  Types of traumatic events 
ranged from sexual abuse, vehicle accidents, to the death of loved ones.  Hormone levels 
were assessed between 8:00 a.m. to 10:00 a.m. via blood samples following an overnight 
fast.  Results indicated that lower cortisol levels were associated with greater severity of 
PTSD symptomatology.  The authors proposed that variability in the cortisol and PTSD 
literature may be due to severity of PTSD symptoms.  The researchers also hypothesized 
that HPA dysregulation may be more problematic in individuals with more severe levels 
of PTSD (Olff et al., 2006).  Similar to the findings of other researchers (e.g., Oquendo et 
al., 2003; Yehuda, Halligan, Golier, Grossman, & Bierer, 2004), the current results 
demonstrated that there were no significant effects in cortisol levels resulting from 
comorbid MDD (Olff et al., 2006).  After accounting for demographic variables (e.g., 
age, sex), no significant difference was found between ratios of cortisol to DHEA within 
the different groups.  Limitations of the study included the small sample size used in this 
study, use of blood sampling at only one time point, and levels of insomnia (Olff et al., 
2006). 
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 Previous research suggests that there may be a relationship between childhood 
experiences of sexual abuse and greater body weight (e.g., Lemieuz & Coe, 1995).  One 
study assessed for the relationship between childhood experiences of sexual abuse, 
obesity in adulthood, and cortisol levels.  Participants consisted of 28 women that were 
placed into three groups: women with PTSD diagnoses that experienced sexual abuse as a 
child (n = 11), women who did not have PTSD but still experienced sexual abuse as a 
child (n = 8), and women in the control group with no prior experiences of sexual abuse 
(n = 9).  All participants completed three questionnaires assessing for severity of PTSD 
symptoms, general health, and premenstrual symptoms.  Urinary samples were averaged 
over a 24-hour time period, and all urine samples were collected during the premenstrual 
phase of their menstrual cycle (i.e., luteal phase). For participants who were being treated 
with psychotropic medication, no significant differences were found with respect to 
cortisol levels.  Results indicated that cortisol levels were not significantly associated 
with weight levels.  Cortisol levels were found to be higher in women with PTSD who 
had experienced sexual abuse as a child than women with PTSD who had not 
experienced childhood sexual abuse and women in the control group.  Interestingly, 
women in the PTSD group with childhood experiences of abuse tended to be more 
overweight and reported higher levels of premenstrual symptoms (Lemieux & Coe, 
1995).  One significant limitation of this study was that urinary cortisol levels were 
averaged over a 24 hour time period, when research has demonstrated that cortisol levels 
vary throughout the day (e.g., Crofford et al., 2004).  Overall, childhood experiences of 
sexual abuse were found to be associated with higher levels of cortisol than other forms 
of PTSD. 
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 HPA Axis Effects Resulting from Age of Trauma.  Yehuda and colleagues 
(2001) have examined cortisol levels in individuals whose parents were Holocaust 
survivors.  Participants were 20 adult males and 31 adult females who were children of 
Holocaust survivors.  Forty-one control participants were also included who were of the 
same age range.  Ten participants were taking psychotropic medications; however, these 
effects were not included in the analyses as they were not shown to provide significant 
effects in previous studies (Yehuda et al., 1995; Yehuda et al., 2000).  Participants 
provided urine samples for 24 hours, and they were instructed to obtain these samples on 
a day in which they were not likely to be stressed out.  Thus, many participants remained 
at home for the day.  Results indicated that participants who reported emotional abuse 
had lower averages of cortisol levels for the 24 hour period than individuals who did not 
report emotional abuse.  Conversely, self-report of childhood sexual abuse was associated 
with higher averages of urinary cortisol for the 24 hour period.  Children of Holocaust 
survivors tended to report higher levels of childhood trauma than other individuals in 
their demographic group.  Higher levels of abuse among Holocaust survivors tended to be 
associated with parental diagnoses of PTSD (Yehuda et al., 2001).  Results of the current 
study may be partially limited since many of the participants tended to stay home for the 
day while others did not.  Such variations in schedule could potentially alter cortisol 
outcomes. 
 Recent research has also assessed for effects of early adverse experiences and the 
frequency of stressful events in adulthood (Heim et al., 2002).  Researchers wanted to 
discover if early life experiences of trauma were more predictive of alterations in HPA-
axis regulation, or if experiences of stressful events in adulthood accounted for more of 
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the variance.  In this study, 49 females were divided into four groups: a control group 
with no history of early life stress (n = 12), women without a current diagnosis of MDD 
who were abused as children (n = 14), women with a current diagnosis of MDD who 
were also abused as children (n = 13), and women with a current diagnosis of MDD who 
were not abused as children (n = 10).  None of the women reported the use of 
psychotropic medications and medications that could alter their hormone levels.  
Participants were admitted as inpatients, and were instructed to remain in bed until the 
experiment began.  Participants were then brought to the experimental area via a wheel 
chair to avoid exercise while walking.  All women participated in a stress condition that 
consisted of a speech and math task.  Blood samples were taken prior, during, and after 
the stress task.  When compared to the control group, all three patient groups reported 
experiencing greater numbers of stressful events in the previous month.  Results indicated 
that a history of abuse during childhood predicted greater ACTH responsivity, even when 
controlling for stressful events in adulthood.  In addition, ACTH responsivity was 
increased even more when the women experienced traumatic events in adulthood as well.  
Thus, trauma during adulthood was found to play an additional role in regulating ACTH 
responsiveness to a stressful event beyond that of just childhood experiences of abuse. 
Depressive symptoms were found to be associated with the highest levels of ACTH 
concentrations, which contrasted to the results within the PTSD group without depression 
(Heim et al., 2002). 
 HPA Axis Regulation as a Potential Risk Factor.  Although many studies have 
assessed HPA dysregulation following traumatic events, one study attempted to assess 
the role of low cortisol levels as both a risk factor and/or as a result of maladaptive 
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responses to stress such as that seen in PTSD in an animal model (Cohen et al., 2006).  In 
this study, adult male Lewis, Fischer 344, and Sprague-Dawley rats were exposed to a 
stressful event when they were placed on used cat litter for 10 minutes.  These rats differ 
in their sensitivity to stimuli.  Control rats were exposed to unused cat litter for 10 
minutes as well.  Some of the rats were injected with corticosterone (a glucocorticoid in 
rodents) prior to being placed in the cat litter.  Responses to the cat litter were categorized 
as “extreme behavioral responses” (EBR) and “minimal behavioral responses” (MBR).  
Rats participated in an elevated plus maze, acoustic startle response task, and the Morris 
water maze.  Blood samples from all rats were collected during times when the rats were 
experiencing low levels of stress.  At baseline, the Lewis rats demonstrated greater 
anxiety responses (i.e., less time spent in open areas) than the Fischer 344 and Sprague-
Dawley rats, although their cortisol levels were not significantly different.  Results 
indicated that rats who demonstrated a blunted HPA response following the stressful task 
were more likely to demonstrate EBRs than those with regular HPA functioning.  
Similarly, the rats that were exposed to corticosterone prior to the stressful task were less 
likely to demonstrate EBRs.  Thus, administration of corticosterone to the Lewis rats 
significantly decreased the amount of EBRs that they demonstrated.  Overall, results 
suggest that susceptibility to PTSD may be decreased by administrating cortisol prior to 
the experience of a traumatic event by reducing the likelihood of blunted HPA responses 
to such events (Cohen et al., 2006). 
 HPA Axis Functioning Following Treatment for PTSD.  A recent study 
investigated cortisol levels in individuals who were treated for PTSD.  Participants (n = 
21), with varying types of traumatic events (e.g., assault, work accident, loss of loved 
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ones, car accident, etc.) were included (Olff, de Vries, Güzelcan, Assies, and Gersons, 
2007).  All participants met criteria for PTSD, and all participants began the study with 
low baseline levels of cortisol.  Participants received a Brief Eclectic Psychotherapy 
treatment that contained both aspects of cognitive behavior therapy (e.g., 
psychoeducation, imaginal exposure, writing assignments, and cognitive restructuring) 
and psychodynamic elements (e.g., “giving meaning” to events and a farewell ritual 
toward the end of therapy).  Without taking depressive symptomatology into account, no 
changes in cortisol levels were found following treatment.  When controlling for severity 
of depressive symptoms, cortisol levels were found to increase in individuals who were 
“successfully treated.”  Cortisol levels decreased further in individuals who were not 
successfully treated.  Since participants with depression tended to have higher baseline 
levels of cortisol, cortisol levels following the treatment were found to be associated with 
these baseline levels of depression.  Cortisol levels following treatment were also found 
to be associated with progress that participants made with respect to depressive 
symptoms.   
Various limitations of the study should be taken into consideration when looking 
at these results.  Typically, aspects of cognitive behavior therapy and psychodynamic 
treatment are not viewed as being compatible with each other.  As such, the type of 
treatment given to participants could potentially be a limitation of the study.  Other 
limitations include the small sample size, no control group for comparison, and cortisol 
was only assessed between 8:00 a.m. and 10:00 a.m.  Treatment results were also only 
significant when various aspects of treatment for depressive symptoms were taken into 
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account (Olff et al., 2007).  Regardless of the limitations, this study represents a first 
attempt examining the effects of psychotherapy on HPA dysregulation in PTSD. 
HPA Axis and Chronic Pain 
Research has consistently associated the increased experience of fibromyalgia 
symptoms, among other forms of chronic pain, with physical and emotional stress (e.g., 
Clauw & Chrousos, 1997; Turk, Okifuji, Starz, & Sinclair, 1996; Van Houdenhove & 
Egle, 2004).  Subsequently, several researchers have hypothesized the importance of the 
role of the HPA axis in chronic pain patients (e.g., Crofford et al., 2004; Okifuji & Turk, 
2002); however, few studies have assessed this relationship in chronic musculoskeletal 
pain samples.  Furthermore, no research studies were found that assessed for the 
relationship between the HPA axis and perceptions of pain. 
 In a recent study, researchers examined HPA axis functioning in a sample of 
individuals with chronic pelvic pain and in a sample with fibromyalgia (Wingenfeld et 
al., 2008).  Salivary-free cortisol levels were assessed following the Trier Social Stress 
Test and in response to pharmacological ACTH stimulation where ACTH was injected 
into participants.  Results indicated that participants with fibromyalgia had lower total 
cortisol levels following the TSST and ACTH stimulation as compared to controls.  
Conversely, no significant differences were found between the chronic pelvic pain and 
control groups (Wingenfeld et al., 2008).  Similar results were reported in another study 
that assessed for HPA functioning in participants with fibromyalgia (n = 12) and a 
control group (n = 12).  Results indicated that the fibromyalgia sample had a lower 
cortisol response to CRH physiological stimulation. These results provide support for the 
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hypothesis that HPA functioning is disrupted in individuals with fibromyalgia (Crofford 
et al., 1994).   
The basal circadian rhythm of HPA axis functioning has also been found to be 
disrupted within a fibromyalgia sample.  ACTH levels were found to be lower across a 
24-hour time period within the fibromyalgia group when compared to a control group, 
and cortisol levels were found to be slightly higher within the fibromyalgia group.  
However, these results were only approaching significance.  No experimental stressor 
was used within this study.  These results suggest that fibromyalgia may be associated 
with decreased resiliency of HPA axis functioning.  Thus, it may be more difficult for 
individuals with fibromyalgia to return to baseline ACTH and cortisol levels following 
activation of the HPA axis (Crofford et al., 2004).  Results from these studies suggest that 
fibromyalgia may be associated with decreased activation and resiliency of HPA axis 
functioning. 
Summary 
 From a review of the current literature, it is clear that hypothalamic-pituitary-
adrenal axis (HPA) functioning has implications in the experience of PTSD and chronic 
musculoskeletal pain conditions.  What seems less clear is the potential role of HPA axis 
functioning in the development and maintenance of PTSD and chronic pain, or if 
alterations in HPA axis functioning play a direct role in the experience of traumatic 
events and the onset of both conditions.  Preliminary results in the study by Cohen and 
colleagues (2006) seem to suggest that cortisol levels prior to the experience of traumatic 
experiences may be a risk factor in the development of PTSD.  However, Cohen and 
colleagues (2006) study was conducted with rats, and the generalizability of the study 
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data to humans is unknown.  Unfortunately, it would be extremely time consuming, 
expensive, and difficult to obtain preventative data with humans because that would 
require longitudinal research to obtain information both before and after the experience of 
traumatic events and comorbid diagnoses.  A variety of designs will be needed in future 
research to help clarify the role of HPA axis functioning in both conditions.  To date, no 
research studies have been found that assessed for the role of the HPA axis functioning in 
a sample of both PTSD and chronic musculoskeletal pain participants. 
Overview and Statement of Purpose 
 Not only have high rates of PTSD and musculoskeletal pain been reported in the 
literature (e.g., Davis et al., 2001; Geisser et al., 1996; Kessler et al., 1995; Wolfe et al., 
1995), but research has also indicated that high comorbidity rates exist between these two 
conditions (e.g., Asmundson & Hadjistavropolous, 2006; Asmundson et al., 1998).  Both 
conditions occur more frequently within female populations (e.g., Kessler et al., 1995; 
Khouzam et al, 2005; Wolfe et al., 1995).  Comorbid PTSD and chronic pain are also 
associated with increased perceptions of pain, affective distress, interference in daily 
activities, and high rates of disability (Otis et al., 2003; Sherman et al., 2000).  Thus, 
comorbid conditions of PTSD and musculoskeletal pain have been associated with a large 
cost to individuals and to society. 
 Currently, three models have been proposed to account for the high comorbidity 
rates between PTSD and chronic pain (i.e., mutual maintenance model, shared 
vulnerability model, and triple vulnerability model).  Given that the triple vulnerability 
model (Otis et al., 2003) accounts for biological, psychological, and social aspects of 
PTSD and chronic pain, it is thought to hold the most promise as a comprehensive 
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theoretical model.  This model was derived from Barlow’s (2000, 2002) original triple 
vulnerability model that was developed to account for anxiety symptomatology.  
According to this model, individuals must have a generalized biological vulnerability 
(e.g., inherited personality traits that lead individuals to react to environmental stressors 
in a defensive manner), a generalized psychological vulnerability (e.g., sense of 
uncontrollability and perceived inability to cope), and a specific psychological 
vulnerability (e.g., development of learned alarms) before PTSD and chronic pain can 
develop (Barlow, 2000; Barlow, 2002; Keane & Barlow, 2002; Otis et al., 2003).  A 
learned alarm may elicit both symptoms of chronic pain and PTSD (Otis et al., 2006), and 
the two diagnoses may work together to maintain or even worsen symptoms of both 
conditions (Otis et al., 2003). 
 Human stress responses can be greatly accounted for by the role of the HPA axis 
(Tanriverdi et al., 2007).  Subsequently, the HPA axis has gained increasing attention in 
accounting for PTSD and musculoskeletal pain symptomatology.  Although some 
research has provided conflicting results, previous research assessing HPA axis 
functioning in PTSD and musculoskeletal pain populations have generally demonstrated 
that both conditions tend to be associated with a blunted cortisol response when 
compared to control groups (e.g., Crofford et al., 1994; Olff et al., 2006; Rasmusson & 
Friedman, 2002; Wingenfeld et al., 2008; Yehuda, 2003).  Thus, assessing for cortisol 
and psychological reactivity following a stress induction task (i.e., TSST) within PTSD 
and chronic pain samples may provide beneficial information regarding the generalized 
biological and psychological vulnerabilities proposed within the triple vulnerability 
model. 
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 The purpose of the current study was to test aspects of the triple vulnerability 
model (Barlow, 2000; Barlow, 2002; Otis et al., 2003) in PTSD and chronic 
musculoskeletal pain populations.  Since limited research has tested aspects of this model 
with a comorbid PTSD and chronic pain population, subsequent study results can 
contribute to a greater understanding of the relationship between these two diagnoses.  
These results may have important implications for future research and treatment of both 
diagnoses. 
 In the current study, aspects of the triple vulnerability model were examined 
within the following groups of women: women who have PTSD without chronic pain (n 
= 11), women who have musculoskeletal pain without PTSD (n = 10), women with both 
PTSD and musculoskeletal pain (n = 10), and women without PTSD and chronic pain (n 
= 15).  Cortisol reactivity and anxious mood were assessed before and after the Trier 
Social Stress Task (TSST).  Participants also completed questionnaires to assess for other 
potential indicators of the triple vulnerability model.  
Hypotheses: Experimental Stressor 
1. A general biological vulnerability was predicted to be evident in all three clinical 
groups (i.e., PTSD and pain group, PTSD group, pain group), although this was 
not predicted to be demonstrated in the control group.  This would be 
demonstrated by: a) lower baseline cortisol levels prior to the experimental 
stressor, and b) blunted salivary cortisol levels following the experimental 
stressor.   
2. Anxious mood was hypothesized to exist on a continuum across the measurement 
occasions of the experimental stressor.  Participants in the PTSD and pain group 
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were anticipated to report the highest levels of anxious mood (both at baseline and 
in response to the experimental stressor), followed by the PTSD and the pain only 
groups.  Participants in the control group were anticipated to report the lowest 
levels of anxious mood. 
3. Participants in the three clinical groups were predicted to report greater use of 
negative coping strategies (i.e., denial, behavioral disengagement, self-blame) in 
response to the experimental stressor, while participants in the control group were 
predicted to report greater use of positive coping strategies (i.e., active coping, 
positive reframing, acceptance).   
Hypotheses: Questionnaire Data 
4. It was hypothesized that depression levels would exist on a continuum.  Women 
in the PTSD and pain group were anticipated to report the highest levels of 
depression symptoms, followed by women in the PTSD only and the pain only 
groups.  Women in the control group were anticipated to report the lowest level of 
depression symptoms. 
5. A general psychological vulnerability will be evident in all three clinical groups, 
although this is not hypothesized to be demonstrated in the control group.  This 
will be evident by higher levels of learned helplessness (e.g., greater levels of 
internal, stable, and global attributions). 
6. Support for a general psychological vulnerability will also be evident in all three 
clinical groups by increased mean impact ratings of negative life events and 
general levels of self-perceived stress.  Subsequently, these participants will also 
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be more likely to view ambiguous situations as more threatening than participants 
in the control group. 
7. Participants in the three clinical groups were predicted to report greater use of 
negative coping strategies (i.e., denial, behavioral disengagement, self-blame) in 
general, while participants in the control group were predicted to report greater 
use of positive coping strategies (i.e., active coping, positive reframing, 
acceptance) in general.   
8. Differential learned alarms will be evident for the three clinical groups.  Due to 
the nature of PTSD, it is expected that both the PTSD group and the PTSD and 
pain group will demonstrate a learned alarm with respect to PTSD (self-report).  It 
is hypothesized that participants in the pain only group and PTSD and pain group 
will report greater anxiety associated with pain than participants in the PTSD only 
group or control group.  All three clinical groups are hypothesized to report 
greater levels of anxiety sensitivity than the control group. 
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Chapter 2 
METHOD  
Participants 
 Participants were 46 females who were 18 years of age or older.  All participants 
were recruited from the local community and undergraduate psychology courses at the 
University of Maine.  Based on initial screening criteria (see below), participants were 
categorized into the following four groups: (1) women who have PTSD without chronic 
pain (hereafter referred to as the PTSD group; n = 11), (2) women who have 
musculoskeletal pain without PTSD (hereafter referred to as the pain group; n = 10), (3) 
women with both PTSD and musculoskeletal pain (hereafter referred to as the PTSD and 
pain group; n = 10), and (4) women without PTSD and chronic pain (hereafter referred to 
as the control group; n = 15).  Power analyses were conducted using the GPower 3.0 
program (Faul, Erdfelder, Lang, & Buchner, 2007).  With an alpha level of .05, power 
analyses revealed that a sample size of 48 would result in a power of .97 for cortisol 
analyses.  This calculation was based on a 4 (Group: PTSD, pain, PTSD and pain, 
control) X 5 (Measurement collection point: baseline, 10 minute post-stress induction, 20 
minute post-stress induction, 40 minute post-stress induction, and 60 minute post-stress 
induction) mixed between-within-subjects ANOVA.  Previous research has indicated that 
there is a correlation of .76 between cortisol samples that are taken by the same 
individual within 20 minutes of each other, with variance of .042 and an effect size of .20 
(Hruschka, Kohrt, & Worthman, 2005). 
Participants from the local community received $20 for participation in the study, 
and participants from undergraduate psychology courses at the University of Maine 
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received 4 research credits.  Participants were also offered enrollment in a free treatment 
study.  All participants read and signed an informed consent form (Appendix A) prior to 
their participation in the study.  Individuals were notified that they could discontinue their 
participation in the study at any time, and that they could choose to not answer any 
questions that they did not feel comfortable answering.  Once participation was 
completed, all participants were debriefed regarding the study protocol.   
Study Criteria 
 Participants were enrolled in the PTSD group if they: 1) met DSM-IV-TR 
research criteria for PTSD, and 2) did not report experiencing chronic pain.  Participants 
in the PTSD and Pain group: 1) met diagnostic criteria for PTSD, and 2) had self-reported 
symptoms of chronic musculoskeletal pain.  The Pain group had: 1) self-reported 
symptoms of chronic musculoskeletal pain, and 2) they did not meet criteria for PTSD.  
In order for the musculoskeletal pain to be defined as chronic pain, it must have lasted for 
at least the last three months (International Association for the Study of Pain, 1986).  For 
the purposes of this study, self-report of chronic pain symptoms was utilized to categorize 
participants.  To qualify for the control group: 1) participants did not meet criteria for 
PTSD, and 2) they did not report experiencing any chronic pain conditions.  Participants 
in all groups were excluded if they reported having: 1) cardiovascular disorder, 2) current 
alcohol or substance abuse disorders, 3) a history of psychotic disorder, 4) a history of 
bipolar disorder, 5) daily use of opioid medications, or 6) were receiving hormone 
replacement therapy.   
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Recruitment 
 Participants were recruited from the local community, websites, and 
undergraduate psychology courses at the University of Maine.  Flyers were hung up 
within approving local establishments and doctors’ offices.  All potential participants 
who contacted the principal investigator were given a brief description of the study and 
completed a phone screening (Appendix B).  All participants who met the initial 
screening criteria were invited to participate in the study.   
Experimenters 
 A fifth-year graduate student was the principal investigator and oversaw all 
aspects of the study.  Other graduate students in clinical psychology who were trained to 
administer diagnostic interviews helped to interview participants.  A graduate student 
who was blind to the participants’ group status also reviewed each audiotape recording of 
the SCID-I interview to establish interrater reliability for diagnostic status.  
Undergraduate research assistants were trained on study procedures to assist in the 
experimental task and with data entry.  All personnel read the American Psychological 
Association ethics code regarding research, were familiar with IRB procedures, and 
completed the University of Maine IRB website training for human subjects.   
Measures  
 Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research 
Version, Patient Edition (SCID- I/P). The SCID-I/P was used to establish PTSD 
diagnoses, establish comorbid diagnoses, and to rule out the existence of exclusionary 
diagnoses.  The SCID-I/P is a semi-structured interview designed to assess for both 
current and lifetime Axis I diagnoses (First, Spitzer, Gibbon, & Williams, 2002).  During 
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the interview, individuals are asked questions regarding potential symptoms that they 
may experience with regard to Axis I diagnoses such as depression (e.g., In the past 
month, has there been a period of time when you were feeling depressed or down most of 
the day nearly every day?), and anxiety (e.g., In the past six months, have you felt 
particularly nervous or anxious?). 
 The SCID has been used extensively in studies to establish anxiety disorder 
diagnoses, and to rule out the presence of other psychiatric disorders (e.g., Horsch, 
McManus, Kennedy, & Edge, 2007; Mehner & Koch, 2007; Orr et al., 1998).  Studies 
that have assessed for the reliability of the SCID-I have demonstrated good interrater 
reliability with kappa values of .57-1.00, and test-retest reliability with kappa values of 
.35 -.78 (Zanarini & Frankenburg, 2001; Zanarini et al., 2000).  The SCID-I has also 
demonstrated superior validity when compared to routine clinical interviews (Basco et 
al., 2000; Shear et al., 2000).  
 Short Screening Scale for PTSD. The Short Screening Scale for PTSD is a brief 
clinician-administered interview to assess for a PTSD diagnosis (Appendix B; Breslau, 
Peterson, Kessler, & Schultz, 1999).  The Short Screening Scale for PTSD was used as a 
prescreening measure to be administered over the phone since it can be administered in 3 
minutes (Orsillo, Batten, & Hammond, 2001).  The measure consists of 7 yes/no 
questions to assess for various aspects of a DSM-IV diagnosis of PTSD (e.g. Did you 
avoid being reminded of this experience by staying away from certain places, people, or 
activities?).  A score of 4 or higher has been shown to have the greatest sensitivity (.80 - 
.85), specificity (.84 - .97), and predictive value (.71 positive predictive value, and .98 
negative predictive value) when considering a DSM-IV diagnosis for PTSD (Breslau et 
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al., 1999; Kimerling et al., 2006).  Furthermore, the measure has good test-retest 
reliability with a Spearman’s rank correlation of .84 (Kimerling et al., 2006). 
 McGill Pain Questionnaire (MPQ).  The MPQ is a self-report questionnaire, 
designed to assess for pain descriptors, the spatial distribution of pain, temporal 
properties of pain, and an overall pain intensity rating (Melzack, 1975; Appendix C).  
Pain descriptor words are grouped into four major subgroups: Sensory (e.g., pulsing, 
pricking, pinching), Affective (e.g., tiring, sickening, blinding), Evaluative (e.g., 
annoying, troublesome), and Miscellaneous (e.g., tight, cold, nagging).  Drawings of the 
human body are provided to mark the location of both internal and external pain.  Finally, 
pain intensity levels are rated on a 6 point Likert scale (0 = “No Pain” to 5 = 
“Excruciating”).  The MPQ is a widely used questionnaire, and has been administered in 
over 350 studies assessing various pain populations.  For the purposes of this study, the 
MPQ was used to confirm symptoms of musculoskeletal pain (i.e., location of pain), and 
to determine the number of tender points reported by participants (Melzack & Katz, 
2001). 
 The MPQ has demonstrated good test-retest reliability within a chronic low back 
pain sample (Love, Leboeuf, & Crisp, 1989).  Factor analyses have remained 
inconsistent, with the factor loadings possibly being dependent of the type of pain that is 
being assessed.  The measure has been shown to be sensitive to treatment effects in 
reducing pain levels, and has demonstrated discriminative ability between various forms 
of chronic pain (Melzack & Katz, 2001). 
 Expanded Attributional Style Questionnaire (Expanded ASQ). The Expanded 
ASQ is a 24-item self-report scale, designed to assess for attributional styles associated 
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with the learned helplessness model of depression.  In particular, the measure assesses for 
three subscales: Internality, Stability, and Globality (Appendix D; Peterson & Villanova, 
1988).  Each of the 24 items involves reactions to a range of hypothetical negative events.  
Individuals were asked to imagine themselves in each situation, and then to rate three 7-
point Likert scales with regards to internality (1 = “totally due to others,” and 7 = “totally 
due to me”), stability (1 = the cause of the situation will be “never present” in the future, 
and 7 = the cause of the situation will be “always present” in the future), and globality (1 
= the cause is associated with “just this situation,” and 7 = the cause is associated with 
“all situations”).   
The Expanded ASQ was derived from the original Attributional Style 
Questionnaire (ASQ; Peterson et al., 1982) to improve upon the measure’s reliability 
(Peterson & Villanova, 1988).  The Expanded ASQ demonstrated good reliability with 
Cronbach’s coefficient alpha scores of .66 for the Internality subscale, .85 for the 
Stability subscale, and .88 for the Globality subscale.  The expanded version also 
demonstrated good predictive validity, and greater internal consistency than the original 
ASQ (Peterson & Villanova, 1988). 
 Life Experiences Survey (LES). The LES is a 57-item self-report measure 
designed to assess individuals’ experiences with a wide range of situations in the past 6 
and 12 months (Appendix E; Sarason, Johnson, & Siegel, 1978).  Three additional blank 
spaces were also included in the LES in the event that an individual experienced a 
situation that was not listed in the questionnaire.  Items were chosen to represent a wide 
range of situations that are frequently experienced by the general population (e.g., 
marriage, new job, death of a close family member, serious illness or injury).  Each item 
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that an individual has experienced within the past year is rated on a 7-point Likert scale 
from -3 (“extremely negative”) to +3 (“extremely positive”).  The LES yields a positive 
change score (sum of the positive impact ratings), a negative change score (sum of the 
negative impact ratings), and a total change score (sum of all impact ratings).  Research 
indicates that the negative change scores have demonstrated the greatest test-retest 
reliability across a 5-6 week time period (.56 - .88, p < .001), followed by the total 
change scores (.63 - .64, p < .001) and positive change scores (.19 - .53, p < .001).  When 
compared to the other change scores, the negative change score was found to be most 
predictive of health status.  In addition, negative change scores demonstrated a positive 
correlation with state (.29, p < .01) and trait (.46, p <.01) anxiety (Sarason et al., 1978).  
Since the negative change score has demonstrated the greatest test-retest reliability, is 
most predictive of health, and is positively correlated with trait anxiety symptomatology, 
only the negative change score will be used for the purposes of this study.  The LES was 
also slightly modified to assess for experiences that each individual has experienced 
within the past 12 months, and within their lifetime. 
 Brief Cope. The Brief Cope is a 28-item self-report scale, designed to assess for 
the use of a variety of coping strategies.  Fourteen subscale scores are obtained for 
individual coping strategies including: Active Coping, Planning, Positive Reframing, 
Acceptance, Humor, Religion, Using Emotional Support, Using Instrumental Support, 
Self-Distraction, Denial, Venting, Substance Use, Behavioral Disengagement, and Self-
Blame (Appendix F; Carver, 1997).  The Brief Cope was derived from the longer original 
version of the COPE, which consisted of 60-items (Carver, Scheier, & Weintraub, 1989).  
The Brief Cope was designed to obtain similar reliability and validity ratings in a shorter 
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amount of time (Carver, 1997).  Each individual item ranges from 1 (“I haven’t been 
doing this at all”) to 4 (“I’ve been doing this a lot”).  Reliability analyses have yielded 
acceptable coefficient alpha scores for the individual subscales, ranging from .50 to .90 
(with most exceeding .60; Carver, 1997).  For the purposes of this study, participants 
completed the Brief Cope with regards to how they cope in general and in response to the 
experimental stress task. 
 Impact of Event Scale – Revised (IES – Revised). The IES – Revised is a self-
report measure to assess PTSD symptomatology based upon DSM-IV diagnostic criteria 
(Appendix G; Weiss & Marmar, 1997).  The IES – Revised consists of 22 items, with 
each item ranging from 0 (“Not at all”) to 4 (“Extremely”).  The measure is broken down 
into three subscales: Intrusion, Avoidance, and Hyperarousal (Weiss & Marmar, 1997).  
The measure was derived from the original Impact of Event Scale (IES; Horowitz, 
Wilner, & Alvarez, 1979), with some changes to add the Hyperarousal subscale and 
update the diagnostic criteria from DSM-III criteria to DSM-IV criteria (Weiss & 
Marmar, 1997).  The IES – Revised has demonstrated high internal consistency within 
various studies for the Intrusion subscale (coefficient alpha scores ranging from .87 - 
.92), Avoidance subscale (alpha scores ranging from .84 - .84), and the Hyperarousal 
subscale (alpha scores ranging from .79 - .90).  Test-retest reliability was also assessed in 
two samples, demonstrating acceptable reliability for all of the subscales (Weiss & 
Marmar, 1997).   
 Pain Anxiety Symptom Scale-20 (PASS-20).  The PASS-20 is a self-report 
measure designed to assess anxiety and fear that is associated with pain conditions 
(Appendix H; McCracken & Dhingra, 2002).  The PASS-20 was derived from the 
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original PASS (McCracken, et al., 1993) to decrease the amount of time and effort 
needed to administer the questionnaire within clinical and research populations 
(McCracken & Dhingra, 2002).  The PASS-20 consists of 20 items that are rated on a 6-
point Likert scale, ranging from 0 (“Never”) to 5 (“Always”).  Responses on the PASS-
20 are used to compute 4 subscales: Cognitive, Escape/Avoidance, Fear, and 
Physiological Anxiety.  A total score may also be computed by adding all items of the 
questionnaire (McCracken & Dhingra, 2002).   
 The PASS-20 has demonstrated good reliability and validity within a chronic pain 
sample.  Subscale scores on the PASS-20 are highly correlated with the original subscale 
scores of the PASS with 40 items (ranging from r = 0.93 to r = 0.97).  The PASS-20 
demonstrated good internal consistency (ranging from α = 0.75 to α = 0.91).  Results also 
supported the predictive and construct validity of the PASS-20 (McCracken & Dhingra, 
2002).  Research with fibromyalgia and chronic low back pain samples also supported the 
one and four-factor structures of the PASS-20 (Roelofs et al., 2004). 
 Anxiety Sensitivity Index (ASI).  The ASI (Reiss, Peterson, Gursky, & McNally 
(1986); Appendix I) is a 16 item self-report questionnaire designed to measure fear of 
symptoms related to anxiety.  In particular, anxiety sensitivity is a functional diagnostic 
dimension in which high levels may serve as a risk factor for anxiety disorders (Reiss, 
1991).  High levels of anxiety sensitivity are associated with catastrophic views regarding 
consequences of anxiety related symptoms (Peterson & Reiss, 1992).  Each item in the 
ASI is rated using a 5-point Likert scale ranging from 0 (“very little”) to 4 (“very much”).  
The total score is determined by adding up the scores for all 16 items.    
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 Numerous studies have been conducted looking at internal reliability scores 
within the ASI, with Cronbach’s alpha coefficient scores ranging from .82 to .91 
(Peterson & Heilbronner, 1987; Taylor et al., 1991; Taylor, Koch, McNally, & Crocket, 
1992; Telch et al., 1989).  The two-week test-retest reliability of the ASI, as computed by 
Pearson product-moment correlations, was 0.74 for the women (Reiss et al., 1986).  
Similarly, the ASI was found to have a three year test-retest reliability of .71 (Maller & 
Reiss, 1992).  There is also strong evidence supporting the construct validity of the ASI 
(Peterson & Reiss, 1992).   
 Intolerance of Uncertainty Scale – Short Version (IUS-12). The IUS-12 is a 
self-report measure designed to assess individual reactions to uncertainty, ambiguous 
situations, and to the future (Appendix J; Carleton, Norton, & Asmundson, 2007).  In 
particular, intolerance to uncertainty may mean that an individual views that there is no 
way to predict negative events, to the point that all ambiguous information is viewed as 
being threatening (Heydayati, Dugas, Buhr, & Francis, 2003).  The IUS-12 was derived 
from the original IUS to decrease the number of questions and boost the measure’s factor 
structure (Carleton et al., 2007).  The IUS-12 consists of 12 items that are rated on a 5-
point Likert scale ranging from 1 (“not at all characteristic of me”) to 5 (“entirely 
characteristic of me”).  The sum of all items creates a total score for a general intolerance 
of uncertainty.  The IUS-12 has demonstrated very good internal consistency (α = .91), 
and is highly correlated with the original 27-item IUS (r = .96).  The IUS-12 also 
demonstrated convergent validity with the Generalized Anxiety Disorder Questionnaire-
IV (GADQ; r = .61), the Penn State Worry Questionnaire (PSWQ; r = .54), and the Beck 
Anxiety Inventory (BAI; r = .57; Carleton et al., 2007). 
  68   
 Profile of Mood States (POMS). The POMS is a self-report measure of transitory 
mood states (e.g., nervous, irritated, bored, etc.; McNaire, Lorr, & Droppleman, 1971; 
Appendix K).  The POMS consists of six subscales that may be used individually or in 
combination with each other as one measure.  Items are rated on a 5-point Likert scale, 
ranging from 0 (“not al all”) to 4 (“extremely”).  For the purposes of this study, the 
anxiety (POMS-A) subscale was administered prior to and following the experimental 
task.  This assisted in measuring participants’ anxiety levels before and after the stress 
task.  Research has demonstrated that the POMS has good reliability and validity, with 
coefficient alpha levels ranging from .90 or greater (McNair et al., 1971). 
 Visual Analog Stress Scale (VASS).  A 7-point Likert scale (Appendix L) was 
constructed to assess for the level of stress that participants experienced during the 
experimental task.  Items on the scale range from 0 (“Not at all stressful”) to 7 
(“Extremely stressful”).  Since the Trier Social Stress Task is expected to induce 
moderate levels of psychological and physiological stress (Kirschbaum, Pirke, & 
Hellhammer, 1993), it is important to measure self perceptions of stress as a manipulation 
check. 
 Perceived Stress Scale (PSS).  The PSS is a 14-item self-report measure designed 
to assess general self-perceptions of stress over the previous month (Cohen, Kamarck, & 
Mermelstein, 1983; Appendix M).  This is a measure of stress in general, and not a 
measure of cumulative stressful events.  Items are rated on a 5-point Likert scale ranging 
from 0 (“never”) to 4 (“very often”).  Research indicates that the PSS has good internal 
consistency (r = 0.84 - 0.86) and test-retest reliability (r = 0.85; Cohen et al., 1983).  In 
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addition, scores on the PSS have been found to be positively correlated with negative 
health outcomes (e.g., Cohen, Tyrell, & Smith, 1993). 
 Beck Depression Inventory-II (BDI-II). The BDI-II (Beck, Steer, & Brown, 
1996; Appendix N) is a 21-item self-report measure used to assess the severity of 
depressive symptomatology.  Each item response ranges from 0 to 3 possible points (with 
0 representing that the participant does not experience the individual symptom and 3 
representing the most severe degree that the symptoms may be experienced).  Total 
scores may range from 0 to 63 points.  For the purposes of this study, the BDI was used 
to assess for comorbid depressive symptoms. 
In a meta-analysis of studies that assessed for the psychometric properties of the 
initial BDI (Beck, Steer, & Carbin, 1988), the average internal consistency found for the 
measure demonstrated a Cronbach’s alpha coefficient of .86 for clinical samples and .81 
for nonclinical samples.  The BDI-II has demonstrated high levels of internal consistency 
within a sample of clinical outpatients (α = 0.92; Beck et al., 1996).  Statistical analyses 
have demonstrated that the BDI-II has stronger factorial validity than the initial version 
of the BDI (Dozois, Dobson, & Ahnberg, 1998).  In a study that assessed psychometric 
properties of the BDI-II within an older adult population, results supported the internal 
reliability of the measure (α = .86).  The convergent and discriminant validity of the BDI-
II was also supported within this population (Segal, Coolidge, Cahill, & O’Riley, 2008). 
Experimental Task 
 Trier Social Stress Test (TSST). The TSST (Kirschbaum et al., 1993) has been 
used within both the PTSD and chronic pain literature to induce moderate physiological 
and psychological stress (e.g., Dorn et al., 2003; Jones, Rollman, & Brooke, 1997; 
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McRae et al., 2006; Simeon et al., 2007; Wingenfeld et al., 2008).  The TSST was 
established to elicit HPA axis activation in a large proportion of participants, and has 
been found to double or even quadruple salivary cortisol levels within numerous samples.  
Within the TSST, participants are first given a ten minute anticipation time period, during 
which they are instructed to prepare a five minute speech regarding why they are the 
perfect applicant for a particular job.  Participants are told that they will be giving the 
speech in front of two “managers” that are trained to monitor nonverbal behavior (these 
individuals are really research assistants trained in study protocol).  Following the ten 
minute anticipation period, participants are told that their speech is also being videotaped 
(which is not true).  Participants then begin their 5 minute speech.  If their speech does 
not last for the full five minute period, they are prompted to continue with a series of 
previously prepared questions.  Following the five minute speech, the participant is 
instructed to serially subtract 13 from 1,022 as quickly and accurately as possible for a 
five minute period.  If a mathematical error is made during this time period, then they are 
asked to start over from the beginning (Kirschbaum et al., 1993). 
Psychophysiological Recording.  Salivary cortisol samples were collected using a 
Salimetrics drool tube.  Participants were instructed to drool a small amount of saliva into 
a plastic tube and then replace the lid on the tube.  This method of collecting salivary 
cortisol levels has been found to have better volume recovery of saliva than the 
Salivette® (Jennifer Jewell, personal communication, November, 2008).  Research has 
demonstrated high correlations between salivary cortisol levels and blood-based samples 
of cortisol (r > 0.90 in most reports; e.g., Kirschbaum & Hellhammer, 1989).  Salivary 
cortisol samples were utilized for this study because they are less invasive and could be 
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sent for analysis through the mail.  In an attempt to increase reliability and validity of 
cortisol samples, participants were instructed to not eat anything, drink anything (other 
than water), not exercise, or smoke cigarettes for up to 1.5 hours before coming in for 
their research visit.  Menstrual cycle phase was also controlled.  All of these variables 
have been found to alter salivary cortisol levels (Kirschbaum & Hellhammer, 1989).   
Procedure 
Participants who met screening criteria (see above) were invited to participate in 
the study.  Participants who expressed an interest in participating were scheduled to come 
in to the laboratory in the Psychology Department for their research visit.  Premenopausal 
women were scheduled during the luteal phase of their menstrual cycle (1 to 7 days 
before menstruation begins).  All participants were scheduled between 2:00 to 6:00 p.m.  
Previous research has demonstrated that there are diurnal rhythms to cortisol levels, 
subsequently, similar time restrictions have been used in previous research that assessed 
cortisol levels (e.g., Kirschbaum, Klauer, Filipp, & Hellhammer, 1995; Kirschbaum et al., 
1999; Rohleder, Wolf, Piel, & Kirschbaum, 2003).   
Upon arriving for their scheduled appointment, participants were asked to read 
and sign an informed consent form (Appendix A) before participating in the study.  The 
experimenter also reviewed the content of the consent form with each participant, and 
answered any questions that participants had.  Each participant completed the MPQ to 
confirm self-report of chronic musculoskeletal pain.  Participants were then interviewed 
using the SCID-I/P to confirm diagnoses or rule out the specified exclusionary diagnoses.  
Participants who met exclusionary criteria following administration of the MPQ and 
SCID-I/P were debriefed regarding the study and received $5 for their participation.   
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Participants who met criteria for any of the experimental groups (PTSD group, 
pain group, or PTSD and pain group) or the control group were placed in a sound-
attenuated room to help minimize the effects of external stimuli during the study 
protocol.  Prior to receiving experimental instructions for the TSST, participants were 
asked to sit quietly for a 10-minute baseline period while they adjusted to the laboratory 
setting.  Following the adaptation period, participants were asked to complete the POMS, 
and a baseline salivary cortisol sample was collected.  After baseline assessments, 
participants began the experimental task using the TSST study protocol described above.  
Following the completion of the TSST, participants were asked to remain in their chair 
and rest quietly for 60 minutes.  Ten minutes after the completion of the TSST, 
participants completed measures assessing changes in their mood state (POMS) following 
the experimental task.  Participants also completed a Brief Cope as a measure of coping 
strategies utilized during the experimental task, and the VASS as a measure of self-
perceived stress during the TSST.  A second salivary cortisol sample was collected at this 
time, and at 20 minutes following the TSST, to assess for peak salivary cortisol levels.  
Research has demonstrated that cortisol levels are at their highest during these time 
points (e.g., Kirschbaum et al., 1993).  The POMS was completed with each saliva 
sample to measure changes in mood following the experimental task.  A fourth cortisol 
sample and POMS was collected at 40 minutes after the completion of the TSST to 
measure changes in cortisol as the participant begins to relax again.  To ensure that stress 
levels have been lowered before leaving the lab, participants then listened to a 20 minute 
relaxation exercise before leaving the lab.  Following the relaxation exercise, participants 
completed their fifth salivary cortisol sample and POMS.   
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Participants were then debriefed regarding study procedures (Appendix P), and 
were given instructions for completion of their counterbalanced packet of questionnaires 
including: Expanded ASQ, LES, Brief Cope, IES-Revised, PASS-20, ASI, IUS-12, PSS, 
BDI-II, and the POMS.  Included in this packet of questionnaires was a demographics 
information form (Appendix O) which included the date, age, race, education (in years), 
current household income, current medications, weight, height, and menstrual cycle 
status.  Finally, participants were compensated for their participation. 
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Chapter 3 
RESULTS 
 The current study represents a quasi-experimental, four groups (PTSD, pain, 
PTSD and pain, control), design.  Data analyses were completed using PASW version 
18.0 software for Windows.  Participant characteristics and results for each hypothesis 
are presented in this section.   When possible, power and effect size (eta2) were 
calculated.  Cohen (1988) suggested guidelines with respect to interpreting effect size in 
which .10 is small, .25 is medium, and .40 is large.  Marginal results were reported with 
alphas <.10 for omnibus tests. Chi-square analyses were used for frequency data.  When 
the test of sphericity was significant in a mixed design, degrees of freedom were adjusted 
using the Greenhouse-Geisser correction (Brace, Kemp, & Snelgar, 2009). In general, 
post-hoc comparisons were conducted using Tukey’s HSD test with alpha set at .05.  
Given specific predictions in the hypotheses of this study, a priori planned comparisons 
were completed when appropriate with independent samples t-tests by combining group 
scores that were hypothesized to be similar.  This was completed as part of the ANOVA 
calculations. 
Participant Characteristics 
 The total sample consisted of 46 females.  Participants ranged in age from 18 to 
66 (see Table 3.1.for group averages).  The four groups of participants (PTSD and pain, 
PTSD only, pain only, controls) differed significantly in age [F(3,43) = 6.15, p<.01].  
Post-hoc analyses revealed that the pain only group was significantly older than the 
PTSD only and control groups.  Similarly, women in the PTSD and pain group were 
significantly older than controls.  There were no significant differences in age between 
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the PTSD and pain and pain only groups, between the PTSD and pain and PTSD only 
groups, or between the PTSD only and control groups.  The four groups of participants 
also differed significantly in body mass index; BMI [F(3,41) = 3.86, p = .02].  Post-hoc 
analyses revealed that the pain only group had a significantly higher BMI rating than the 
PTSD only and control groups. 
Table 3.1.  Group Averages in Age and BMI 
 PTSD and pain 
(n = 10) 
PTSD only 
(n = 11) 
Pain only 
(n = 10) 
Control 
(n = 15) 
Mean Age 42.80ab 
(15.39) 
27.44bc 
(15.90) 
45.90a 
(15.62) 
25.27c 
(11.05) 
 
BMI 28.19ab 
(7.09) 
23.75b 
(3.89) 
31.73a 
(6.29) 
24.59b 
(5.29) 
 
Note. Standard deviations are in parentheses. Means with different subscripts differ 
significantly at p < .05. 
Chi-square analyses indicated that there were significant group differences in 
diagnoses of depression [χ2 (3, N = 45) = 17.22, p = .001].  In particular, the PTSD and 
pain group had the highest prevalence of depression, followed by the PTSD only, control, 
and pain only groups respectively.  No significant group differences were found for social 
phobia [χ2 (3, N = 45) = 0.14, ns], specific phobia [χ2 (3, N = 45) = 0.43, ns], obsessive-
compulsive disorder [χ2 (3, N = 45) = 7.33, ns], panic disorder [χ2 (3, N = 45) = 3.15, ns], 
agoraphobia [χ2 (3, N = 45) = 1.07, ns], or generalized anxiety disorder [χ2 (3, N = 45) = 
.17, ns].  See Table 3.2 for specific percentages of these diagnoses. 
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Table 3.2. DSM-IV Diagnoses 
 PTSD & 
Pain 
PTSD Only Pain Only Control 
 
Depression 70% 40% 0% 7% 
Social Phobia 30% 10% 10% 0% 
Specific Phobia 40% 10% 30% 20% 
OCD 20% 0% 0% 0% 
Panic Disorder 20% 20% 0% 7% 
Agoraphobia 0% 10% 10% 7% 
Generalized 
Anxiety Disorder 
40% 20% 10% 7% 
 
Advanced clinical graduate students reviewed audiotapes of the SCID-IV 
interviews and rated whether or not the participants met criteria for PTSD.  These ratings 
were compared to diagnoses given to the participants during their laboratory session.  
Unfortunately, inter-rater reliability could only be assessed for 17 out of 46 interviews 
(37%).  Many of the interviews could not be reviewed due to equipment failure during 
the recording process.  Several of the interviews were also missing from the laboratory 
tapes.    Of the 17 interviews that were rated, the principal investigator and the advanced 
clinical graduate students agreed 100% that women in the PTSD and pain and PTSD only 
groups met DSM-IV criteria for PTSD, and that women in the pain only and control 
groups did not meet criteria for PTSD.   
Participant demographics are found in Table 3.3.  Chi-square analyses indicated 
that there were no significant group differences in race [χ2 (3, N=43) = 1.91, ns], income 
[χ2 (24, N=41) = 23.32, ns], or education [χ2 (21, N=44) = 24.05, ns]. However, there 
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were significant differences between groups regarding relationship status [χ2 (9, N=44) = 
22.60, p < .007].  Women in the PTSD and pain and pain only groups were more likely to 
be married or divorced, whereas women in the PTSD only and control groups were more 
likely to be single.   
Table 3.3. Participant demographics 
 PTSD & 
Pain 
PTSD 
Only 
Pain Only Control 
 
Race 
     Caucasian 
     Asian 
     Unknown 
 
100% 
0% 
0% 
 
100% 
0% 
0% 
 
90% 
0% 
10% 
 
93% 
7% 
0% 
Education 
     < High school 
     High school diploma 
     Associate’s degree 
     Partial undergraduate 
     Bachelor’s degree 
     Partial graduate 
     Master’s degree 
     Doctorate  
 
10% 
0% 
30% 
20% 
30% 
0% 
10% 
0% 
 
0% 
33% 
0% 
56% 
0% 
11% 
0% 
0% 
 
0% 
20% 
10% 
40% 
20% 
0% 
10% 
0% 
 
0% 
33% 
7% 
40% 
0% 
7% 
7% 
7% 
Family Income 
     < 30,000 
     30,000 – 39,999 
     40,000 – 49,999 
     >50,000 
     Unknown 
 
60% 
0% 
20% 
20% 
0% 
 
44% 
22% 
11% 
11% 
12% 
 
20% 
30% 
0% 
40% 
10% 
 
47% 
0% 
13% 
33% 
7% 
Relationship Status 
     Single 
     Living with partner 
     Married 
     Divorced 
 
0% 
10% 
60% 
30% 
 
78% 
0% 
11% 
11% 
 
20% 
20% 
50% 
10% 
 
73% 
7% 
20% 
0% 
 
 There were no significant group differences regarding the use of birth control pills 
[χ2 (3, N=44) = 5.38, ns].  Significant group differences in menstrual status were reported 
[χ2 (3, N=44) = 8.15, p = .04]. Women in the PTSD only and control groups were more 
likely to be premenstrual than women in the other two groups. Women in the PTSD and 
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pain and pain only groups reported more postmenopausal status than women in the other 
two groups (see Table 3.4. for specific percentages). 
Table 3.4. Menstrual Cycle Demographics 
 PTSD & 
Pain 
PTSD Only Pain Only Control 
 
Birth Control 20% 
 
56% 20% 53% 
Pre-menopausal 60% 
 
89% 50% 93% 
Post-menopausal 40% 
 
11% 50%   7% 
  
There were significant group differences regarding family history of PTSD [χ2 (3, 
N=44) =8.15, p = .04]. Women with PTSD and chronic pain and PTSD only were more 
likely to report a family history of PTSD than those without a diagnosis of PTSD ([pain 
only and control groups). There were also significant group differences in family history 
of chronic pain [χ2 (3, N=44) =13.02, p = .005]. Women who reported experiencing 
chronic pain (PTSD and pain and pain only groups) were more likely to report a family 
history of chronic pain than those without chronic pain (PTSD only and control groups 
(see Figure 3.1 for specific percentages). 
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Figure 3.1. Family History of PTSD and Chronic Pain 
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Hypothesis Results: Experimental Stressor 
Hypothesis One 
 According to hypothesis one, participants in the clinical group (for combination 
hypotheses, the three clinical groups combined are referred to as the clinical group) were 
predicted to demonstrate: a) lower baseline cortisol levels prior to the experimental 
stressor, and b) blunted salivary cortisol levels following the experimental stressor as 
compared to controls.  Two participants were considered outliers  (at least 2 standard 
deviations above the mean) and were removed from statistical analyses for cortisol 
related hypotheses.  First, comparisons of baseline cortisol levels were assessed using a 
one-way ANOVA with incorporated planned comparisons.  Planned comparisons in 
baseline cortisol levels between the clinical group and control group were not significant 
(t = -.78, df = 38, ns).  Post-hoc power analyses were completed for t-test results on 
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baseline levels of cortisol between the clinical and control groups.  Given the observed 
effect size and variability within the current study, power analyses revealed that a sample 
size of 40 would result in a power of .18.  In addition, a one-way ANOVA did not reveal 
a significant difference between the groups on baseline cortisol levels [F(3,41) = .36, ns].   
Planned comparisons in cortisol levels across occasions for the clinical group  and 
control group were completed within a 2 (Group: clinical group, control) X 5 (Occasion: 
baseline, 10 minutes post-stress induction, 20 minutes post-stress induction, 40 minutes 
post-stress induction, and 60 minutes post-stress induction) repeated measures ANOVA. 
Given that the test of sphericity was found to be significant, degrees of freedom were 
adjusted using the Greenhouse-Geisser correction.  The Group x Occasion interaction 
effect was not significant [F(2.50, 99.91) = .66, ns].  The main effect for Group [F(1, 40) 
= .67, ns] was not significant.  The main effect for Occasion was significant [F(2.50, 
99.91) = 5.89, p < .01, partial η2 = .13, power = .92].   
Paired samples t-tests revealed that baseline levels of cortisol were higher than 
those at 40 [t = 2.56, df = 41, p = .01] and 60 min [t = 2.96, df = 41, p = .01].  Cortisol 
levels at 10 minutes following the TSST were greater than those at 40 minutes [t = 3.70, 
df = 41, p = .01] and at 60 minutes [t = 3.62, df = 41, p = .01].  Finally, cortisol levels at 
20 minutes were higher than those at 40 minutes [t = 3.82, df = 41, p = .01] and at 60 
minutes [t = 3.38, df = 51, p = .01].  All other paired samples t-tests did not reveal any 
significant differences in cortisol levels.  Group averages are presented in Table 3.5 and 
Figure 3.2. 
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Table 3.5. Cortisol Means (nmol/L)Across Time Periods 
Time Period Control 
 
Clinical Group Total Sample 
Baseline 6.62a 
(3.94) 
 
5.80a 
(2.73) 
6.09 
(3.19) 
10 Min Post TSST 6.19a 
(3.16) 
 
6.17a 
(3.78) 
6.18 
(3.54) 
20 Min Post TSST 6.16a 
(3.04) 
 
5.82a 
(3.70) 
5.94 
(3.45) 
40 Min Post TSST 4.93a 
(2.88) 
 
4.97a 
(3.04) 
4.96 
(2.95) 
60 Min Post TSST 5.46a 
(3.08) 
 
4.63a 
(2.44) 
 
4.93 
(2.68) 
Total Sample 5.87 
(.74) 
 
5.48 
(.55) 
 
  
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p < 05. 
Figure 3.2 Cortisol Levels across Occasions 
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To further assess for any group differences, a 4 (Group: PTSD, pain, PTSD and 
pain, control) X 5 (Occasion: baseline, 10 minutes post-stress induction, 20 minutes post-
stress induction, 40 minutes post-stress induction, and 60 minutes post-stress induction) 
repeated measures ANOVA was completed. Given that the test of sphericity was found to 
be significant, degrees of freedom were adjusted using the Greenhouse-Geisser 
correction.  The Group x Occasion interaction effect was not significant [F(7.41, 93.84) = 
.45, ns].  The main effect for Group [F(1, 38) = .63, ns] was not significant.  The main 
effect for Occasion was significant [F(2.47,93.84) = 5.97, p = .002, partial η2 = .14.  
Please refer to planned comparisons for paired samples t-test analyses (see Figure 3.3 and 
refer to table 3.6 for individual group averages).  A logarithmic transformation of the 
cortisol values yielded the same results.  The interaction effect for Group x Occasion was 
not significant when age was included as a covariate [F(7.47, 87.12) = .84, ns].  
Similarly, the interaction effect for Group x Occasion was not significant when BMI was 
used as a covariate [F(7.47, 84.58) = .87, ns].   
Figure 3.3. Cortisol levels across occasions: Individual Groups 
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Table 3.6. Cortisol Means (nmol/L) Across Time Periods: Individual Groups 
Time Period PTSD & 
Pain 
PTSD Only Pain Only Control 
 
Total 
Sample 
 
Baseline 5.31a 
(2.07) 
6.37a 
(3.26) 
5.70a 
(2.94) 
6.62a 
(3.94) 
 
6.09 
(3.19) 
10 Min Post 
TSST 
5.60a 
(2.82) 
7.16 a 
(4.85) 
5.77a 
(3.63) 
6.19a 
(3.16) 
 
6.18 
(3.53) 
20 Min Post 
TSST 
4.58a 
(2.14) 
6.98a 
(4.13) 
5.89a 
(4.44) 
6.16a 
(3.04) 
 
5.94 
(3.45) 
40 Min Post 
TSST 
3.89a 
(1.79) 
5.93a 
(3.55) 
5.09a 
(3.42) 
4.93a 
(2.88) 
 
4.96 
(2.94) 
60 Min Post 
TSST 
3.99a 
(1.80) 
5.37a 
(2.80) 
4.53a 
(2.69) 
5.46a 
(3.08) 
 
4.93 
(2.68) 
Total Sample 4.68 
(.96) 
6.36 
(.96) 
5.40 
(.96) 
5.87 
(.74) 
 
 
 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p < 05. 
Ancillary Findings 
Cortisol Levels within Groups. Although not hypothesized, analyses were 
conducted to determine within group differences in cortisol levels across the stress task. 
As the test of sphericity was found to be significant across occasions in the PTSD and 
pain group, degrees of freedom were adjusted using the Greenhouse-Geisser correction.  
There was a significant Occasion effect for women in the PTSD and pain group [F(4, 32) 
= 2.87, p = .04, partial η2 = .26]. Paired samples t-tests revealed that cortisol levels at 10 
min were greater than those at 40 min [t = 2.65, df = 8, p = .03], 60 min [t = 2.27, df = 8, 
p = .05].  Cortisol levels at 20 min were greater than those at 40 min [t = 2.39, df = 8, p = 
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.05] for women in the PTSD and pain group. There were no significant Occasion effects 
for women in the PTSD only [F(4,32) = 1.89, ns] pain only [F(4,32) = 1.19, ns], and 
control groups [F(4,32) = 1.19, ns]. 
Hypothesis Two   
It was predicted that group means for anxious mood would exist on a continuum 
across the measurement occasions of the experimental task (POMS anxiety subscale).  
Participants in the PTSD and pain group were anticipated to report the highest levels of 
anxious mood, followed by the PTSD and the pain only groups.  Participants in the 
control group were anticipated to report the lowest levels of anxious mood.  Two 
participants considered to be outliers for cortisol results were excluded from experimental 
session analyses. To test this hypothesis, the PTSD only and pain only were combined to 
form a PTSD only plus pain only group. 
As the test of sphericity was found to be significant in the 2 (Groups: PTSD and 
pain, PTSD only plus pain only) X 5 (Occasions) mixed-factor ANOVA, degrees of 
freedom were adjusted using the Greenhouse-Geisser correction.  The main effect for 
Occasion [F(1.92,49.95) = 21.24, p <.0001, partial η2 = .45] and Group [F(1,26) = 13.18, 
p <.001, partial η2 = .34] were significant.   The test of the Group x Occasion interaction 
effect was marginally significant [F(1.92, 49.95) = 2.65, p= .08,  partial η2 = .09].  The 
PTSD and pain group reported significantly higher levels of anxious mood than the 
PTSD only and pain only group.  Refer to Table 3.7 for group averages.   
Paired samples t-tests indicated that baseline levels of anxious mood were 
significantly higher than levels of anxious mood at 10 minutes [t = -.2.58, df = 27, p = 
.02].  Levels of anxious mood were significantly lower from baseline at 20 minutes [t = 
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2.95, df = 27, p = .007], 40 minutes [t = 4.00, df = 27, p = .001], and at 60 minutes [t = 
4.82, df = 27, p = .0001].  Levels of anxious mood were significantly higher at 10 
minutes following the TSST than at 20 [t = 4.98, df = 27, p = .0001], 40 [t = 5.29, df = 27, 
p = .0001], and 60  [t = 5.79, df = 27, p = .0001] minutes.  Levels of anxious mood at 20 
minutes were significantly higher than anxious mood at 60 minutes [t = 3.75, df = 27, p = 
.001].  Finally, levels of anxious mood at 40 minutes were significantly higher than those 
at 60 minutes [t = 3.06, df = 27, p = .005].   
As the test of sphericity was found to be significant in the 2 (Groups: PTSD only 
plus pain only, control) X 5 (Occasions) mixed-factor ANOVA, degrees of freedom were 
adjusted using the Greenhouse-Geisser correction.  The main effect for Occasion [F(1.64, 
52.59) = 16.98, p <.0001, partial η2 = .35] was significant.  The Group [F(1,32) = .96, ns] 
and Group x Occasion interaction [F(1.64, 52.59) = 1.16, ns] were not significant.    
Paired samples t-tests indicated that baseline levels of anxious mood were 
significantly higher than levels of anxious mood at 10 minutes [t = -.3.81, df = 33, p = 
.001].  Levels of anxious mood were significantly lower from baseline at 20 minutes [t = 
2.79, df = 33, p = .009], 40 minutes [t = 2.50, df = 33, p = .02], and at 60 minutes [t = 
3.54, df = 33, p = .001].  Levels of anxious mood were significantly higher at 10 minutes 
following the TSST than at 20 [t = 5.14, df = 33, p = .0001], 40 [t = 4.50, df = 33, p = 
.0001], and 60  [t = 4.84, df = 33, p = .0001] minutes.  Finally, levels of anxious mood at 
40 minutes were significantly higher than those at 60 minutes [t = 2.03, df = 33, p = .05].  
All other paired samples t-tests were not significant.  Refer to Table 3.7 for group 
averages.   
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Table 3.7. POMS Anxiety Levels Across Time Points 
Occasion PTSD & Pain PTSD Only 
& 
Pain Only 
Control 
 
Total 
Sample 
Baseline 13.33a 
(4.80) 
6.26a 
(2.83) 
5.67a 
(3.39) 
 
7.53 
(4.56) 
10 Min Post 
TSST 
13.11a 
(5.65) 
10.26a 
(6.45) 
7.93a 
(5.68) 
 
10.05 
(6.19) 
20 Min Post 
TSST 
8.67a 
(3.50) 
5.16a 
(2.52) 
4.07a 
(1.28) 
 
5.51 
(2.93) 
40 Min Post 
TSST 
7.56a 
(3.28) 
4.58a 
(1.77) 
4.73a 
(1.53) 
 
5.26 
(2.37) 
60 Min Post 
TSST 
6.11a 
(2.15) 
4.00a 
(0.75) 
4.27a 
(1.03) 
 
4.53 
(1.47) 
Total Sample 9.76 
(.77) 
6.05 
(.53) 
5.33 
(.60) 
 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05 
As the test of sphericity was found to be significant in the 4 (Groups) X 5 
(Occasions) mixed-factor ANOVA, degrees of freedom were adjusted using the 
Greenhouse-Geisser correction.  The main effect for Occasion [F(1.90, 74.09) = 28.42, p 
= .0001, partial η2 = .42] and Group [F(3,39) = 7.82, p = .0001, partial η2 = .38] were 
significant.   The test of the Group x Occasion interaction effect was also significant 
[F(5.70, 74.09) = 2.32, p=.05,  partial η2 = .15].  Refer to Table 3.8 and Figure 3.4 for 
group averages. 
F tests for the significant Group x Occasion interaction effect revealed the 
following: baseline [F(3, 42) = 10.47, p < .0001, partial η2 = .45, power = .99], 10 min 
[F(3, 42) = 2.41, ns], 20 min [F(3, 42) = 6.81, p < .001, partial η2 = .34, power = .96], 40 
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min[F(3, 42) = 4.48, p = .009, partial η2 = .26, power = .85], and 60 min [F(3, 42) = 6.07, 
p < .002, partial η2 = .32, power = .94].   
Tukey’s HSD indicated that participants in the PTSD and pain group reported 
significantly higher baseline levels of anxious mood than the PTSD only (Mean 
Difference = 6.56, SE = 1.66, p = .002), pain only (Mean Difference = 7.53, SE = 1.62, p 
< .001), and control groups (Mean Difference = 7.67, SE = 1.49, p < .001).  No 
significant group differences were demonstrated at 10 minutes following the TSST.  The 
PTSD and pain group reported significantly higher levels of anxious mood at 20 minutes 
following the TSST than the PTSD only (Mean Difference = 3.57, SE = 1.16, p = .02), 
Pain only (Mean Difference = 3.47, SE = 1.13, p = .02), and control groups (Mean 
Difference = 4.60, SE = 1.04, p < .001).  The PTSD and pain group reported significantly 
higher levels of anxious mood at 40 minutes following the TSST than the PTSD only 
(Mean Difference = 2.89, SE = 1.00, p = .04), pain only (Mean Difference = 3.06, SE = 
.98, p = .02) and control groups (Mean Difference = 2.82, SE = .90, p = .02).  Finally, the 
PTSD and pain group reported significantly higher levels of anxious mood at 60 minutes 
following the TSST than the PTSD only (Mean Difference = 2.11, SE = .59, p = .01) and 
pain only (Mean Difference = 2.11, SE = .58, p = .01) groups (Group averages are 
presented in Table 3.6).  Overall, the PTSD and pain group reported higher levels of 
anxious mood across all time points except at 10 minutes following the TSST (see Figure 
3.3).  
Paired samples t-tests indicated that baseline levels of anxious mood were 
significantly lower than levels of anxious mood at 10 minutes [t = -3.28, df = 42, p = 
.002], and significantly greater than at 20 minutes [t = 3.63, df = 42, p = .001], 40 minutes 
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[t = 3.75, df = 42, p = .001], and 60 minutes [t = 4.72, df = 42, p = .0001].  Levels of 
anxious mood were significantly higher at 10 minutes following the TSST than at 20 [t = 
5.74, df = 42, p = .001], 40 [t = 5.53, df = 42, p = .0001], and 60  [t = 5.60, df = 42, p = 
.0001] minutes.  Levels of anxious mood at 20 minutes were significantly higher than 
anxious mood at 60 minutes [t = 2.90, df = 42, p = .006].  Finally, levels of anxious mood 
at 40 minutes were significantly higher than those at 60 minutes [t = 2.30, df = 42, p = 
.005].   
There was a significant within-group effect for women in the PTSD and pain 
group [F(2.04, 16.32) = 9.97, p = .001, partial η2 = .56, power = .96], PTSD only group 
[F(1.59, 12.69) = 11.1, p = .003, partial η2 = .58, power = .94], pain only group [F(1.46, 
13.11) = 4.58, p < .05, partial η2 = .34, power = .59], and control group [F(1.64, 22.97) = 
4.78, p < .05, partial η2 = .25, power = .68]. 
For the simple main effect for Group, Tukey’s HSD indicated that women in the 
PTSD and pain group reported significantly higher baseline levels of anxious mood than 
at 60 minutes (Mean Difference = 7.22, SE = 1.71, p = .03) following the TSST.  Anxious 
mood at 10 minutes (Mean Difference = 7.00, SE = 1.84, p = .05) was also significantly 
higher than levels of anxious mood at 60 minutes following the TSST.  The PTSD only 
group reported a significantly higher levels of anxious mood at 10 minutes following the 
TSST than at 20 minutes (Mean Difference = 7.56, SE = 1.83, p = .03), 40 minutes (Mean 
Difference = 8.00, SE = 2.11, p = .05), and 60 minutes (Mean Difference = 8.67, SE = 
2.29, p = .05).  No significant differences across occasions were demonstrated for the 
pain only group.  Finally, the control group reported a significant decrease in anxious 
mood from 10 to 20 minutes follow-up (Mean Difference = 3.87, SE = 1.29, p < .05). 
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Ancillary Analyses 
Since the PTSD and pain group reported significantly higher levels of anxious 
mood at baseline than the remaining three groups [F(3,44) = 14.16, p < .0001], a repeated 
measures ANOVA with baseline levels of anxious mood entered as a covariate was 
conducted on the remaining 4 occasions.  The main effects for Occasion [F(1.40, 54.18) 
= .61, ns] and Group [F(3, 38) = .55, ns] were not significant.  The Group x Occasion 
interaction effect was significant [F(4.20, 54.18) = 2.96, p = .03, partial η2 = .19, power = 
.77].  A breakdown of the interaction revealed no significance differences between 
groups regarding anxious mood.  Results continue to indicate that women in the PTSD 
and pain group reported the highest levels of anxious mood across most time points. 
Table 3.8. POMS Anxiety Levels Across Time Points: Individual Groups 
Occasion PTSD & 
Pain 
PTSD Only Pain Only Control 
 
Total 
Sample 
Baseline 13.33a 
(4.80) 
6.78b 
(3.11) 
5.80b 
(2.62) 
5.67b 
(3.39) 
 
7.53 
(4.56) 
10 Min Post 
TSST 
13.11a 
(5.65) 
12.67a 
(6.91) 
8.10a 
(5.47) 
7.93a 
(5.68) 
 
10.05 
(6.19) 
20 Min Post 
TSST 
8.67a 
(3.50) 
5.11b 
(1.83) 
5.20b 
(3.12) 
4.07b 
(1.28) 
 
5.51 
(2.92) 
40 Min Post 
TSST 
7.56a 
(3.28) 
4.67b 
(1.50) 
4.50b 
(2.07) 
4.73b 
(1.53) 
 
5.26 
(2.37) 
60 Min Post 
TSST 
6.11a 
(2.15) 
4.00b 
(0.50) 
4.00b 
(.94) 
4.27b 
(1.03) 
 
4.53 
(1.47) 
Total Sample 9.76 
(.77) 
6.64 
(.77) 
5.52 
(.73) 
5.33 
(.60) 
 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05 
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Figure 3.4. Anxious Mood across Experimental Task: Individual Groups 
POMS Anxious Mood
0
2
4
6
8
10
12
14
Baseline 10 min Post
TSST
20 min Post
TSST
40 min Post
TSST
60 min Post
TSST
A
nx
io
us
 M
oo
d 
Le
ve
l S
co
re
s
PTSD & Pain
PTSD Only
Pain Only
Controls
 
Visual Analog Stress Scale 
  Although not originally incorporated into the study hypotheses, 
participants completed the Visual Analog Stress scale immediately after completing the 
experimental stressor as a means of measuring their self-perceived stress levels during 
this task.  A one way ANOVA demonstrated that no significant group differences were 
reported in self-reported stress levels in response to the TSST [F(3,40) = .93, ns].  In 
general, all groups reported experiencing moderate levels of stress during the TSST.  
Group averages are presented in Table 3.9. 
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Table 3.9.  Visual Analog Stress Scale 
 PTSD and pain PTSD only Pain only Control 
Mean VASS 
Score 
4.89a 
(1.36) 
4.78a 
(2.22) 
4.50a 
(1.41) 
4.00a 
(.76) 
Note. Standard deviations are in parentheses.  Means with different subscripts are 
significantly at p < 05. 
Hypothesis Three 
 Participants in the three clinical groups were predicted to report greater use of 
negative coping strategies (i.e., denial, behavioral disengagement, self-blame), while 
participants in the control group were predicted to report greater use of positive coping 
strategies (i.e., active coping, positive reframing, acceptance).  This trend was 
hypothesized to occur in both general use of coping strategies and coping strategies 
utilized in response to the TSST (general use of coping strategies will be discussed with 
questionnaire data).   
 Planned comparisons did not indicate any significant group differences between 
the clinical group and the control group for levels of denial [t = .21, df = 38, ns], 
behavioral disengagement [t = .62, df = 38, ns], self-blame [t = 1.57, df = 38, ns], active 
coping [t = 1.33, df = 38, ns], positive reframing [t = .45, df = 38, ns], and acceptance [t = 
.27, df = 38, ns].  Refer to Table 3.10 for group averages. 
 
 
 
 
  92   
Table 3.10. Brief COPE Scores in Response to TSST 
Subscales Control 
 
Clinical Group 
Active Coping 2.47a 
(.58) 
 
2.81a 
(.91) 
Positive Reframing 
 
2.47a 
(.95) 
2.59a 
(.81) 
Acceptance 
 
 
2.67a 
(.98) 
2.74a 
(.74) 
Denial 
 
 
1.37a 
(.61) 
1.41a 
(.61) 
Behavioral Disengagement 
 
1.30a 
(.49) 
1.41a 
(.56) 
Self-Blame 1.77a 
(.62) 
 
2.15a 
(.86) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
A series of one-way ANOVAs were completed to assess for additional group 
differences.  These analyses indicated a near significant group difference in self-blame 
[F(3,41) = 2.65, p = .06] in response to the TSST.  No significant group differences were 
demonstrated for denial [F(3,41) = .85, ns], behavioral disengagement [F(3,41) = .80, 
ns], active coping [F(3,41) = 1.28, ns], positive reframing [F(3,41) = .32, ns], or 
acceptance [F(3,41) = .14, ns].  Individual group averages are presented in Table 3.11. 
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Table 3.11. Individual Group Brief COPE Scores in Response to TSST 
Subscales PTSD & Pain PTSD Only Pain Only Control 
 
Active Coping 2.50a 
(.75) 
2.94a 
(.77) 
3.00a 
(1.17) 
2.47a 
(.58) 
 Positive Reframing 
 
2.67a 
(1.00) 
2.72a 
(.91) 
2.39a 
(.49) 
2.47a 
(.95) 
Acceptance 
 
 
2.61a 
(.86) 
2.83a 
(.66) 
2.78a 
(.75) 
2.67a 
(.98) 
Denial 
 
 
1.67a 
(.83) 
1.28a 
(.36) 
1.28a 
(.51) 
1.37a 
(.61) 
Behavioral 
Disengagement 
 
1.61a 
(.65) 
1.28a 
(.44) 
1.33a 
(.56) 
1.30a 
(.49) 
Self-Blame 2.17a 
(.61) 
2.56a 
(.85) 
1.72a 
(.97) 
1.77a 
(.62) 
 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
Hypothesis Results: Questionnaire Data 
Hypothesis Four   
 It was predicted that depression levels would exist on a continuum.  Women in 
the PTSD and pain group were anticipated to report the highest levels of depression 
symptoms, followed by women in the PTSD only and the pain only groups.  Women in 
the control group were anticipated to report the lowest level of depression symptoms.  
Planned comparisons between the PTSD and pain group and the combined PTSD only 
and pain only groups did not indicate any significant group differences in levels of 
depression [t = 1.82, df = 39, ns].  Similarly, planned comparisons between the combined 
PTSD only and pain only groups and the control group did not demonstrate any 
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significant group differences [t = 1.74, df = 39, ns].  Please refer to table 3.12 for group 
averages. 
Table 3.12. Depression Severity Scores 
 PTSD & Pain PTSD Only & 
Pain Only 
Control 
 
BDI-II 19.78a 
(3.63) 
13.58a 
(11.08) 
8.43a 
(5.81) 
 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05 
To further assess for individual group differences, a one-way ANOVA indicated 
significant group differences in levels of depression on the BDI-II [F(3,41) = 7.19, p< 
.001].  Post-hoc analyses revealed that the PTSD and pain and PTSD only groups 
reported significantly higher levels of depression than the pain only and control groups.  
BDI-II scores reported by the PTSD and pain and PTSD only groups were indicative of 
mild to moderate levels of depression, whereas scores reported by the pain only and 
control groups were in line with minimal levels of depression.  Group averages are 
presented in Table 3.13. 
Table 3.13.  Depression Severity Scores: Individual Groups 
 PTSD and pain PTSD only Pain only Control 
BDI-II 19.78a 
(3.63) 
19.22a 
(12.31) 
8.5b 
(7.10) 
8.43b 
(5.81) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
Hypothesis Five 
 It was predicted that all three clinical groups would report higher levels of learned 
helplessness than the control group.  Planned comparisons did not reveal significant 
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group differences between the three clinical groups and the control group for Internality 
(t = 1.26, df = 39, ns), Stability (t = 1.03, df = 39, ns), or Globality (t = .43, df = 39, ns) 
subscales on the Expanded Attributional Style Questionnaire.  Group averages are 
presented in Table 3.14. 
Table 3.14. Expanded Attributional Style Questionnaire Subscales 
ASQ Subscales Control 
 
Clinical Group 
Internality 4.28a 
(.94) 
 
4.58a 
(.62) 
Stability 4.28a 
(1.21) 
 
4.58a 
(.68) 
Globality 4.09a 
(1.10) 
 
4.19a 
(.63) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
Individual group differences in learned helplessness were completed using a 4 
(Group: PTSD, pain, PTSD and pain, control) X 3 MANOVA with the 3 ASQ subscales 
(Internality, Stability, Globality) as criterion variables. Results did not indicate a 
significant effect for Group on the combined dependent construct of learned helplessness 
[F(9, 90.20) = .77, ns; Wilks’ Lambda = .86; partial η2 = .05].  Analysis of individual 
dependent variables indicated no significant Group effects for Internality [F(3, 39) = .72, 
ns, partial η2 = .05]; Stability [F(3, 39) = .89, ns, partial η2 = .06]; or Globality [F(3, 39) 
= 1.13, ns, partial η2 = .08].  Individual group averages are presented in Table 3.15.   
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Table 3.15. Expanded Attributional Style Questionnaire Subscales: Individual Groups 
ASQ Subscales PTSD & Pain PTSD Only Pain Only Control 
 
Internality 4.74a 
(.73) 
4.53a 
(.25) 
4.49a 
(.53) 
4.28a 
(.94) 
 
Stability 4.89a 
(.68) 
4.45a 
(.30) 
4.40a 
(.52) 
4.28a 
(1.21) 
 
Globality 4.55a 
(.61) 
4.17a 
(.27) 
3.88a 
(.63) 
4.09a 
(1.10) 
 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
Hypothesis Six 
 Participants in all three clinical groups were predicted to report greater levels of 
negative life events and general stress than the control group.  Participants in the three 
clinical groups were also anticipated to report viewing ambiguous situations as being 
more threatening.  To test these hypotheses group differences on self-reported measures 
(LES, IUS-12, PSS) were assessed in a series of one-way ANOVAs.   
Life Experiences Survey. Planned comparisons revealed significant group 
differences between the three clinical groups and the control group for the mean impact 
of life experiences in the previous year [t = -3.41, df = 35, p < .01].  Overall, the three 
clinical groups combined reported significantly more negative mean impacts of life 
events than the control group.  Refer to Table 3.16 for planned comparison group 
averages.  Similarly, a one-way ANOVA indicated that there was a significant effect for 
mean impact levels of life experiences in the previous year [F(3, 38) = 4.22, p = .01, 
partial η2 = .27].  Post-hoc analyses revealed that the PTSD and pain and PTSD only 
groups reported significantly more negative impact levels of life experiences in the past 
  97     
   
   
 
year than the control group (see Figure 3.5).  Refer to Table 3.17 for individual group 
averages. 
Figure 3.5. Mean Impact of Life Experiences in past Year 
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Perceived Stress Scale. Planned comparisons indicated significant group 
differences between the three clinical groups and the control group on general levels of 
perceived stress in the past month [t = 2.15, df = 39, p < .05].  Refer to Table 3.16 for 
planned comparison group averages.  A one-way ANOVA also indicated that there was a 
significant effect for overall ratings of stress [F(3, 42) = 4.79, p < .01, partial η2 = .23]. 
Post-hoc analyses demonstrated that the PTSD and pain group reported significantly 
higher levels of stress than the pain only and control groups in the past month (see Figure 
3.6).  Refer to Table 3.17 for individual group averages. 
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Figure 3.6. General Levels of Stress 
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Intolerance of Uncertainty Scale – Short Version. Planned comparisons between 
the three clinical groups and the control group did not reveal significant group differences 
for intolerance of uncertainty [t = .94, df = 39, ns].  Refer to Table 3.16 for planned 
comparison group averages.  Similarly, a one-way ANOVA did not indicate significant 
group differences in levels of intolerance of uncertainty [F(3, 42) = 1.43, ns, partial η2 = 
.03].  Refer to Table 3.17 for individual group averages. 
Table 3.16. Stress Levels and Negative Life Experiences 
 Control 
 
Combined Clinical 
Groups 
LES: Mean Impact .69a 
(1.15) 
 
-.69b 
(1.26) 
PSS 
 
 
23.20a 
(5.70) 
27.71b 
(8.31) 
IUS-12 29.47a 
(8.39) 
 
32.39a 
(11.29) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
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Table 3.17. Stress Levels and Negative Life Experiences: Individual Groups 
 PTSD & Pain PTSD Only Pain Only Control 
 
LES: Mean 
Impact 
-1.09a 
(1.23) 
-.72a 
(1.53) 
-.34ab 
(1.01) 
.69b 
(1.15) 
 
PSS 
 
 
31.22a 
(5.48) 
30.22ab 
(8.58) 
22.20b 
(7.86) 
23.20b 
(5.70) 
IUS-12 37.33a 
(12.93) 
31.55a 
(11.39) 
28.70a 
(8.83) 
29.47a 
(8.39) 
 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
Ancillary Findings 
Frequency of Life Events. Although not originally included in hypotheses, group 
differences on self-reported frequencies of negative and positive life events (i.e. LES) 
were assessed in a series of one-way between subjects ANOVAs.  Since the assumption 
of homogeneity of variance was violated when assessing for group differences in total 
frequency of positive and negative life events in the previous year, two Kruskal-Wallis 
one-way between-subjects analyses were completed.  There was not a significant effect 
for frequency of positive life events [X2(3, N=39) = 2.34, ns] or frequency of negative life 
events [X2(3, N=39) = 4.68, ns].  Please refer to Table 3.18 for group averages. 
Table 3.18. Frequency of negative and positive life events in past year 
 PTSD & Pain PTSD Only Pain Only Control 
 
LES: Freq of 
Negative Life Events 
9.14a 
(6.59) 
6.33a 
(3.94) 
4.44a 
(2.70) 
4.36a 
(5.05) 
 
LES: Freq of 
Positive Life Events 
3.00a 
(2.58) 
2.33a 
(1.58) 
2.33a 
(1.32) 
4.43a 
(3.63) 
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Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
Hypothesis Seven 
 As mentioned earlier, participants in the three clinical groups were predicted to 
report greater use of general negative coping strategies (i.e., denial, behavioral 
disengagement, self-blame), while participants in the control group were predicted to 
report greater use of general positive coping strategies (i.e., active coping, positive 
reframing, acceptance).    
Planned comparisons between the clinical group and the control group with 
regards to general use of coping strategies indicated significant group differences in 
levels of self-blame [t = 2.01, df = 38, p = .05].  In particular, the three clinical groups 
combined reported higher levels of self-blame than the control group.  Planned 
comparisons did not indicate any significant group differences in denial [t = -.20, df = 38, 
ns], behavioral disengagement [t = .15, df = 38, ns], active coping [t = -.10, df = 38, ns], 
positive reframing [t = -.97, df = 38, ns], or acceptance [t = -.85, df = 38, ns].  Refer to 
Table 3.19 for planned comparison group averages.   
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Table 3.19. General Brief COPE 
 
Subscales  Control 
 
Clinical Group 
Active Coping 2.75a 
(.85) 
 
2.73a 
(.92) 
Positive Reframing 
 
2.68a 
(.97) 
2.39a 
(.86) 
Acceptance 
 
 
2.96a 
(.89) 
2.71a 
(.89) 
Denial 
 
 
1.21a 
(.47) 
1.18a 
(.46) 
Behavioral Disengagement 
 
1.39a 
(.71) 
1.41a 
(.51) 
Self-Blame 1.50ab 
(.71) 
 
1.89a 
(.72) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
A series of one-way ANOVAs were completed to further assess for group 
differences.  There were significant group differences in self-blame [F(3,41) = 5.82, 
p<.01].  Post-hoc analyses revealed that the PTSD only group reported significantly 
higher levels of self-blame than the pain only and control groups.  The PTSD and pain 
group also reported significantly higher levels of self-blame than the pain only group.  No 
significant group differences were demonstrated for denial [F(3,41) = 1.19, ns], 
behavioral disengagement [F(3,41) = 1.32, ns], active coping [F(3,41) = .87, ns], positive 
reframing [F(3,41) = .74, ns], or acceptance [F(3,41) = .40, ns].  Individual group 
averages are presented in Table 3.20.  
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Table 3.20. General Brief COPE: Individual Groups 
 
Subscales  PTSD & Pain PTSD Only Pain Only Control 
 
Active Coping 2.72a 
(.67) 
2.39a 
(.99) 
3.05a 
(1.01) 
2.75a 
(.85) 
 
Positive Reframing 
 
2.56a 
(.85) 
2.11a 
(.93) 
2.50a 
(.85) 
2.68a 
(.97) 
Acceptance 
 
 
2.72a 
(.83) 
2.56a 
(.95) 
2.85a 
(.97) 
2.96a 
(.89) 
Denial 
 
 
1.39a 
(.70) 
1.17a 
(.35) 
1.0a 
(.00) 
1.21a 
(.47) 
Behavioral 
Disengagement 
 
1.67a 
(.50) 
1.44a 
(.58) 
1.15a 
(.34) 
1.39a 
(.71) 
Self-Blame 2.17bc 
(.66) 
2.28c 
(.67) 
1.30a 
(.42) 
1.50ab 
(.71) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
Hypothesis Eight 
 It was predicted that only participants in the PTSD group and PTSD and pain 
group would report evidence of a PTSD specific learned alarm.  Similarly, it was 
predicted that only participants in the pain group and PTSD and pain group would report 
evidence of a pain specific learned alarm.  All three clinical groups were predicted to 
report higher levels of anxiety sensitivity than the control group.  Self-report measures 
(i.e., IES-Revised, PASS-20, ASI) associated with evidence of a learned alarm were 
assessed in a series of one-way between subjects ANOVAs.   
Pain Anxiety Symptom Scale. No significant group differences between the two 
chronic pain groups and the PTSD only and control groups were demonstrated with 
planned comparisons for pain related avoidance [t = 1.44, df = 37, ns], cognitions [t = 
1.23, df = 37, ns], physiological symptoms [t = 1.08, df = 37, ns], or total PASS scores [t 
  103     
   
   
 
= 1.59, df = 37, ns];  however, a marginal significant difference was found for pain 
related fear [t = 1.90, df = 37, p = .06]. Refer to Table 3.21 for planned comparison group 
averages.   
Table 3.21. Pain Related Anxiety 
 Control 
&  
PTSD Only 
PTSD & Pain 
&  
Pain Only 
PASS: Total 
 
31.59a 
(21.55) 
41.63a 
(17.73) 
PASS: Fear 5.91a 
(4.33) 
 
8.89a 
(5.50) 
PASS: Avoidance 
 
9.05a 
(5.67) 
11.47a 
(4.67) 
PASS: Cognitive 
 
10.73a 
(6.95) 
13.53a 
(5.36) 
PASS: Physiological 5.91a 
(4.51) 
 
7.74a 
(5.26) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
A one-way ANOVA did not indicate any significant group differences in the total 
score for pain related anxiety [F(3,40) = 1.40, ns].  Similarly, no significant group 
differences were found on the avoidance [F(3,40) = .85, ns], cognitive [F(3,40) = 1.07, 
ns], or physiological [F(3,40) = 1.90, ns] subscales of the PASS; however, a marginal 
significant group difference was found for pain related fear [F(3,40) = 2.36, p = .09].  In 
particular, the PTSD and pain group reported the highest levels of pain related fear, 
followed by the pain only group, PTSD only group, and control groups respectively.    
Please refer to Table 3.24 for individual group averages.   
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Impact of Event Scale – Revised. Planned contrasts between the two PTSD 
groups and the pain only and control groups indicated significant group differences for 
total PTSD related symptoms on the IES-R [t = 2.14, df = 39, p < .05] and symptoms of 
hyperarousal [t = 3.21, df = 39, p < .01].  Inspection of the data suggested that 
participants with PTSD reported significantly higher levels of total PTSD symptoms and 
symptoms of hyperarousal than those without PTSD.  Planned contrasts did not indicate 
significant group differences for levels of avoidance [t = 1.70, df = 39, ns] or intrusion [t 
= .94, df = 39, ns].  Refer to Table 3.22 for planned comparison group averages.   
Table 3.22. PTSD Related Anxiety 
 Control 
&  
Pain Only 
PTSD & Pain 
&  
PTSD Only 
IES: Avoidance 
 
1.03a 
(.84) 
1.45a 
(.80) 
IES:  
Intrusion 
 
1.25a 
(.80) 
1.51a 
(.95) 
IES: Hyperarousal 
 
.87a 
(.73) 
1.69b 
(.86) 
IES: 
Total 
 
23.40a 
(14.28) 
33.89b 
(16.67) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
A series of one-way between subjects ANOVAs indicated significant group 
differences for symptoms of hyperarousal [F(3,42) = 2.59, p = .01].  Post-hoc analyses 
revealed that the PTSD and pain group reported significantly higher levels of 
hyperarousal than the control group.  No significant group differences were found for 
total scores on the IES-R [F(3,42) = 1.69, ns] or for the avoidance [F(3,42) = 1.50, ns] 
  105     
   
   
 
and intrusion subscales [F(3,42) = .46, ns].  Please refer to Table 3.23 for individual 
group averages.   
Anxiety Sensitivity Index. Planned contrasts between the three clinical groups and 
the control group did not reveal significant group differences [t = 1.11, df = 38, ns]. Refer 
to Table 3.21 for planned comparison group averages.  However, results of a one-way 
between subjects ANOVA indicated significant group differences in levels of anxiety 
sensitivity on the ASI, [F(3,41) = 3.62, p < .02].  Post-hoc analyses revealed that the 
PTSD and pain group reported significantly higher levels of anxiety sensitivity than the 
pain only group.  Please refer to Table 3.24 for individual group averages.   
Table 3.23. Anxiety Sensitivity 
 Control 
 
Combined Clinical 
Groups 
ASI 17.64a 
(11.24) 
 
21.82a 
(14.59) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
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Table 3.24. Measures of a Learned Alarm: Individual Groups 
 PTSD & Pain PTSD Only Pain Only Control 
 
ASI 30.22a 
(14.66) 
23.67ab 
(15.22) 
12.60b 
(8.55) 
17.64ab 
(11.24) 
 
PASS:  
Total 
 
45.78a 
(21.30) 
35.00a 
(14.80) 
 37.90a 
(13.88) 
29.64a 
(21.55) 
PASS:  
Fear 
10.89a 
(5.90) 
6.62a 
(3.02) 
7.10a 
(4.70) 
5.50a 
(4.99) 
 
PASS: 
Avoidance 
 
10.67a 
(5.31) 
8.75a 
(5.85) 
12.20a 
(4.16) 
9.21a 
(5.78) 
PASS: 
Cognitive 
 
14.44a 
(5.29) 
12.37a 
(6.02) 
12.70a 
(5.56) 
9.78a 
(7.48) 
PASS: 
Physiological 
9.78a 
(6.65) 
7.25a 
(3.49) 
5.90a 
(2.85) 
5.14a 
(4.96) 
 
IES: Avoidance 
 
1.21a 
(.86) 
1.69a 
(.69) 
.94a 
(.81) 
1.09a 
(.88) 
IES:  
Intrusion 
 
1.37a 
(.73) 
1.65a 
(1.16) 
1.27a 
(.98) 
1.23a 
(.68) 
IES: 
Hyperarousal 
 
1.83a 
(.87) 
1.55ab 
(.88) 
1.01ab 
(.98) 
.78b 
(.53) 
IES: 
Total 
 
31.67a 
(16.60) 
36.11a 
(17.44) 
23.60a 
(18.66) 
23.27a 
(11.22) 
Note. Standard deviations are in parentheses.  Means with different subscripts differ 
significantly at p< .05. 
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Chapter 4 
DISCUSSION 
The purpose of the current study was to test aspects of the triple vulnerability 
model (Barlow, 2000; Barlow, 2002; Otis et al., 2003) in PTSD and chronic 
musculoskeletal pain populations.  According to this model, individuals have a 
generalized biological vulnerability (e.g., inherited personality traits that lead individuals 
to react to environmental stressors in a defensive manner), generalized psychological 
vulnerability (e.g., sense of uncontrollability and perceived inability to cope), and a 
specific psychological vulnerability (e.g., development of learned alarms) that lead 
individuals to develop both PTSD and chronic pain (Barlow, 2000; Barlow, 2002; Keane 
& Barlow, 2002; Otis et al., 2003).  Furthermore, PTSD and chronic pain may serve as a 
reminder of each other, and may therefore maintain and worsen symptomatology of each 
condition (Otis et al., 2003).  Results of the current study are assessed within the context 
of the vulnerability (i.e., generalized biological, generalized psychological, & specific 
psychological) that they were hypothesized to represent. 
Generalized Biological Vulnerability 
  According to Barlow (2000, 2002), a generalized biological vulnerability is 
thought to be characterized by a genetic tendency to demonstrate emotional instability 
and reactivity in response to changes and stressors in one's environment.  Inherited 
personality traits that are indicative of this vulnerability may consist of being high-strung, 
nervousness, emotionality, negative affectivity, or neuroticism (Barlow, 2002; Clark et 
al., 1994).  Furthermore, neuroticism is characterized as experiencing emotions 
associated with the fight or flight response (e.g., fear, anxiety, distress), which may lead 
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to increased experience of negative moods (Eysenck, 1967, 1981).  In assessing for a 
generalized biological vulnerability for PTSD and chronic pain, three different 
hypotheses were assessed.   
Salivary Cortisol. If a biological vulnerability to demonstrate stress reactivity to 
stressful events is similar for PTSD and chronic pain, then baseline levels of 
physiological hyperarousal and physiological reactivity to environmental stressors were 
predicted to be similar in the three clinical groups as opposed to the control group.  In 
particular, participants in the three clinical groups were hypothesized to demonstrate 
lower baseline levels of cortisol prior to the experimental stressor and blunted cortisol 
levels following the experimental stressor.  Contrary to this hypothesis, results of the 
current study did not demonstrate significant group differences in baseline levels of 
cortisol between the three clinical groups and the control group.  This finding is similar to 
previous research comparing baseline levels of cortisol among fibromyalgia and control 
group samples (Wingenfeld et al., 2008).  Previous research studies assessing for basal 
cortisol levels among participants with PTSD have also generally demonstrated 
conflicting results (Meewisse, Reitsma, De Vries, Gersons, & Olff, 2007).    
Visual inspection of the data suggested that the PTSD only group reported the 
greatest increase in cortisol following the TSST; however, no significant group 
differences were demonstrated between groups across all time points.  Limited research 
has assessed for the role of cortisol reactivity in response to the TSST among individuals 
with PTSD or chronic pain, although McRae and colleagues (2006) reported that 
participants with PTSD demonstrated higher cortisol reactivity in response to the TSST 
than to a cold pressor task.  The PTSD and pain and pain only groups appeared to 
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demonstrate a blunted cortisol response following the TSST; however, this trend was also 
unexpectedly demonstrated by the control group.  Previous research has demonstrated 
similar blunted cortisol reactivity in response to the TSST among participants with 
fibromyalgia (Wingenfeld et al., 2008), although no previous  studies have been found 
that demonstrated a blunted response by a control group.  It is possible that this may be a 
result of publication biases in which researchers are less likely to publish non-significant 
or atypical results (Meewisse et al., 2007).  Levels of cortisol declined in all groups from 
20 minutes to 40 minutes following the experimental stressor, although they began to 
increase again in the control group from 40 to 60 minutes as participants were listening to 
the relaxation soundtrack.  It is possible that participants in this group began to feel 
restless toward the end of their participation in the study. 
As expected on the visual analog stress scale, all groups reported that the TSST 
was perceived as a moderately stressful experience.  Taking this into consideration, it 
appears as though the TSST was successful in eliciting the level of stress reactivity that 
was intended.  Although several variables were controlled for in the current study (e.g., 
food intake, exercise, smoking, menstrual cycle), it is possible that cortisol levels may 
have been influenced by the difficulty of controlling for other external variables (e.g., 
comorbid diagnoses, type of trauma).  In a meta-analysis that assessed for basal cortisol 
levels in participants with PTSD and control groups across 37 studies, results 
demonstrated that basal levels of cortisol tend to be highly variable across studies 
(Meewisse et al., 2007).  Results also indicated that PTSD tends to be associated with 
lower basal cortisol levels when participants experienced physical or sexual abuse; 
however, no significant group differences were demonstrated between participants in the 
  110   
PTSD groups and control groups when other forms of trauma were assessed (Meewisse et 
al., 2007).  Controlling for type of trauma was beyond the scope of the current study, 
although it is possible that type of trauma may have influenced study results.   
Anxiety. It was hypothesized that self-reports of anxious mood during the lab visit 
would exist on a continuum.  Participants in the PTSD and pain group were predicted to 
report the highest levels of anxiety across each occasion, followed by the PTSD only and 
pain only groups, and then by the control group.  This hypothesis was partially supported.  
The PTSD and pain group reported significantly higher levels of anxiety across most time 
points; however, no significant group differences were demonstrated between the PTSD 
only, pain only, and control groups.  No significant group differences were demonstrated 
at 10 minutes following the TSST, although, trends indicate that the PTSD and pain and 
PTSD only groups reported the highest levels of anxiety.  The pain only and control 
groups reported similar increases in anxiety at 10 minutes following the TSST.  Although 
not significantly different, the PTSD only group reported the second highest levels of 
anxiety at 10 minutes following the TSST, while the pain only and control groups 
continued to report similar levels of anxiety.  After listening to the relaxation track in the 
final 20 minutes of follow-up, the PTSD only, pain only, and control groups reported 
minimal levels of anxiety, while the PTSD and pain group continued to report 
significantly higher levels of anxiety.  Given that the TSST is supposed to induce 
moderate physiological and psychological stress (e.g., Dorn et al., 2003; Jones, Rollman, 
& Brooke, 1997; McRae et al., 2006; Simeon et al., 2007; Wingenfeld et al., 2008), 
results of the current study are in line with previous research demonstrating that 
individuals with PTSD tend to report high levels of anxiety in response to everyday 
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stressful life events than those without PTSD (Koopman, Gore-Felton, Classen, Kim, 
Spiegel, 2001). 
Overall, these findings support the hypothesis that comorbid diagnoses of PTSD 
and pain are associated with increased anxiety both prior to and following the 
experimental stressor; however, this trend was not the same for the PTSD only and pain 
only groups.  Although not significantly different, the PTSD only group reported higher 
levels of anxiety than the pain only and control groups immediately following the 
experimental stressor, although this trend was not demonstrated at other time points.  
Finally, the pain only and control groups reported similar levels of anxiety at all time 
points.  As a result, it appears as though the combined influence of PTSD and pain may 
lead to increased self-reports of anxious mood for individuals with these diagnoses. 
Although it does not appear that the PTSD only and pain only groups are linked to a 
similar vulnerability to respond to stressful situations with similar increases in self-
reported anxious mood. 
 Depression. It was predicted that self-reported symptoms of depression would 
also exist on a continuum.  Participants in the PTSD and pain group were predicted to 
report the highest levels of depression during the previous two weeks, followed by the 
PTSD only and pain only groups.  Participants in the control group were predicted to 
report the lowest symptoms of depression.  Contrary to this hypothesis, the PTSD and 
pain and PTSD only groups reported similar and significantly higher levels of depression 
than the pain only and control groups.  These findings are similar to that of previous 
research that has assessed for the high comorbidity rates between PTSD and depression 
(Taft, Resick, Watkins, & Panuzio, 2009); however it is surprising that participants in the 
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pain only group did not report higher levels of depression because high comorbidities 
between these diagnoses have been reported in previous research (e.g., Gormsen, 
Rosenberg, Bach, & Jensen, 2010). Findings in the current study suggest that symptoms 
of depression may be associated with having a diagnosis of PTSD and not necessarily 
chronic pain.  When considering depression as a component of negative affectivity and 
negative mood (Watson, Clark, & Carey, 1988), it does not appear as though PTSD and 
chronic pain have the same vulnerability for these personality traits. 
 Family History of PTSD and Chronic Pain. Finally, self-report data indicated 
that participants in the PTSD and pain and PTSD only groups were significantly more 
likely to report a family history of PTSD than the pain only and control groups.  This 
finding is similar to that of previous research reporting that individuals with PTSD are 
more likely to report a family history of PTSD than those without PTSD (Davidson et al., 
1985; McFarlane, 1988).  Similarly, participants in the PTSD and pain and pain only 
groups were significantly more likely to report a family history of chronic pain than 
participants in the PTSD only and control groups.  This finding also supports previous 
research assessing for a family history of chronic pain among individuals with 
generalized chronic widespread pain or a specific diagnosis of fibromyalgia (Bergman, 
2005).  Overall, these findings support the notion that there may be a genetic 
vulnerability toward developing PTSD and/or chronic pain due to the high family history 
rates of each diagnosis.  Given that participants in the chronic pain only group did not 
report significant frequencies of a family history of PTSD, and participants in the PTSD 
only group did not report significant frequencies of a family history of chronic pain, 
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results suggest that genetic vulnerabilities toward developing each diagnosis may be 
independent of one another.   
In summary, results of the current study do not provide support for the hypothesis 
that PTSD and chronic pain have a similar biological vulnerability to respond to stressful 
situations with an alarm reaction.  Results do provide initial support for the potential role 
of a biological vulnerability for individuals with PTSD to respond to stressful situations 
with an alarm reaction.  This was evident with regards to anxiety reactivity, heightened 
symptoms of depression, and self-reported family histories of PTSD; however, it is 
unclear as to whether several of these factors represent an actual vulnerability or a 
reaction to having the diagnosis.  Participants with chronic pain also reported 
significantly higher family history rates of chronic pain, although participants in the pain 
only group did not report heightened levels of anxiety in response to the experimental 
stressor or general levels of depression.  As such, evidence for this vulnerability was not 
readily evident among participants with chronic pain without PTSD.   
Given that no significant results were demonstrated with cortisol analyses, 
additional research will be needed to determine the role of cortisol reactivity in both 
populations.  As hypothesized, participants with comorbid PTSD and chronic pain 
reported the highest levels of anxiety reactivity.  This group also reported similarly high 
levels of depression to that of the PTSD only group.  As a result, it may be possible that 
several of these factors served as an initial vulnerability for PTSD, although it is also 
possible that having both conditions may serve to worsen symptoms experienced by this 
population.  This hypothesis would be in line with Otis and colleagues proposal  that 
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PTSD and chronic pain may work together to maintain and worsen symptomatology of 
each condition (Otis et al., 2003).   
Generalized Psychological Vulnerability 
 A generalized psychological vulnerability is thought to refer to a general sense of 
uncontrollability and perceived inability to cope with unpredictable negative life events 
(Barlow, 2000, 2002). Barlow (2002) also highlighted the importance of inducing a stress 
response to measure changes in coping strategies.  Otis and colleagues (2003, 2006) 
notion that a generalized psychological vulnerability may be applied to both PTSD and 
chronic pain was assessed within three hypotheses. 
 Learned Helplessness. According to the fourth hypothesis, all three clinical 
groups were predicted to report higher levels of learned helplessness than the control 
group.  Results of the current study indicate that there were no significant group 
differences for learned helplessness factors of internality, stability, or globality.  
Consequently, results suggest that the construct of learned helplessness may not serve as 
a psychological vulnerability for PTSD or chronic pain.  This lack of significant group 
differences conflicts with limited research that has found PTSD to be associated with a 
helpless attributional style (Casella & Motta, 1990; Gibb, 2002), although results are 
similar to those previously found within the chronic pain literature that did not 
demonstrate an increase in learned helplessness among participants with chronic pain 
(Ingram et al., 1990).  As the Attributional Style Questionnaire (ASQ; Peterson & 
Villanova, 1988) does not specifically target symptoms associated with PTSD and 
chronic pain populations, it is possible that responses to the ASQ scenarios do not 
generalize to real life experiences. 
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 Life experiences. If individuals with PTSD and chronic pain experience a general 
sense of uncontrollability and perceived inability to cope with negative life events, then it 
was hypothesized that the three clinical groups would report greater levels of negative 
life events, perception of stress over the past month, and intolerance of uncertainty.  
Results of the current study support the hypothesis that having a diagnosis of PTSD 
and/or chronic pain is associated with greater impact of negative life events than the 
control group.  When considering all four groups independently, results revealed that the 
PTSD and pain and PTSD only groups, in particular, reported significantly more negative 
impact ratings of stressful events than the control group.  Of particular interest, is that the 
control group was the only group that rated the average impact of their life events as 
being in the positive range.   
Previous research has demonstrated that PTSD or chronic pain populations are 
more likely to experience negative life events than individuals without these diagnoses 
(e.g., Naidoo & Pillay, 1994; Solomon, Zur-Noah, Horesh, Zerach, & Keinan, 2008).  
When assessing for the frequency of negative life events reported by participants in the 
current study, no significant group differences were demonstrated; however, participants 
in the PTSD and pain group did report the highest frequencies of negative life events, 
followed by the PTSD only, pain only, and control groups respectively.  These findings 
also provide preliminary support for the hypothesis that individuals with PTSD and 
chronic pain tend to report life events more negatively, which may suggest that they may 
experience greater difficulty in coping with these events for them to rate the impact of 
these events in this way.   
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 Stress. As mentioned above, it was hypothesized that participants in the three 
clinical groups would report greater perceptions of stress over the past month than the 
control group.  Planned comparisons indicated that the three clinical groups combined 
reported significantly greater perceptions of stress than the control group.  When 
considering the four groups independently, results revealed that the PTSD and pain group 
reported significantly higher perceptions of stress than the pain only and control groups.  
Although not significantly different from the pain only and control groups, the PTSD 
only group also reportedly similar levels of stress as the PTSD and pain group.  The high 
rates of general stress reported by participants with PTSD provides further support for 
previous research that has also indicated that individuals with PTSD tend to report high 
levels of stress (Fincham, Altes, Stein, & Seedat, 2009).  As a result, it appears as though 
having a co-morbid diagnosis of PTSD and pain is associated with the highest 
perceptions of stress over the past month, followed by the PTSD only, control, and pain 
only groups respectively.    
 Intolerance of Uncertainty.  It was also predicted that the three clinical groups 
would report higher levels of intolerance of uncertainty than the control group.  Planned 
comparisons between the three clinical groups and the control group did not indicate 
significant group differences in levels of this construct.  Similarly, analysis of the four 
groups independently did not demonstrate any significant group differences for 
intolerance of uncertainty.  As a result, it does not appear that intolerance of uncertainty 
plays a major role as a psychological vulnerability for either PTSD or chronic pain.  
These findings conflict with previous research that has demonstrated a relationship 
between intolerance of uncertainty and symptoms of anxiety (Kirby & Yardly, 2009).  
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Previous research has also demonstrated that uncertainty regarding illness within a 
fibromyalgia population was associated with increased difficulty in coping with 
symptoms of fibromyalgia (Johnson, Zautra, & Davis, 2006).  No known research studies 
have been found that directly assessed for the relationship between intolerance of 
uncertainty within PTSD or chronic pain populations.   
 Coping Strategies. Finally, it was predicted that  the clinical groups would report 
greater use of negative coping strategies than the control group.  Conversely, it was 
predicted that the control group would report greater use of positive coping strategies 
than the three clinical groups.  Coping strategies were assessed as both general use of 
coping strategies and coping strategies utilized in response to the experimental stressor.   
Planned comparisons of general coping strategies indicated that the three clinical 
groups combined reported significantly higher levels of self-blame than the control 
group.  However, planned comparisons did not indicate significant group differences in 
levels of denial, behavioral disengagement, active coping, positive reframing, or 
acceptance.  When each group was considered independently, results further indicated 
that the PTSD only group reported using significantly higher levels of self-blame coping 
than the pain only and control groups.  Although not significantly different from the 
control and pain only groups, the PTSD and pain group reported similar levels of self-
blame to that of the PTSD only group.  The pain only group actually reported the lowest 
levels of self-blame.  These results are similar to that of previous research that has not 
found an increase in self-blame within a chronic pain population that reported comorbid 
symptoms of depression (Lopez-Lopez, Montorio, Izal, & Velasco, 2008).  With regards 
to symptoms of PTSD, the current results support previous research that has found 
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symptoms of PTSD to be positively correlated with self-blame (e.g., Najdowski, & 
Ullman, 2009).   
When considering coping strategies in response to the experimental stressor, 
planned comparisons did not suggest any significant group differences in self-blame, 
behavioral disengagement, denial, acceptance, positive reframing, or active coping.  
Similar to that of general coping strategies that were reported, analysis of individual 
group differences demonstrated that participants in the PTSD only group reported higher 
levels of self-blame coping in response to the TSST than the pain only group, although 
this was only a marginal result.  The pain only group continued to report the lowest levels 
of self-blame when compared to the other three groups.  No other significant group 
differences in coping strategies were demonstrated in response to the experimental 
stressor.   
Overall, these findings suggest that individuals with PTSD are significantly more 
likely to utilize negative coping strategies such as self-blame than individuals who have 
chronic pain without PTSD.  No significant group differences were reported with regards 
to the use of positive coping strategies.  Furthermore, this trend held true when assessing 
for both general use of coping strategies and coping strategies utilized in response to the 
experimental stressor.  Thus, the current results support the potential role of negative 
coping strategies among individuals with chronic pain, although this trend was not 
supported for individuals with chronic pain without PTSD.  It is possible that analyses of 
group coping strategies were limited by the small sample size.   
 In summary, results of the current study suggest that PTSD may be associated 
with a generalized psychological vulnerability.  This was evident by greater perceptions 
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of stress over the past month, negative impact ratings of significant life events over the 
past year, and greater report of negative coping strategies (i.e., self-blame) than the pain 
only group.  The only indicator of a psychological vulnerability that was supported for 
the clinical group was the negative mean impact ratings of life events.  However, having 
a comorbid diagnosis of both PTSD and chronic pain appears to be associated with the 
greatest levels of stress and negative impact ratings of life events.  Similar to findings 
focusing on a generalized biological vulnerability, results of the current study suggest 
that having both diagnoses may maintain and even worsen symptoms experienced by 
these individuals.  The findings among the PTSD and pain group are not surprising as 
previous research has also demonstrated that comorbid diagnoses of PTSD and pain are 
associated with greater psychological distress and disability (Sherman et al., 2000). 
Specific Psychological Vulnerability 
According to Barlow (2002), a specific psychological vulnerability refers to the 
development of a learned alarm, which may occur after the experience of a traumatic 
event.  With regards to chronic pain, activities and sensations that are associated with the 
experience of pain may also serve as learned alarms (Asmundson et al., 1999; 
McCracken et al., 1993; Otis et al., 2003).  To assess for this vulnerability, the current 
study predicted that PTSD and chronic pain would be associated with learned alarms that 
are specific to the particular diagnosis.  It was hypothesized that participants in the PTSD 
and pain and PTSD only groups would report specific learned alarms associated with 
PTSD, while participants with chronic pain would report evidence of a learned alarm 
associated with chronic pain.  All three clinical groups were predicted to report higher 
levels of anxiety sensitivity than the control group. 
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 PTSD Related Anxiety. As expected, results of the current study suggested 
evidence of a related learned alarm among participants with PTSD.  This was indicated 
by higher levels of total PTSD related symptoms and symptoms of hyperarousal among 
participants with PTSD.  No significant group differences were reported for the intrusion 
and avoidance subscales of the IES-R.  All participants in the current study met DSM-IV 
diagnostic criteria for PTSD on a structured clinical interview, so it is likely that results 
of the current study were limited due to the small number of participants.  Despite this 
limitation, evidence for a PTSD specific learned alarm was still evident among 
participants with PTSD as opposed to those without PTSD. 
 Pain Related Anxiety. No significant group differences were demonstrated for 
total scores for pain-related anxiety.  Similarly, no significant group differences were 
demonstrated for the avoidance, cognitive, and physiological subscales of the PASS; 
however, near significant group differences were demonstrated for pain- related fear.  In 
particular, the PTSD and pain group reported the highest levels of pain- related fear, 
followed by the pain only group, PTSD only group, and control groups respectively.  
This suggests that significant group differences in pain- related fear would likely be 
evident with a larger sample size.  Given that participants in the PTSD and pain group 
reported the highest levels of pain- related fear, results of the current study provide 
preliminary support for the role of a learned alarm among individuals with chronic pain.  
Furthermore, it appears as though having a comorbid diagnosis of PTSD and chronic pain 
contributes to increased pain-related fear among this population.  It is possible that pain 
related fear is elevated within this group because symptoms of chronic pain may serve as 
a reminder of an individual’s traumatic event (Straub & Straub, 2009). 
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 Anxiety Sensitivity. With regards to anxiety sensitivity, planned comparisons 
between the three clinical groups and the control group did not demonstrate any 
significant group differences.  Analyses of individual group differences demonstrated that 
the PTSD and pain group reported significantly higher levels of anxiety sensitivity than 
the pain only group.  Although not significantly different, the PTSD only group reported 
the second highest levels of anxiety sensitivity, followed by the control and pain only 
groups respectively.  These results are in line with results of the current study given that 
participants with PTSD and chronic pain reported the highest levels of pain related fear.  
Previous research has also demonstrated that pain anxiety may be accounted for by 
anxiety sensitivity (Greenburg & Burns, 2003).  The relationship between anxiety 
sensitivity and PTSD has also been well established within the extant literature (Kilic et 
al., 2008; Taylor, 2004).  Overall, results of the current study support the potential role of 
anxiety sensitivity as a vulnerability for PTSD; however, results do not support the 
hypothesis that anxiety sensitivity serves as a vulnerability for chronic pain without 
PTSD.  Having comorbid diagnoses of PTSD and chronic pain appears to lead to greater 
self-reports of anxiety sensitivity for individuals with these diagnoses. 
 In summary, preliminary evidence for a specific learned alarm associated with 
PTSD was demonstrated.  This was evidenced by total PTSD related symptoms and 
symptoms of hyperarousal.  Similarly, preliminary evidence for a specific learned alarm 
among participants with chronic pain was also demonstrated.  Although there was only a 
marginal significant difference, the PTSD and pain group reported the highest levels of 
pain related fear, followed by the pain only, PTSD only, and control groups respectively.  
Finally, results did not support the role of anxiety sensitivity in all three clinical groups; 
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however, the PTSD and pain group reported significantly higher levels of anxiety 
sensitivity than the pain only group.   
Summary of Findings 
The purpose of the current study was to test aspects of the triple vulnerability 
model (Barlow, 2000; Barlow, 2002; Otis et al., 2003) in PTSD and chronic 
musculoskeletal pain populations.  This model proposed that individuals have a 
generalized biological vulnerability (e.g., inherited personality traits that lead individuals 
to react to environmental stressors in a defensive manner), generalized psychological 
vulnerability (e.g., sense of uncontrollability and perceived inability to cope), and a 
specific psychological vulnerability (e.g., development of learned alarms) to develop both 
PTSD and chronic pain (Barlow, 2000; Barlow, 2002; Keane & Barlow, 2002; Otis et al., 
2003).  PTSD and chronic pain may also serve as a reminder of each other, which may 
maintain and worsen symptoms of each condition (Otis et al., 2003).   
Results of the current study do not provide support for the hypothesis that PTSD 
and chronic pain have a similar biological vulnerability to respond to stressful situations 
with an alarm reaction; however, initial support for the role of a biological vulnerability 
for individuals with PTSD to respond to stressful situations with an alarm reaction was 
demonstrated.  This was evident by participants’ anxiety reactivity, heightened symptoms 
of depression, and self-reported family histories of PTSD.  Participants with chronic pain 
also reported significantly higher family history rates of chronic pain, although measures 
of anxiety and depression were not heightened in the pain only group.  No significant 
results were demonstrated with cortisol analyses, so additional research is needed to 
assess for cortisol reactivity in both populations.  As hypothesized, participants with 
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comorbid PTSD and chronic pain reported the highest levels of anxiety in response to the 
experimental stressor.  This group also reported high levels of depression.  As a result, it 
may be possible certain vulnerabilities may exist for PTSD to initially develop, and that 
having both diagnoses may serve to worsen and maintain symptoms experienced by this 
population.  This result also supports, Otis and colleagues’ contention that PTSD and 
chronic pain may maintain and worsen symptoms of each condition (Otis et al., 2003).   
 Preliminary support for a generalized psychological vulnerability among 
participants with PTSD was demonstrated.  This was evident by greater perceptions of 
stress over the past month, negative impact ratings of significant life events over the past 
year, and greater report of negative coping strategies (i.e., self-blame) than the pain only 
group.  Having a diagnosis of chronic pain was only associated with negative mean 
impact ratings of life events when combined with the other clinical groups.  Having both 
PTSD and chronic pain is associated with the greatest levels of stress and negative impact 
ratings of life events.  As such, results of the current study further suggest that having 
both conditions may maintain and potentially worsen psychological symptoms 
experienced by these individuals.   
 Preliminary evidence for a specific learned alarm associated with PTSD was 
demonstrated.  Participants with PTSD reported higher total PTSD related symptoms and 
symptoms of hyperarousal.  Preliminary evidence for a specific learned alarm among 
participants with chronic pain was also demonstrated.  Although there was only a 
marginal significant difference, the PTSD and pain group reported the highest levels of 
pain related fear, followed by the pain only, PTSD only, and control groups respectively.  
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Finally, the PTSD and pain group reported significantly higher levels of anxiety 
sensitivity than the pain only group.   
 Overall, results of the current study support the role of a generalized biological, 
generalized psychological, and specific psychological vulnerabilities toward developing 
PTSD.  Limited findings have supported the potential role of these vulnerabilities toward 
developing chronic pain; however, results of these measures were not similar to that of 
PTSD (e.g., family history of chronic pain).  As such, it is not thought that PTSD and 
chronic pain are associated with the same vulnerabilities.  Across many measures, having  
PTSD and chronic pain was associated with an increase in symptoms.  At this point in 
time, it is thought that having both diagnoses may serve to maintain and possibly worsen 
symptoms experienced by this population. 
Study Limitations 
 There are several limitations associated with the current study.  Small sample 
sizes may have limited the ability to find significant group differences.  Due to 
difficulties with recruiting participants, women were recruited from both community and 
student populations.  As a result, participants in the PTSD only and control groups were 
significantly younger than those in the pain only group.  Conflicting results have been 
found regarding whether or not there are differences in cortisol reactivity across the 
lifespan (Gotthardt et al., 1995; Kudielka et al., 1999; Kudielka et al., 2000; Kudielka et 
al., 2004).  This may have increased variability in both cortisol levels and self-report 
measures, although no significant group differences in cortisol were demonstrated when 
age was utilized as a covariate.  It is also possible that undergraduate students may 
respond differently to stressful situations than the general population.   
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 Due to financial constraints, salivary cortisol was the only indicator of stress 
reactivity in the HPA axis that was measured.  The current results may have been limited 
by not assessing for other changes in the HPA axis (e.g., CRH, ACTH, DHEA).  
Variability in stress reactivity may also have been increased by including participants 
who were both premenopausal and postmenopausal.  In an attempt to control for this, 
participants who were premenopausal were scheduled during the premenstrual phase of 
their menstrual cycle; however, this may not have eliminated all variability (Kudielka et 
al., 2004).  Similarly, an inability to control for use of oral contraceptives may have 
influenced cortisol analyses (Kirschbaum et al., 1999). 
 Significant group differences were also demonstrated with regards to body mass 
index.  In particular, the pain only group had significantly higher BMI ratings than the 
PTSD only and control groups.  It is possible that BMI may have influenced cortisol 
reactivity, although this is unlikely given that previous research has not demonstrated 
significant group differences between obese and non-obese women with regards to 
cortisol reactivity in response to the TSST (Therrien et al., 2010). 
 Participants in the current study were primary Caucasian females.  This may limit 
generalizability of study results to other racial and ethnic groups.  Ability to generalize 
results to male populations may be limited as well.  
 The use of the TSST as a stress inducing event may not have been stressful 
enough to induce levels of cortisol across all populations.  Although all groups reportedly 
perceived the TSST as being a moderately stressful event on the VASS, it is concerning 
that the control group did not demonstrate an increase in cortisol levels following the 
TSST as has been reported in previous research (e.g., Kirschbaum et al., 1993).  It is also 
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possible that levels of cortisol in the control group were influenced by other axis I 
diagnoses that were not ruled out (Young, Abelson, & Cameron, 2004). Individual 
differences in raters for the TSST may have also influenced cortisol levels for the control 
group. Male and female raters were used but approximately 10 different sets of raters 
were used in the current study. In addition, college students may be less reactive to a 
stress task given IRB requirements regarding harm and previous experience with 
psychological experiments. 
 Due to the constraints of the current study, no formal medical chart review was 
conducted to confirm chronic pain diagnoses.  Although the current study attempted to 
limit variability within the chronic pain groups by only including participants with 
chronic musculoskeletal pain, it is possible that including participants with different types 
of musculoskeletal pain could have influenced cortisol reactivity.  Similarly, the current 
study was unable to account for type of traumatic events among participants with PTSD.  
It is possible that this may have also influenced cortisol reactivity among these 
participants (Meewisse et al., 2007).  Participants with differential conditions of PTSD 
and or chronic pain may also have varying sleep-wake schedules.  Although time of day 
was controlled for in the current study, it is possible that variations in sleep-wake cycles 
may have influenced cortisol reactivity (e.g., Neylan, Otte, Yehuda, Marmar, 2006). 
 Finally, participants in the current study appeared to be relatively high functioning 
when demographic information was examined (e.g., education, family income).  
Individuals who experience more severe levels of PTSD and chronic pain may have been 
less likely to respond to recruitment efforts.  Approximately 50% - 60% of participants 
who completed the initial phone screening did not show up for their laboratory visit.  
  127     
   
   
 
Several efforts were made to reschedule these participants, however many of them never 
participated.  It is unknown if severity in symptoms of PTSD, chronic pain, or disability 
may have played a role in these individuals not showing up for their research 
appointment. 
Future Directions 
 Additional research will be needed to further assess for the role of biological and 
psychological factors that may influence the high comorbidity rates of PTSD and chronic 
pain.  It is likely that study analyses were limited due to the small number of participants 
and high variability among several of the factors.  As such, a larger sample size would 
likely be beneficial.  Furthermore, future research will be needed to generalize study 
findings to other populations (e.g., male, racial/ethnic minorities). 
 The current study was only able to assess for salivary cortisol reactivity due to 
financial constraints.  It will be helpful for future research to assess for the role of other 
hormones in the HPA axis in attempt to obtain a complete picture of HPA axis 
functioning.  Although it would be extremely difficult, longitudinal data is needed to 
determine the temporal course of cortisol reactivity, in addition to other biological and 
psychological markers, before and after experiencing a traumatic event.  Changes in pain 
sensitivity before and after experiencing a stressful event would also provide interesting 
information regarding the effects of daily stressors on chronic pain.   
 Finally, the current study provides preliminary support for several indicators of 
biological and psychological vulnerabilities toward developing PTSD and/or chronic 
pain.  Results also indicate that having comorbid diagnoses of PTSD and chronic pain is 
associated with increased symptoms on many of the measures utilized in this study.  As 
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such, it will be imperative for future research to consider treatment implications for 
individuals with both diagnoses.  It would be interesting to investigate if symptoms of 
chronic pain lessen when symptoms of PTSD are treated.  Furthermore, preventative 
efforts should be developed that address the potential vulnerabilities demonstrated in the 
current study. 
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APPENDICES 
 Appendix A 
CONSENT FORMS 
 
Traumatic Events and Chronic Pain 
Informed Consent Form – Community Participants 
 
Because you are a female 18 years of age or older, and you responded to recruitment 
efforts, you are invited to participate in a research project investigating the relationship 
between posttraumatic stress disorder (PTSD) and chronic musculoskeletal pain.  This 
study is being conducted by Anna Cassel, a graduate student in the Psychology 
department at the University of Maine, and is being supervised by Dr. Sandy Sigmon, a 
professor in the Psychology department at the University of Maine. 
 
How do I qualify for this study? 
 
• You have already responded to some brief questions over the phone.   
• Next, you will be asked to come into the lab to answer some questions from a 
diagnostic interview (e.g., In the past six months, have you felt particularly nervous or 
anxious?). 
• You will also be asked to draw the location of your pain on a human figure and answer 
a few brief questions regarding your pain condition. 
• There are four ways that you may qualify for this study: 
• Meet diagnostic criteria for PTSD without a chronic pain condition (PTSD group) 
• Meet diagnostic criteria for PTSD and chronic musculoskeletal pain (PTSD and pain 
group) 
• Meet diagnostic criteria for chronic musculoskeletal pain without PTSD (pain group) 
• Never had a diagnosis of either PTSD or chronic pain 
 
What does this study involve? 
 
• If you qualify based on information that you have given regarding the initial phone 
screening criteria, you will be scheduled to come into the lab at the University of Maine.  
During this visit, you will be asked to answer further questions (discussed above) to 
confirm your eligibility for this study.  It is estimated that it will take approximately 60 
minutes for this portion of the study.  Next, you will complete two mentally challenging 
tasks.  Following the challenging tasks, you will be asked to stay for an additional hour.  
During the last 20 minutes of this hour, you will listen to some relaxing music.  Saliva 
samples and pain sensitivity will be assessed at various points throughout a 90 minute 
period.  Overall, it is estimated that the laboratory visit will take approximately 2 to 2.5 
hours. 
 • Levels of pain sensitivity will be measured using a device that will apply a small 
 amount of pressure on to your thumb.  You will be asked to report when you first 
 perceive symptoms of pain.   
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• Salivary cortisol samples will be collected using a plastic tube.  You will be 
asked to drool into the plastic tube. 
 
• Following the completion of your laboratory visit, you will be asked to complete a 
packet of questionnaires.  Questionnaires may be completed on surveymonkey.com, or 
you may be given a packet of questionnaires with a return envelope.  It is estimated that it 
will take approximately 45 minutes to complete the packet of questionnaires.  You will 
be asked questions about: 
• Your reactions to various situations and life events (e.g., “You confront a 
serious conflict in your values”) 
 • Life experiences (e.g., “Serious injury or Illness”) 
 • Coping strategies (e.g., “I've been expressing my negative feelings”) 
 • Symptoms associated with a stressful experience (“Pictures about it popped into 
 my mind”) 
• Symptoms associated with the experience of pain (e.g., “I think that if my pain 
gets too severe, it will never decrease”) 
 • Symptoms of anxiety (e.g., “It is important to me not to appear nervous”) 
 • Feelings of uncertainty (e.g., “I can’t stand being taken by surprise”) 
• Feelings of stress (e.g., “In the past month, how often have you felt that you 
were unable to control the important things in your life?”) 
 • Symptoms of depression (e.g., “I am so sad or unhappy that I can’t stand it.”) 
 • Basic demographic questions (e.g., “Current household income”) 
 
Voluntary 
 
Your participation in this research project is voluntary.  You have the right to withdraw 
from this study at any point.  You may also choose to not answer any question that you 
do not feel comfortable answering.  If you do withdraw from the study, then you will be 
compensated for the parts of the study that you participated in. 
 
Are there any potential risks? 
 
In previous research, any risk associated with participating in the mentally challenging 
tasks has not been any greater than what you would normally encounter in your daily life.  
While measuring pain sensitivity, you may temporarily experience a minimal level of 
pain.  This method of measuring pain sensitivity has been used in previous research 
studies with no other adverse side effects being reported.  There are no known risks 
associated with collecting and analyzing the saliva samples.  No identifying information 
is sent with the samples when they are analyzed.  In addition, there have been no long 
lasting effects of completing questionnaires included in this study.  All questionnaires 
and tasks utilized in this study have been used in previous research with no reported 
negative effects.  You may, however, experience some discomfort when answering 
questions that involve stressful events or situations.  Anna Cassel (the principal 
investigator) and Dr. Sandy Sigmon (her supervisor) will be available to talk with you if 
you would like to discuss this discomfort.  You may also request referral information for 
psychological services at any time. 
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Potential risks associated with completing online questionnaires on SurveyMonkey.com 
are thought to be no greater than those encountered during routine access of the internet. 
SurveyMonkey.com has taken precautions to secure the website and protect its users 
from fraud or compromised confidentiality.  In addition, they will not utilize customers’ 
data for their own purposes 
 
What are the benefits of participating in this study? 
 
Your responses may help us to gain a better understanding of the relationship between 
chronic pain and PTSD.  You will receive $20 for completing participation in this study.  
If you do not qualify for participation, then you will receive $5 for the diagnostic 
interview.  You may also be eligible to participate in a free treatment study. This 
treatment study will involve treatment for individuals who are still bothered by traumatic 
events that have happened to them. You will have the option of participating or not in this 
treatment study. The treatment consists of learning new skills in how to deal with 
recurring thoughts and images that you may be bothered with. 
 
Will my answers be confidential? 
 
Your participation and all of your answers will be confidential. All study materials will 
be stored in Dr. Sigmon’s locked laboratory.  You will be assigned a participant number 
for the study that will be written on all information that you give us.  A list that contains 
your identifying information will be stored in a separate location.  This list will be 
destroyed after the study is completed.  Your answers will only be used for research 
purposes.  If any data becomes published or presented at a conference, then all of your 
answers will remain anonymous and be compiled in a group format. The data will be kept 
in Dr. Sigmon’s lab for an indefinite period of time. 
 
Who do I contact if I have any questions? 
 
In the event that you have any questions regarding this study, you may contact Anna 
Cassel (581-2030, 301 Little Hall, Orono, ME, 04469 or by email: 
anna.cassel@umit.maine.edu) or her advisor, Dr. Sandy Sigmon (581-2049, 376 Little 
Hall, Orono, ME, 04469 or by email: sandra.Sigmon@umit.maine.edu).  In the event that 
you have questions regarding your right as a research participant, you may contact Gayle 
Anderson who is the Assistant to the Protection of Human Subjects Review Board (581-
1498, 114 Alumni Hall, Orono, ME, 04469, or by email: 
gayle.anderson@umit.maine.edu). 
 
If you would like a copy of the results of this study when it is completed, please indicate 
below.  Also, please indicate if you would like to be contacted regarding the free 
treatment study. 
 
You will receive a copy of this consent form. 
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Participant Signature: ______________________________ Date: ________________ 
 
Print Name Here: _________________________________ Phone: _______________ 
 
Please indicate if you would like a summary of study results: _____ yes  _____ no 
 
Would you like to be contacted regarding the free treatment study? _____ yes  _____ no 
 
If you would like the results of this study, please write down your permanent address: 
 
________________________________________________________________________ 
 
________________________________________________________________________ 
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Traumatic Events and Chronic Pain 
Informed Consent Form – Student Version 
 
Because you are a female 18 years of age or older, and you responded to recruitment 
efforts, you are invited to participate in a research project investigating the relationship 
between posttraumatic stress disorder (PTSD) and chronic musculoskeletal pain.  This 
study is being conducted by Anna Cassel, a graduate student in the Psychology 
department at the University of Maine, and is being supervised by Dr. Sandy Sigmon, a 
professor in the Psychology department at the University of Maine. 
 
How do I qualify for this study? 
 
• You have already responded to some brief questions over the phone.   
• Next, you will be asked to come into the lab to answer some questions from a 
diagnostic interview (e.g., In the past six months, have you felt particularly nervous or 
anxious?). 
• You will also be asked to draw the location of your pain on a human figure and answer 
a few brief questions regarding your pain condition. 
• There are four ways that you may qualify for this study: 
• Meet diagnostic criteria for PTSD without a chronic pain condition (PTSD 
group) 
• Meet diagnostic criteria for PTSD and chronic musculoskeletal pain (PTSD and 
pain group) 
• Meet diagnostic criteria for chronic musculoskeletal pain without PTSD (pain 
group) 
 • Never had a diagnosis of either PTSD or chronic pain 
 
What does this study involve? 
 
• If you qualify based on information that you have given regarding the initial phone 
screening criteria, you will be scheduled to come into the lab at the University of Maine.  
During this visit, you will be asked to answer further questions (discussed above) to 
confirm your eligibility for this study.  It is estimated that it will take approximately 60 
minutes for this portion of the study.  Next, you will complete two mentally challenging 
tasks.  Following the challenging tasks, you will be asked to stay for an additional hour.  
During the last 20 minutes of this hour, you will listen to some relaxing music.  Saliva 
samples and pain sensitivity will be assessed at various points throughout a 90 minute 
period.  Overall, it is estimated that the laboratory visit will take approximately 2 to 2.5 
hours. 
 • Levels of pain sensitivity will be measured using a device that will apply a small 
 amount of pressure on to your thumb.  You will be asked to report when you first 
 perceive symptoms of pain.   
• Salivary cortisol samples will be collected using a plastic tube.  You will be 
asked to drool into the plastic tube. 
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• Following the completion of your laboratory visit, you will be asked to complete a 
packet of questionnaires.  Questionnaires may be completed on surveymonkey.com, or 
you may be given a packet of questionnaires with a return envelope.  It is estimated that it 
will take approximately 45 minutes to complete the packet of questionnaires.  You will 
be asked questions about: 
• Your reactions to various situations and life events (e.g., “You confront a 
serious conflict in your values”) 
 • Life experiences (e.g., “Serious injury or Illness”) 
 • Coping strategies (e.g., “I've been expressing my negative feelings”) 
 • Symptoms associated with a stressful experience (“Pictures about it popped into 
 my mind”) 
• Symptoms associated with the experience of pain (e.g., “I think that if my pain 
gets too severe, it will never decrease”) 
 • Symptoms of anxiety (e.g., “It is important to me not to appear nervous”) 
 • Feelings of uncertainty (e.g., “I can’t stand being taken by surprise”) 
• Feelings of stress (e.g., “In the past month, how often have you felt that you 
were unable to control the important things in your life?”) 
 • Symptoms of depression (e.g., “I am so sad or unhappy that I can’t stand it.”) 
 • Basic demographic questions (e.g., “Current household income”) 
 
Voluntary 
 
Participation in this research project is voluntary.  You have the right to withdraw from 
this study at any point.  You may also choose to not answer any question that you do not 
feel comfortable answering.  If you do withdraw from the study, then you will be 
compensated for the parts of the study that you participated in.  You will receive 1 credit 
for completing the initial interview, 1 credit for participation in the mentally challenging 
tasks, 1 credit for remaining in the lab for an additional hour while saliva samples are 
collected, and then 1 credit for completing the questionnaires. 
 
Are there any potential risks? 
 
In previous research, any risk associated with participating in the mentally challenging 
tasks has not been any greater than what you would normally encounter in your daily life.  
While measuring pain sensitivity, you may temporarily experience a minimal level of 
pain.  This method of measuring pain sensitivity has been used in previous research 
studies with no other adverse side effects being reported.  There are no known risks 
associated with collecting and analyzing the saliva samples.  No identifying information 
is sent with the samples when they are analyzed.  In addition, there have been no long 
lasting effects of completing questionnaires included in this study.  All questionnaires 
and tasks utilized in this study have been used in previous research with no reported 
negative effects.  You may, however, experience some discomfort when answering 
questions that involve stressful events or situations.  Anna Cassel (the principal 
investigator) and Dr. Sandy Sigmon (her supervisor) will be available to talk with you if 
you would like to discuss this discomfort.  You may also request referral information for 
psychological services at any time. 
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Potential risks associated with completing online questionnaires on SurveyMonkey.com 
are thought to be no greater than those encountered during routine access of the internet. 
SurveyMonkey.com has taken precautions to secure the website and protect its users 
from fraud or compromised confidentiality.  In addition, they will not utilize customers’ 
data for their own purpose. 
 
What are the benefits of participating in this study? 
 
Your responses may help us to gain a better understanding of the relationship between 
chronic pain and PTSD.  You will receive 5 credits for completing participation in this 
study.  If you do not qualify for participation, then you will receive 1 credit for the 
diagnostic interview.  If you do qualify for the study, you will receive 1 credit for 
completing the diagnostic interview, 1 credit for participation in the mentally challenging 
tasks, 1 credit for remaining in the lab for an additional hour while saliva samples are 
collected, and then 1 credit for completing the questionnaires.  You may also be eligible 
to participate in a free treatment study. This treatment study will involve treatment for 
individuals who are still bothered by traumatic events that have happened to them. You 
will have the option of participating or not in this treatment study. The treatment consists 
of learning new skills in how to deal with recurring thoughts and images that you may be 
bothered with. 
 
Will my answers be confidential? 
 
Your participation and all of your answers will be confidential. All study materials will 
be stored in Dr. Sigmon’s locked laboratory.  You will be assigned a participant number 
for the study that will be written on all information that you give us.  A list that contains 
your identifying information will be stored in a separate location.  This list will be 
destroyed after the study is completed.  Your answers will only be used for research 
purposes.  If any data becomes published or presented at a conference, then all of your 
answers will remain anonymous and be compiled in a group format. The data will be kept 
in Dr. Sigmon’s lab for an indefinite period of time. 
 
Who do I contact if I have any questions? 
 
In the event that you have any questions regarding this study, you may contact Anna 
Cassel (581-2030, 301 Little Hall, Orono, ME, 04469 or by email: 
anna.cassel@umit.maine.edu) or her advisor, Dr. Sandy Sigmon (581-2049, 376 Little 
Hall, Orono, ME, 04469 or by email: sandra.Sigmon@umit.maine.edu).  In the event that 
you have questions regarding your right as a research participant, you may contact Gayle 
Anderson who is the Assistant to the Protection of Human Subjects Review Board (581-
1498, 114 Alumni Hall, Orono, ME, 04469, or by email: 
gayle.anderson@umit.maine.edu). 
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If you would like a copy of the results of this study when it is completed, please indicate 
below.  Also, please indicate if you would like to be contacted regarding the free 
treatment study. 
 
You will receive a copy of this consent form. 
 
Participant Signature: ______________________________ Date: ________________ 
 
Print Name Here: __________________________________Phone: ______________ 
 
Please indicate if you would like a summary of study results: _____ yes  _____ no 
 
Would you like to be contacted regarding the free treatment study? _____ yes  _____ no 
 
If you would like the results of this study, please write down your permanent address: 
 
________________________________________________________________________ 
 
________________________________________________________________________ 
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Appendix B 
 
SHORT SCREENING SCALE FOR DSM-IV PTSD 
 
1. Did you avoid being reminded of this experience by staying away from certain places, 
people, or activities? (REMIND RESPONDENT OF LIFE EVENT IF NECESSARY.) 
 
1. YES 
2. NO 
 
2. Did you lose interest in activities that were once important or enjoyable? (REMIND 
RESPONDENT OF LIFE EVENT IF NECESSARY.) 
 
1. YES 
2. NO 
 
3. Did you begin to feel more isolated or distant from other people? (REMIND 
RESPONDENT OF LIFE EVENT IF NECESSARY.) 
 
1. YES 
2. NO 
 
4. Did you find it hard to have love or affection for other people? (REMIND 
RESPONDENT OF LIFE EVENT IF NECESSARY.) 
 
1. YES 
2. NO 
 
5. Did you begin to feel that there was no point in planning for the future? (REMIND 
RESPONDENT OF LIFE EVENT IF NECESSARY.) 
 
1. YES 
2. NO 
 
6. After this experience, were you having more trouble than usual falling asleep or 
staying asleep? (REMIND RESPONDENT OF LIFE EVENT IF NECESSARY.) 
 
1. YES 
2. NO 
 
7. Did you become jumpy or get easily startled by ordinary noises or movements?  
(REMIND RESPONDENT OF LIFE EVENT IF NECESSARY.) 
 
1. YES 
2. NO 
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Appendix C 
 
MPQ 
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Appendix D 
 
EXPANDED ASQ 
  
Interpretations of Events 
 
Please try to imagine yourself in the situations that follow.  If such a situation happened 
to you, what would you feel would have caused it?  While events may have many causes, 
we want you to pick only one—The MAJOR CAUSE IF THIS EVENT HAPPENED TO 
YOU. 
 
Please write the cause in the blank provided after each event.  Next we want you to 
answer three questions about the cause you provided.  First, is the cause of this event 
something about you or something about other people or circumstances?  Second, is the 
cause of this event something that will persist across time or something that will never 
again be present?  Third, is the cause of this event something that affects all situations in 
your life or something that just affects this type of event? 
 
To summarize, we want you to:  
 
 1. Read each situation and vividly imagine it happening to you. 
 
 2. Decide what you feel would be the one major cause of the situation if it  
                happened to you. 
 
 3. Write the cause in the blank provided. 
 
 4. Answer three questions about the cause. 
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1. You have been looking for a job unsuccessfully for some time. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people  or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
2. A friend comes to you with a problem, and you don’t try to help. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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3. You give an important talk in front of a group, and the audience reacts negatively. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
4. You meet a friend who acts hostilely to you.   
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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5. You can’t get all the work done that others expect of you.  
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
6. You go out on a date, and it goes badly. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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7. Your stead romantic relationship ends. 
 
 A. Write down one major cause:  
 
 
 B. Is the cause of this due to something about you or something about other 
people or  circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
8. You experience a major personal injury. 
 
 A. Write down one major cause:  
 
 
 B. Is the cause of this due to something about you or something about other 
people or  circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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9. You are found guilty of a minor violation of the law. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
10. You and your family have a serious argument. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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11. You are fired from your job. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
12. After your first term at school, you are on academic probation. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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13. Your best friend tells you that you are not to be trusted. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
14. You have a lot of trouble understanding what your new employer requires of you. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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15. You cannot sleep soundly. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
16. You experience sexual difficulties. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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17. You confront a serious conflict in your values. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
18. Your roommate tells you he/she is switching to a room down the hall. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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19. There are few recreational activities in which you are interested. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
20. Your holiday vacation plans are cancelled. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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21. You have trouble with one of your instructors. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
 
22. You experience financial difficulties.  
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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23. Your attempt to capture the interest of a specific person of the opposite sex is a 
failure. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
 
 
24. You feel sick and tired all of the time. 
 
 A. Write down one major cause:  
 
 
B. Is the cause of this due to something about you or something about other 
people or circumstances?  (circle one number) 
 
 totally due        totally due 
 to others 1 2 3 4 5 6 7 to me 
 
 C. In the future, will this cause be present again?  (circle one number) 
 
 never         always 
 present  1 2 3 4 5 6 7 present 
 
 D. Is this cause something that affects just this type of situation, or does it also 
 influence other areas of your life?   (circle one number) 
 
 just this        all 
 situation 1 2 3 4 5 6 7 situations 
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Appendix E 
 
LIFE EXPERIENCES SURVEY 
 
Listed below are a number of events which sometimes bring about change in the lives of those 
who experience them and which necessitate social readjustment.  For events that have happened 
to you in the past year, please indicate the extent to which you viewed the event as having either 
a positive or negative impact on your life (by putting a number from -3 to +3 in the blank 
space).  That is, indicate the type and extent of impact that the event had.  A rating of -3 would 
indicate an extremely negative impact.  A rating of 0 suggests no impact either positive or 
negative.  A rating of +3 would indicate an extremely positive impact.  Then put a checkmark (√) 
to indicate when in your lifetime that the event occurred (either in the past year, or in your 
lifetime) 
   -3                   -2                    -1                   0                   +1                     +2                    +3 
Extremely   Moderately    Somewhat      No            Slightly        Moderately       Extremely 
  negative      negative     negative           impact           positive            positive            positive 
 
Past                                                                          Past          
Impact Event  year   Lifetime  Impact  Event                          year    Lifetime 
1.  Marriage  ____ ____  13. Changed work   
2.  Detention in jail or    situation (different work  
Comparable institution ____ ____  responsibility, major change 
3. Death of Spouse ____ ____  in working conditions,  
4. Major change in    working hours, etc.)  ____ ____ 
sleeping habits (much    14. New Job   ____ ____ 
more or much less    15. Serious illness or injury 
sleep)   ____ ____  of close family member: ____ ____ 
5. Death of close family ____ ____       a. father   ____ ____ 
     a. mother  ____ ____       b. mother   ____ ____ 
     b. father  ____ ____       c. sister   ____ ____ 
     c. brother  ____ ____       d. brother   ____ ____ 
     d. sister  ____ ____       e. grandfather  ____ ____ 
     e. grandmother ____ ____       f. grandmother  ____ ____ 
     f. grandfather ____ ____       g. spouse   ____ ____ 
     g. other (specify) ____ ____       h. other (specify)  ____ ____ 
6.  Major change in eating    16. Sexual difficulties  ____ ____ 
Habits (much more or    17. Trouble with employer 
less food intake) ____ ____  (in danger of losing job, 
7.  Foreclosure on    being suspended, demoted, etc.) ____ ____ 
Mortgage or loan ____ ____  18. Trouble with in-laws ____ ____ 
8.  Death of close friend ____ ____  19. Major change in 
9.  Outstanding personal   financial status (a lot better 
achievement  ____ ____  or a lot worse off)  ____ ____ 
10. Minor law violations   20. Major change in closeness 
(traffic tickets,      of family members 
disturbing the peace,    (increased or decreased)  ____ ____ 
etc.)   ____ ____  21. Gaining a new family member 
11. Male: Wife/girlfriend’s   (through birth, adoption, family 
pregnancy  ____ ____  member moving in, etc.) ____ ____ 
12. Female: Pregnancy ____ ____  22. Change in residence  ____ ____ 
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   -3                   -2                    -1                   0                   +1                   +2                   +3 
Extremely   Moderately     Somewhat     No            Slightly       Moderately    Extremely 
 negative       negative       negative        impact             positive          positive         positive 
     Past                                                                            Past          
Impact Event       year   Lifetime Impact Event                   year    Lifetime 
 
23. Marital separation    38. Divorce    ____ ____  
mate (due from to conflict)  ____     ____ 39. Serious injury or illness 
24. Major change in church    (you or to a close friend) ____ ____ 
activities (increased or    40. Retirement from work ____ ____ 
decreased attendance)       ____      ____ 41. Son or daughter leaving 
25. Martial reconciliation   home    ____ ____ 
with mate        ____      ____ 42. Ending of formal schooling ____ ____ 
26. Major change in number   43. Separation from spouse 
of arguments with     (due to work, travel, etc.) ____ ____ 
spouse (a lot more or a     44. Engagement  ____ ____ 
lot less arguments)       ____       ____ 45. Breaking up with boyfriend 
27. Married male: Change   or girlfriend   ____ ____ 
in wife’s work outside     46. Leaving home for the 
the home (beginning work,   first time   ____ ____ 
ceasing work, change to a    47. Reconciliation with 
new job, etc.)        ____       ____ boyfriend/girlfriend  ____ ____ 
28. Married female: Change   48. Beginning a new school 
in husband’s work, (loss   experience at a higher academic 
of job, beginning a new job,   level (college, graduate school,  
retirement, etc.)        ____       ____ professional school, etc.) ____ ____ 
29. Major change in usual   49. Changing to a new school 
type and/or amount of    at same academic level 
recreation        ____       ____  (undergraduate, graduate, etc.) ____ ____ 
30. Borrowing more than   50. Academic probation  ____ ____ 
$10,000 (buying car, TV,   51. Being dismissed from dormitory 
getting school loan, etc.)      ____       ____ or other residence  ____ ____ 
31. Borrowing less than    52. Failing an important exam ____ ____ 
$10,000 (buying car, TV,   53. Changing a major  ____ ____ 
getting school loan, etc.)       ____       ____  54. Failing a course  ____ ____ 
32. Being fired from a job     ____       ____ 55. Dropping a course  ____ ____ 
33. Male: Wife/girlfriend   56. Joining a fraternity/ sorority ____ ____ 
having an abortion        ____        ____ 57. Financial problems concerning 
34. Female: having an    school (in danger of not having 
abortion         ____        ____ sufficient money to continue) ____ ____ 
35. Major personal       
illness or injury         ____        ____ Other recent experiences which have had an impact 
36. Major change in social   on your life. List and rate. 
activities, e.g. parties,     58. _____________________ ____ ____ 
movies, visiting     59. _____________________ ____ ____ 
(increased or decreased)        ____        ____ 60. _____________________ ____ ____ 
37. Major change in living 
conditions of family (building new home, remodeling,  
deterioration of home, neighborhood, etc.) ____ _____ 
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Appendix F 
BRIEF COPE 
These items deal with ways you've been coping with the stress in your life.  There are 
many ways to try to deal with problems.  These items ask what you've been doing to cope 
with this one.  Each item says something about a particular way of coping.  I want to 
know to what extent you've been doing what the item says – How much or how 
frequently.  Don't answer on the basis of whether it seems to be working or not—just 
whether or not you're doing it.  Use these response choices.  Try to rate each item 
separately in your mind from the others.  Make your answers as true FOR YOU as you 
can.  
                    1   2      3                            4 
       I haven’t been      I’ve been doing             I’ve been doing          I’ve been doing 
      doing this at all       this a little bit       this a medium amount             this a lot 
 
1.  _____ I've been turning to work or other activities to take my mind off things.  
2.  _____ I've been concentrating my efforts on doing something about the situation I'm       
in. 
3.  _____ I've been saying to myself "this isn't real. 
4.  _____ I've been using alcohol or other drugs to make myself feel better. 
5.  _____ I've been getting emotional support from others. 
 
 6.  _____ I've been giving up trying to deal with it.  
 7.  _____ I've been taking action to try to make the situation better.  
 8.  _____ I've been refusing to believe that it has happened.  
 9.  _____ I've been saying things to let my unpleasant feelings escape.  
10. _____ I’ve been getting help and advice from other people.  
 
11.  _____ I've been using alcohol or other drugs to help me get through it.  
12.  _____ I've been trying to see it in a different light, to make it seem more positive.  
13.  _____ I’ve been criticizing myself.  
14.  _____ I've been trying to come up with a strategy about what to do.  
15.  _____ I've been getting comfort and understanding from someone.  
 
16.  _____ I've been giving up the attempt to cope.  
17.  _____ I've been looking for something good in what is happening.  
18.  _____ I've been making jokes about it.  
19.  _____ I've been doing something to think about it less, such as going to movies,  
                 watching TV, reading, daydreaming, sleeping, or shopping.  
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20.  _____ I've been accepting the reality of the fact that it has happened.  
21.  _____ I've been expressing my negative feelings.  
22.  _____ I've been trying to find comfort in my religion or spiritual beliefs.  
23.  _____ I’ve been trying to get advice or help from other people about what to do.  
24.  _____ I've been learning to live with it.  
 
25.  _____ I've been thinking hard about what steps to take.  
26.  _____ I’ve been blaming myself for things that happened.  
27.  _____ I've been praying or meditating.  
28.  _____ I've been making fun of the situation.  
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Appendix G 
 
IES – REVISED 
 
Instructions: The following is a list of difficulties people sometimes have after stressful 
life events.  Please read each item, and then indicate how distressing each difficulty has 
been for you during the past 7 days with respect to __________.  How much were you 
distressed or bothered by these difficulties? 
 
              Not at     A little     Moderately     Quite     Extremely 
     All            bit                   a bit 
1. Any reminder brought back 0        1        2        3              4 
    feelings about it. 
 
2. I had trouble staying asleep. 0        1  2        3              4 
 
3. Other things kept making me 0        1  2        3         4 
    think about it. 
 
4. I felt irritable and angry.  0        1  2        3   4 
 
5. I avoided letting myself get 0        1  2        3   4 
    upset when I thought about it  
    or was reminded of it. 
 
6. I thought about it when  0        1  2        3   4 
    I didn’t mean to. 
 
7. I felt as if it hadn’t happened 0         1  2        3   4 
    or wasn’t real. 
 
8. I stayed away from reminders 0         1  2        3   4 
    about it. 
 
9. Pictures about it popped  0         1  2        3   4 
    into my mind. 
 
10. I was jumpy and easily startled. 0         1  2        3   4 
 
11. I tried not to think about it. 0         1  2        3   4 
 
12. I was aware that I had  0         1  2        3   4 
      a lot of feelings about it,  
      but I didn’t deal with them. 
13. My feelings about it were  0         1  2        3   4 
      kind of numb. 
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              Not at     A little     Moderately     Quite     Extremely 
     All            bit                   a bit 
14. I found myself acting or  0        1  2        3   4 
      feeling like I was back at that time. 
 
15. I had trouble falling asleep. 0        1  2        3   4 
 
16. I had waves of strong  0        1  2        3   4 
      feelings about it. 
 
17. I tried to remove it from  0        1  2        3   4 
      my memory. 
 
18. I had trouble concentrating. 0        1  2        3   4 
 
19. Reminders of it caused me 0        1  2        3   4 
      to have physical reactions, 
      such as sweating, trouble breathing,  
      nausea, or pounding heart. 
 
20. I had dreams about it.  0        1  2        3   4 
 
21. I felt watchful and on guard. 0        1  2        3   4 
 
22. I tried not to talk about it.  0        1  2        3   4  
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Appendix H 
 
PAIN ANXIETY SYMPTOM SCALE 
 
PASS-20 
 
 
 
 
 
 
 
Individuals who experience pain develop different ways to respond to that pain.  We would like 
to know what you do and what you think about when in pain.  Please use the rating scale 
below to indicate how often you engage in each of the following thoughts or activities.  Circle 
any number from 0 (NEVER) to 5 (ALWAYS) for each item.   
1.  
I think that if my pain gets too severe, 
 it will never decrease  
0 1 2 3 4 5 
2.  
When I feel pain I am afraid that something 
 terrible will happen 
0 1 2 3 4 5 
3.  
I go immediately to bed when I feel severe pain 
 
0 1 2 3 4 5 
4.  
I begin trembling when engaged in activity that  
increases pain 
0 1 2 3 4 5 
5.  
I can’t think straight when I am in pain  
 
0 1 2 3 4 5 
6.  
I will stop any activity as soon as I sense pain 
 coming on 
0 1 2 3 4 5 
7.  
Pain seems to cause my heart to pound or race 
 
0 1 2 3 4 5 
8.  
As soon as pain comes on I take medication to  
reduce it 
0 1 2 3 4 5 
9.  
When I feel pain I think that I may be seriously ill 
 
0 1 2 3 4 5 
 NEVER                                    ALWAYS 
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10.  
During painful episodes it is difficult for me to  
think of anything else besides the pain 
 
0 1 2 3 4 5 
11.  
I avoid important activities when I hurt 
 
0 1 2 3 4 5 
12.  
When I sense pain I feel dizzy or faint 
 
0 1 2 3 4 5 
13.  
Pain sensations are terrifying  
 
0 1 2 3 4 5 
14.  
When I hurt I think about the pain constantly 
 
0 1 2 3 4 5 
15.  
Pain makes me nauseous (feel sick)  
 
0 1 2 3 4 5 
16.  
When pain comes on strong I think I might become  
paralyzed or more disable 
0 1 2 3 4 5 
17.  
I find it hard to concentrate when I hurt 
 
0 1 2 3 4 5 
18.  
I find it difficult to calm my body down after periods of 
pain 0 1 2 3 4 5 
19.  
I worry when I am in pain 
 
0 1 2 3 4 5 
20.  
I try to avoid activities that cause pain 
 
0 1 2 3 4 5 
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ASI 
 
Respond to each item by indicating the number of the phrase which best represents the 
extent to which you agree with the item.  If any of the items address something that is not 
part of your experience (i.e., "it scares me when I feel shaky" for someone who has never 
trembled or had the "shakes"), answer on the basis of how you think you might feel if you 
had such an experience.  Otherwise answer all items on the basis of your own experience.  
Be careful to make only one choice for each item and please answer all items. 
 
0  1  2  3  4 
     Very Little        A Little            Some                Much          Very Much 
 
 
______  1. It is important to me not to appear nervous. 
 
______  2. When I cannot keep my mind on a task, I worry that I might be going  
   crazy. 
______  3. It scares me when I feel "shaky" (trembling). 
 
______  4. It scares me when I feel faint. 
 
______  5. It is important to me to stay in control of my emotions. 
 
______  6. It scares me when my heart beats rapidly. 
 
______  7. It embarrasses me when my stomach growls. 
 
______  8. It scares me when I am nauseous. 
 
______  9. When I notice that my heart is beating rapidly, I worry that I might have a  
   heart attack. 
______  10. It scares me when I am short of breath. 
 
______  11. When my stomach is upset, I worry that I might be seriously ill. 
 
______  12. It scares me when I am unable to keep my mind on a task. 
 
______  13. Other people notice when I feel shaky. 
 
______  14. Unusual body sensations scare me. 
 
______  15. When I am nervous, I worry that I might be mentally ill. 
 
______  16. It scares me when I am nervous. 
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Appendix J 
 
IUS-12 
 
Please rate each item based on the following scale. 
 
Not at all                  Entirely 
     characteristic of me                   characteristic of me 
 
                 1                 2      3       4        5 
 
____ 1. Unforeseen events upset me greatly. 
 
____ 2. It frustrates me not having all the information I need. 
 
____ 3. One should always look ahead so as to avoid surprises. 
 
____ 4. A small, unforeseen event can spoil everything, even with the best of planning. 
 
____ 5. I always want to know what the future has in store for me. 
 
____ 6. I can’t stand being taken by surprise. 
 
____ 7. I should be able to organize everything in advance. 
 
____ 8. Uncertainty keeps me from living a full life. 
 
____ 9. When it’s time to act, uncertainty paralyses me. 
 
____ 10. When I am uncertain I can’t function very well. 
 
____ 11. The smallest doubt can stop me from acting. 
 
____ 12. I must get away from all uncertain situations.  
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Appendix K 
 
POMS SCALE 
 
Directions:  Below is a list of words that describe feelings that people have.  Please read 
each one carefully.  Then select the number that best describes HOW YOU FEEL 
RIGHT NOW.  Place that number on the small line to the left of each word.  Do not skip 
any items, and print your numbers clearly. 
 
     0  =  Not at all 
     1  =  A little 
     2  =  Moderately 
     3  =  Quite a bit 
     4  =  Extremely 
 
     _____ 1.  Tense      _____ 13. Restless 
     _____ 2.  Unhappy     _____ 14. Discouraged 
     _____ 3.  Sorry for things done    _____ 15. Nervous 
     _____ 4.  Shaky      _____ 16. Lonely 
     _____ 5.  Sad      _____ 17. Miserable 
     _____ 6.  On edge      _____ 18. Anxious 
     _____ 7.  Blue      _____ 19. Gloomy  
     _____ 8.  Panicky      _____ 20. Desperate  
     _____ 9.  Hopeless      _____ 21. Helpless 
    _____ 10. Relaxed       _____ 22. Worthless  
    _____ 11. Unworthy      _____ 23. Terrified  
    _____ 12. Uneasy       _____ 24. Guilty  
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Appendix L 
 
VISUAL ANALOG STRESS SCALE 
 
Please rate the level of stress you felt during the task. 
 
1-------------2-------------3-------------4-------------5-------------6--------------7 
   Not at all                              Moderately                             Extremely  
    stressed                                 stressed                                         stressed 
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PERCEIVED STRESS SCALE 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate how often you felt or thought a certain 
way. Although some of the questions are similar, there are differences between them and 
you should treat each one as a separate question. The best approach is to answer each 
question fairly quickly. That is, don’t try to count up the number of times you felt a 
particular way, but rather indicate the alternative that seems like a reasonable estimate. 
For each question, choose from the following alternatives:  
 
0------------------1------------------2----------------3------------------4 
    Never Almost Never      Sometimes      Fairly Often        Very Often 
 
 
____ 1. In the very last month, how often have you been upset because of something that  
 happened unexpectedly?  
            
____ 2. In the last month, how often have you felt that you were unable to control the  
 important things in your life? 
 
____ 3. In the last month, how often have you felt nervous and “stressed”? 
 
____ 4. In the last month, how often have you dealt successfully with irritating life  
 hassles? 
 
____ 5. In the last month, how often have you felt that you were effectively coping with  
 important changes that were occurring in your life? 
 
____ 6. In the last month, how often have you felt confident about your ability to handle  
 your personal problems? 
  
____ 7. In the last moth, how often have you felt that things were going your way? 
 
____ 8. In the last month, how often have you found that you could not cope with all the  
 things that you had to do? 
 
____ 9. In the last month, how often have you been able to control irritations in your life? 
 
____ 10. In the last month, how often have you felt that you were on top of things? 
 
____ 11. In the last month, how often have you been angered because of things that  
happened that were outside of your control?  
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____ 12. In the last month, how often have you found yourself thinking about things that  
    you have to accomplish? 
 
____ 13. In the last month, how often have you been able to control the way you spend  
    your time? 
 
____ 14. In the last month, how often have you felt difficulties were piling up so high  
    that you could not overcome them?  
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BDI-II 
 
Instructions:  This questionnaire consists of 21 groups of statements.  Please read each 
group of statements carefully, and then pick out the one statement in each group that 
best describes the way you have been feeling during the past two weeks, including 
today.  Circle the number beside the statement you have picked.  If several statements in 
the group seem to apply equally well, circle the highest number for that group.  Be sure 
that you do not choose more than one statement for any group, including Item 16 
(Changes in Sleeping Pattern) or Item 18 (Changes in Appetite). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.  Sadness 
  0   I do not feel sad. 
  1   I feel sad much of the time. 
  2   I am sad all the time. 
  3   I am so sad or unhappy that I can't stand it. 
 
2.  Pessimism 
  0   I am not discouraged about my future. 
  1   I feel more discouraged about my future than I used  to be. 
  2   I do not expect things to work out for me. 
  3   I feel my future is hopeless and will only get worse. 
 
3.  Past Failure 
  0   I do not feel like a failure. 
  1   I have failed more than I should have. 
  2   As I look back, I see a lot of failures. 
  3   I feel I am a total failure as a person. 
 
4.  Loss of Pleasure 
  0   I get as much pleasure as I ever did from the things I  
       enjoy. 
  1   I don't enjoy things as much as I used to. 
  2   I get very little pleasure from the things I used to enjoy. 
  3   I can't get any pleasure from the things I used to enjoy. 
 
5.  Guilty Feelings 
  0   I don't feel particularly guilty. 
  1   I feel guilty over many things I have done or should  
       have done. 
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Appendix K 
 
Debriefing Statement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.  Self-Criticalness 
  0   I don't criticize or blame myself more than usual 
  1   I am more critical of myself than I used to be. 
  2   I criticize myself for all of my faults. 
  3   I blame myself for everything bad that happens. 
 
9.  Suicidal Thoughts or Wishes 
  0   I don't have any thoughts of killing myself. 
  1   I have thoughts of killing myself, but I would not carry         
       them out. 
  2   I would like to kill myself. 
  3   I would kill myself if I had the chance. 
 
10.  Crying 
  0   I don't cry anymore than I used to. 
  1   I cry more than I used to. 
  2   I cry over every little thing. 
  3   I feel like crying, but I can't. 
 
11.  Agitation 
  0   I am no more restless or would up than usual. 
  1   I feel more restless or wound up than usual. 
  2   I am so restless or agitated that it's hard to stay still. 
  3   I am so restless or agitated that I have to keep moving 
or doing something. 
 
12.  Loss of Interest 
  0   I have not lost interest in other people or activities. 
  1   I am less interested in other people or things than  
       before. 
                 
            
 
   
             
               
                        
         
  192   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15.  Loss of Energy 
  0   I have as much energy as ever. 
  1   I have less energy than I used to have. 
  2   I don't have enough energy to do very much. 
  3   I don't have enough energy to do anything. 
 
16.  Changes in Sleeping Pattern 
  0   I have not experienced any change in my  sleeping pattern.  
  1a I sleep somewhat more than usual. 
  1b I sleep somewhat less than usual.  
  2a I sleep a lot more than usual. 
  2b I sleep a lot less than usual  
  3a I sleep most of the day. 
  3b I wake up 1-2 hours early and can't get back to sleep. 
 
17.  Irritability 
  0   I am no more irritable than usual. 
  1   I am more irritable than usual. 
  2   I am much more irritable than usual.
  3   I am irritable all the time. 
 
18.  Changes in Appetite 
  0   I have not experienced any change in my appetite. 
  1a My appetite is somewhat less than usual. 
  1b My appetite is somewhat greater than usual. 
  2a My appetite is much less than before. 
  2b My appetite is much greater than usual. 
  3a I have no appetite at all. 
  3b I crave food all the time. 
 
19   Concentration Difficulty 
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Appendix O 
 
DEMOGRAPHICS PAGE 
 
Date: __________________ 
 
Age: __________________ 
 
Race: __________________ 
 
Highest Educational Attainment:  _______________ 
 
Current Household Income (circle one): 
 
Under 10,000  10,000-19,999  20,000-29,999 
 
30,000-39,999  40,000-49,999  50,000-59,999 
 
Greater than 60,000  
 
Relationship Status (circle one): 
 
Single  Living with partner  Married 
 
Divorced Widowed Separated 
 
Current medications: _____________________________________________________ 
 
Are you currently taking any form of birth control medications?  _____ yes _____no 
 
If so, which one? _________________________________ 
 
Weight: ____________  
 
Height: ____________ 
 
Please indicate the actual date of your last menstrual cycle, in other words, what 
was the date when you began blood flow (e.g., April 15, 2006). 
 
________________________ 
 
Do you have a family history of posttraumatic stress disorder? _____ yes _____ no 
 
Do you have a family history of chronic pain? _____ yes _____ no 
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DEBRIEFING STATEMENT 
 
Assessing a Biopsychosocial Model for PTSD and Chronic Pain 
Debriefing Statement 
 
 The purpose of this study was to look at aspects of a biopsychosocial model that 
has been proposed to account for the relationship between PTSD and chronic pain.  Four 
groups of women were assessed in this study: women with posttraumatic stress disorder 
(PTSD) without chronic pain, women with musculoskeletal pain without PTSD, women 
with both musculoskeletal pain and PTSD, and women who no not have a diagnosis of 
either PTSD or chronic pain.   
 
 During the course of this study, participants were asked to prepare and give a 
speech about a dream job, and why they would be the perfect applicant for this job.  
Participants were told that they would be giving the speech in front of two “managers” 
that are trained to monitor nonverbal behavior.  These “managers” were actually research 
assistants who did not have any training in monitoring nonverbal behavior.  In addition, 
the videotape was not recording during the speech.  Participants then began a 5 minute 
mental arithmetic task, where they were instructed to serially subtract 13 from 1,022 as 
quickly and accurately as possible for a five minute period.  The purpose of these tasks 
was to induce stress.  Participants were also asked to complete questionnaires regarding 
their thoughts and feelings.  In addition, salivary cortisol samples were collected.  
Cortisol is a hormone in your body that is released in response to stress.  These samples 
were taken to see how participants in each group responded to the stressful event, and to 
see how long it will take their body to return to their original level of cortisol following 
the stress event.  Below is a list of hypotheses that are being assessed in this study: 
 
Study hypotheses: 
 
1. Individuals who have either PTSD, chronic pain, or both conditions will have 
lower  initial levels of cortisol levels before the experimental stressor, and 
blunted (i.e. lower) salivary cortisol levels following the experimental stressor. 
 
2. Individuals in all groups will experience symptoms of depression and anxiety on a 
continuum.  Individuals with PTSD and pain group are anticipated to report the 
highest depressive and anxiety symptomatology (both at baseline and in response 
to the experimental stressor), followed by individuals with only PTSD or chronic 
pain.  Participants in the control group are anticipated to report to least depressive 
and anxiety symptomatology.   
 
3. Individuals who have either PTSD, chronic pain, or both conditions will be more 
likely to make to internal, stabile, and global attributions about events than 
individuals in the control group. 
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4. Individuals who have either PTSD, chronic pain, or both conditions will be more 
likely to report negative life events and general levels of self-perceived stress.  
Subsequently,  these individuals will also be more likely to view ambiguous 
situations as more threatening than individuals in the control group. 
 
5. Individuals who have either PTSD, chronic pain, or both conditions will be more 
likely to use negative coping strategies (i.e., denial, behavioral disengagement, 
self-blame) than individuals in the control group.   
 
6. Individuals who have PTSD or chronic pain and PTSD will be more likely to 
report  symptoms of PTSD.  Similarly, individuals with chronic pain or PTSD 
and chronic pain will be more likely to report anxiety associated with their pain 
condition.   
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